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CHAPTER I 
INTRODUCTION AND REVIEW OF THE RELATED LITERATURE 
1. Endogenous Sources of 
Cholesterol 
I. CHOLESTEROL 
A. Cholesterol 
Cholesterol shown in figure 1 is formed from two carbon units pro-
vided by acetyl CoA. Cholesterol synthesis begins by the condensation 
of two acetyl CoA molecules to acetoacetyl CoA, which is catalyzed by 
acetoacetyl CoA thiolase. The next step for cholesterol synthesis cata-
lyzed by HMG CoA synthase involves the formation of 3-hydroxy-3-methyl 
glutaryl CoA from acetoacetyl CoA. Mevalonic acid is then produced by 
hydrolysis of the thiol ester bond which is catalyzed by the enzyme HMG 
CoA reductase. Mevalonic acid in a series of reactions forms farnesyl 
pyrophosphate a 15 carbon compound, which fuses with another molecule of 
farnesyl pyrophosphate to form squalene a process which is catalyzed by _ 
squalene synthetase. A hydroxyl group is added to the squalene molecule 
at the C-3 position in the beta stereochemical configuration by squalene 
oxidocyclase which also catalyzes the cyclization of squalene to lanes-
terol. Lanosterol after a few other modifications becomes the 27 carbon 
cholesterol with a hydroxyl group at the 3 beta position and a 5,6 car-
bon double bond (Bloch, 1965). 
1 
2 
The rate determining step for cholesterol synthesis has been shown 
to be the conversion of a hydroxy-a methyl glutaryl coenzyme A to meval-
onic acid and the regulatory enzyme responsible for this conversion is 
mevalonate:NADP oxidoreductase (acylating CoA), EC 1.1.1.34 (Nomencla-
ture Committee, 1979) better known as HMG CoA reductase. Feeding rats 
high cholesterol diets has been shown to inhibit the conversion of a 
hydroxy-a methyl glutaryl coenzyme A to mevalonic acid (Frantz et al., 
1954; Siperstein et al., 1960). In addition, a pronounced reduction in 
HMG CoA reductase activity was also noted when rats were fed cholesterol 
(Shefer et al., 1973). Bile acids appeared to be necessary for the 
decrease in HMG CoA reductase activity found in rat liver, but may only 
play a secondary role to that of cholesterol concentration. The mecha-
nism of cholesterol's feedback regulation of HMG CoA reductase activity 
appears to be very complex since not only is activity, but also quantity 
of HMG CoA reductase affected by increasing sterol concentrations 
(Rodwell et al., 1976). A preference for absorbed cholesterol over that 
of endogenous production in the liver has been observed and postulated 
to be due to the more ready availability to the liver of chylomicron 
remnants containing cholesterol (Nervi et al., 1974). This may be true 
for other tissues as well, since extrahepatic tissue cholesterol synthe-
sis appears to be regulated by cholesterol carried to the tissues "from 
the blood by lipoproteins (see section II.C.4. LDL Catabolism). The 
precise mechanism for cholesterol feedback inhibition on HMG CoA reduc-
tase is as yet unknown. 
Endogenous sources of cholesterol include almost every cell in the 
3 
animal, since virtually every tissue is capable of synthesizing 
cholesterol (Dietschy et al., 1967), yet the bulk of endogenous choles-
terol of both human and rat is synthesized in the liver (Dietschy et 
al., 1971; Turley et al., 1981b). Studies have indicated that 50% of 
endogenous cholesterol in the rat is derived from the liver, 24% in the 
small bowel, 8% from the skin and 18% from the remaining tissues (Turley 
et al., 1981a). Unfortunately, cholesterol biosynthesis in rat tissues 
was determined using the digitonin precipitation method for unesterified 
sterols (Sperry, 1950), which was recently found to include methyl ster-
ols that coprecipitated with the unesterified sterols. The rate of cho-
lesterol biosynthesis determined using the digitonin precipitation tech-
nique may appear to be faster than what is actually occurring. The 
inaccuracy of the cholesterol biosynthesis determination would be due to 
the inclusion of methyl sterols as well as the desired unesterified 
sterol in the assay (Tabicik et al., 1983). Although the method for 
determining the rate and amount of cholesterol biosynthesis for each 
tissue may be of uncertain accuracy, the relative percents of choles-
terol synthesis for each tissue, should be good rough estimates (Turley 
et al., 1981a). Moreover, despite the methodology used to determine tis-
sue cholesterol biosynthesis it has been clearly demonstrated that the 
bulk of endogenous cholesterol synthesis occurs in the liver and small 
bowel of both rats and humans (Jeske et al., 1980). 
Cholesterol is ubiquitous in the mammalian system, but certain 
tissues synthesize the cholesterol required for self maintenance while 
other tissues receive cholesterol requirements from circulating plasma 
4 
lipoproteins. The contribution of many rat tissues to their own 
cholesterol content and also the contribution of circulating lipoprotein 
cholesterol to tissue cholesterol content have been determined. Brain, 
ovary, skin, muscle and marrow were found to produce greater than 75% of 
their own cholesterol content. The adrenal produced only 4% of its own 
sterol content, the spleen 6%, the heart 28%, kidney 26% and lung 17%. 
Cholesterol not produced by the tissue is obtained from circulating 
plasma lipoproteins (Andersen et al., 1979; Turley et al., 1981a; 
198lb). 
2. Exogenous Sources of 
Cholesterol 
Diet and bile are the two major sources of cholesterol in the 
intestine (Grundy, 1978). Cholesterol intake from an American diet has 
been found to average between 500-750 mg per day while biliary excretion 
of cholesterol averages between 750-1250 mg per day (Bennion et al., 
1975; Grundy, 1972). Other sources of intestinal cholesterol include 
degraded intestinal cells and intestinal secretions, although their con-
tributions to the total pool of cholesterol within the intestine have 
been difficult to assess (Miettinen et al., 1981). It has been deter-
mined that only 30-60~~ of cholesterol present in the human intestine is 
absorbed (Quintao et al., 1971). Moreover, the rat's ability to absorb 
cholesterol has also been demonstrated to be between 30-60% of the cho-
lesterol present in the intestine (Cook et al., 1951; Pihl, 1955). 
Cholesterol absorption is limited by its solubilization into 
micelles (Hofman et al., 1964) and only unesterified cholesterol can be 
5 
solubilized into these micelles, therefore cholesteryl esters present in 
the diet are hydrolyzed in the intestine and converted to unesterif ied 
cholesterol and free fatty acids by carboxylic-ester hydro lase, EC 
3.1.1.13 (Nomenclature Committee, 1979), a nonspecific lipase secreted 
from the pancreas (Lombardo, et al., 1980). In addition, micelle forma-
tion has been shown to require conjugated bile acids and hydrolytic 
products of triglycerides, lecithin (phosphatidyl choline), fatty acids, 
monoglycerides and lysolecithin (Hofman et al., 1964). Therefore, cho-
lesterol absorption has been found to be dependent on the intraluminal 
availability of bile acids and hydrolytic products of dietary fat (Pihl, 
1955; Swell et al., 1955). 
Cholesterol is absorbed by intestinal mucosal cells. Maximum 
absorption has been demonstrated to occur in the upper intestine where 
the micelles facilitate transport of cholesterol across the unstirred 
water layer adjacent to the surface of the luminal cell (Simmonds et 
al., 1967; Westergaard et al., 1976). Bolar lipids necessary for cho-
lesterol solubilization have also been found to be almost quantitatively 
absorbed at the proximal part of the small intestine (Simmonds et al., 
1967), so cholesterol would precipitate within the lumen of the small 
intestine when the polar lipid concentration needed to solubilize cho-
lesterol decreases (Simmonds et al., 1967), even though bile acids· are 
mainly absorbed in the distil portion of the small intestine (Weiner et 
al., 1968). However, a high fat diet would allow the polar lipids to 
remain in the micelle longer, thus increasing cholesterol absorption. 
Cholesterol absorption into the intestinal cell is believed to occur 
when the cholesterol containing micelle collides with the intestinal 
cell membrane and disaggregates following which bile salts and choles-
terol diffuse across the membrane passively. The entire micelle would 
not be absorbed intact and those portions of the micelle not absorbed 
would be excreted in the feces (Chow et al., 1978; Schultz et al., 
1971). 
6 
Intraluminal intestinal cholesterol is mostly unesterified, yet 
more esterified than unesterified cholesterol has been found in the 
intestinal lymph (Gallo et al., 1963). Microsomal acyl coenzyme A cho-
lesterol acyltransferase, EC 2.3.1.21 (Nomenclature Committee, 1979), 
also known as ACAT, has been shown to be responsible for the formation 
of cholesteryl esters within the intestinal mucosal cell (Haugen et al., 
1976). Unesterified cholesterol and cholesteryl esters have been found 
to be secreted into the mesenteric lymph after being incorporated into 
lipoproteins known as chylomicrons (Sabesin, 1976). Chylomicrons are 
then metabolized by an enzyme known as 1-ipoprotein lipase into chylomi-
cron remnants, which are taken up by the liver (Fielding et al., 1977). 
Chylomicron synthesis and catabolism will be covered in greater detail 
in a later section (see section II.C. Lipoprotein Synthesis and Metabo-
lism). 
7 
B. Cholesterol Distribution 
1. Membrane and Intracellular 
Cholesterol has three major functions in mammalian organisms: (1) 
It is a required structural component of the plasma membrane of all 
cells. (2) It is the precursor for steroid hormones. (3) It is the 
precursor of bile acids (Havel et al., 1980). The unesterified choles-
terol of tissues is found exclusively in the cell membrane, whereas 
excess intracellular unesterif ied cholesterol is esterif ied by ACAT and 
stored within the cell as a liquid cholesterol ester crystal (Brown et 
al., 1975c). Plasma cholesterol on the other hand, is found within sub-
stances known as lipoproteins. 
2. Plasma Lipoprotein 
Lipoproteins transport nonpolar lipids through the plasma. Lipo-
proteins are large macromolecular complexes which are pseudomicellar 
(Havel, 1975). Analysis of the correlations between size and chemical 
composition of lipoproteins in normal humans indicated lipoproteins are 
spherical, surrounded by a monolayer of cholesterol and phospholipids. 
Proteins appear to be closely packed with the hydrophilic head groups of 
phospholipids at the outer surface of the lipoprotein molecule. Hydro-
phobic ends of phospholipids and cholesterol surround and seem to be 
packed tightly at a liquid core of cholesteryl ester and triglyceride. 
The correlations between size and chemical composition of lipoproteins 
also indicated that sharply defined boundaries exist between the hydro-
phobic core and the amphipathic layer surrounding it. Proteins appear 
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to be at the same surface layer as the phospholipid head groups compet-
ing for that surface area. Also, the location of all unesterified cho-
lesterol may be under the protein layer with the alcohol group in direct 
contact with protein and not the surrounding plasma water. Moreover, 
the analysis indicates that all lipoproteins regardless of size, have an 
identical structure. (Shen et al., 1977). However, studies using 
nuclear magnetic resonance suggested that unesterif ied cholesterol rap-
idly exchanges between the core and surface of lipoproteins (Lund-Katz 
et al., 1981). In addition, 40% of the lipoprotein unesterified choles-
terol appeared to exist in the core of the molecule, while 60% appears 
to be present on the surface of the molecule associated with phospholi-
pids. Moreover, the the nuclear magnetic resonance study implied that 
more than 90% of lipoprotein-unesterified cholesterol molecules belong 
to a single kinetic pool, from which they could be available for 
exchange with cholesterol molecules in cells or other lipoproteins 
(Lund-Katz et al., 1984). 
1. Bile and Sloughed 
Intestinal Cells 
C. Cholesterol Clearance 
The main mode of cholesterol excretion has been demonstrated.to be 
via the bile and is dependent on bile salt secretion (Hardison et. al., 
1972; Wheeler, 1972). Unesterified cholesterol is dissolved within the 
bile and bile is formed by cholesterol catabolism, therefore cholesterol 
is excreted from the liver into the intestine in two forms. Moreover, 
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the bulk of the cholesterol which appears in the bile either in the form 
of bile acids or as unesterified cholesterol was found by one study to 
be derived from the liver of rats (Turley, et al., 1981b). However, it 
has been suggested that the major source of bile acids in man is from 
lipoprotein-cholesterol (Schwartz et al., 1981). Sloughed cells and 
secretions from the intestine as mentioned previously are also involved 
in cholesterol excretion, but it has been difficult to determine to what 
extent (Miettinen et al., 1981). 
2. Skin 
Skin surface sterols are a mixture derived both from local synthe-
sis and from the plasma. Therefore, cholesterol has been found to be 
lost from the hair, desquamated cells, sweat and sebaceous secretions, 
which makes skin the second major source for cholesterol excretion in 
the human (Nikkari et al., 1974). 
3. Urine 
Studies on humans have shown that cholesterol is excreted in the 
urine, but in very small amounts of about 1 mg/24 hr, except during 
pregnancy where it can go up to 70 mg/24 hr. (Vela et al., 1969). Uri-
nary excretion however, was not related to plasma cholesterol levels 
(Acevedo et al., 1973) and therefore could not be a major route of" cho-
lesterol excretion. 
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4. Milk 
Another form of cholesterol secretion limited to the female of 
mammalian species is through the milk. Human milk cholesterol content 
has been determined to be 20 mg/dl (Macy et al., 1953), while rat milk 
cholesterol content has been determined to be between 25-65 mg/dl 
(Clarenburg et al., 1966; Reiser et al;, 1972). The sources of choles-
terol in milk may be from the diet, mammary gland synthesis and from 
endogenous synthesis other than the mammary gland. The cholesterol con-
tent of milk in the rat can be increased by cholesterol feeding (Reiser 
et al., 1972) and an estimated 11% of milk cholesterol comes from 
dietary cholesterol, which was determined in rats on a 0.05% cholesterol 
diet (Clarenburg et al., 1966). 
5. Hormone Production 
The adrenal glands, ovaries and testes convert cholesterol to 
steroid hormones. As indicated previously, the ovary was found to pro-
duce over 75% of its own cholesterol requirement, whereas the adrenal 
gland only produced about 4% (Turley et al., 1981a;1981b). The addi-
tional cholesterol required was supplied by plasma lipoproteins. Stud-
ies performed on rats have indicated that when plasma cholesterol 
decreases, adrenal gland cholesterol synthesis increases and the intra-
cellular stores of cholesteryl ester decrease (Andersen et al., 1976). 
The process can be reversed by raising the plasma cholesterol level 
through the infusion of cholesterol carrying lipoproteins 
(Balasubramaniam et al., 1977). Therefore, the low adrenal gland choles-
terol synthesis activity has been postulated to be due to the.adrenal 
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gland receiving its cholesterol requirements from plasma lipoproteins. 
Rat high density lipoprotein (see section II.A.1. Methodological Classi-
fication) appears to be the principle supplier of cholesterol to the 
adrenal gland (Andersen et al., 1976; 1977). Moreover, high density 
lipoprotein binds with high affinity to the rat testes and appears to be 
the main exogenous source of cholesterol to that organ (Andersen et al., 
1977;1978; Chen et al., 1980) however, a high amount of HMG CoA reduc-
tase activity is also present in the rat testes, so most of the choles-
terol needed for steroid hormone synthesis is produced endogenously and 
not supplied by high density lipoprotein. In addition, low density 
lipoprotein appeared to bind with high affinity to human fetal testes 
and bovine corpus luteum indicating that high density lipoprotein as a 
source of cholesterol to gonadal tissue may be species specific (Brown 
etal., 1979). 
Cholesterol homeostasis in human steroid hormone producing cells 
has been postulated to consist of four stages. The first stage being 
the basal stage, when the cell produces hormone at a steady state. The 
cell has a large storage supply of cholesteryl ester and plasma lipopro-
tein-cholesterol is received by lipoprotein receptors (see section 
II.C.4. LDL Catabolism). ID1G CoA reductase activity is also at a steady 
state. The second stage occurs when the.gland receives stimulation to 
increase steroid output, as when ACTH stimulates the adrenal gland. 
Unesterif ied cholesterol is produced by the hydrolysis of esterified 
cholesterol present within the cell and HMG CoA reductase is stimulated 
into producing more unesterified cholesterol for steroid hormone synthe-
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sis. The third stage is reached upon prolonged stimulation of hormone 
production, when the intracellular cholesteryl ester stores are 
depleted, the bulk of cholesterol for hormone production is obtained 
from the plasma by increasing the number of receptors on the cell sur-
face for plasma lipoproteins. filtG CoA reductase activity then becomes 
inhibited by the increased plasma cholesterol input to the cell and 
endogenous synthesis of cholesterol decreases. The fourth stage occurs 
at the end of hormone production stimulation as the cell goes back to 
the basal state. Lipoprotein receptors decrease and cholesteryl esters 
accumulate within the cell until the cell is back to the first stage 
condition (Brown et al., 1979). Although hormone production is a major 
function of cholesterol, it does not appear to be a major source for 
plasma cholesterol clearance, due to the availability of intracellular 
stores and intracellular synthesis of cholesterol in steroid hormone 
producing cells. 
1. Methodological 
Classification 
II. LIPOPROTEINS 
A. Lipoprotein Classification 
Nomenclature of the various classes of lipoproteins is dependent 
on the method of isolation and characterization of the lipoprotein 
classes. Alaupovic (1980) proposed two types of lipoprotein nomencla-
tures (1) operational and (2) chemical. Operational nomenclature is 
dependent on the method of separation of the various lipoprotein 
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classes. The nomenclature for electrophoretic separation would include 
lipoproteins remaining at the origin called origin lipoproteins, alpha1 
lipoproteins are those lipoproteins which migrate in the alpha1-globulin 
fraction and alpha2 lipoproteins are those which migrate in the 
alpha2-globulin fraction, while beta lipoproteins migrate in the beta-
globulin fraction. 
Nomenclature based on hydrated density for human lipoproteins 
would include chylomicrons with densities less than 0.94 g/ml, very low 
density lipoproteins (VLDL) with density greater than 0.94 g/ml and less 
than 1.006 g/ml, low density lipoproteins (LDL) have densities between 
1.006-1.063 g/ml, high density lipoproteins (HDL) have a density range 
from 1.063-1.210 g/ml and very high density lipoproteins (VHDL) have a 
density greater than 1.210 g/ml. Two subtractions of HDL isolated from 
human plasma are HDL2 and HDL3 which have densities of 1.063-1.125 and 
1.125-1.210 g/ml respectively (Nicoll et al., 1980b). Ultracentrifuga-
tion has also allowed for the identification of other subtractions of 
the major classes of lipoproteins such as HDL2a' HDL2b (see section 
II.B.1. Ultracentrifugation), HDL1 and HDLc (see section II.D. Rat Lipo-
protein) (Lindgren, 1979). 
2. Lipoprotein Families 
Chemical nomenclature is based on the concept that plasma lipopro-
teins consist of lipoprotein families or particles which are character-
ized by distinct apolipoproteins. Lipoprotein families are present as 
free, separable forms or association complexes. Lipoprotein families 
are polydisperse and display antigenic homogeneity. Apolipoprqteins are 
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designated by capital letters; constitutive polypeptides by Roman numer-
als; and the polymorphic forms of apolipoproteins or polypeptides by 
Arabic numbers. Examples of this nomenclature are as follows: The apo-
lipoprotein A (apo A) family consists of two polypeptides A-I and A-II 
and the apolipoprotein C (apo C) family has three polypeptides C-I, C-II 
and C-III, whereas apolipoprotein B (apo B), apolipoprotein D (apo D), 
apolipoprotein E (apo E) and apolipoprotein F (apo F) are believed to 
consist of only one polypeptide each (Alaupovic, 1980). Throughout this 
dissertation lipoproteins will be referred to primarily by operational 
nomenclature with mention of the constitutive substances as necessary. 
B. Methodologies for Lipoprotein Separation 
1. Ultracentrifugation 
Isolation of soluble lipoprotein of constant composition was first 
accomplished in 1929 from horse plasma by precipitation using half satu-
rated ammonium sulfate (Macheboeuf, 1929). Twelve years later, the 
lipoprotein fraction isolated by precipitation was found to migrate in 
the alpha1 -globulin region using paper electrophoresis (see section 
II.B.2. Electrophoresis), which would indicate the lipoprotein fraction 
was equivalent to HDL (Macboeuf et al., 1941). Precipitation by ammonium 
sulfate was not an ideal technique for lipoprotein separation, therefore 
other techniques for lipoprotein fractionation were devised, one of 
which was ultracentrifugation. 
Since lipoproteins have densities lower than other naturally 
occuring macromolecules, changes in solvent density has allowed the sep-
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aration of plasma lipoproteins from other macromolecules by floatation 
in a high centrifugal field. The equation for the velocity of sedimen-
tation coefficient of a macromolecule (S) is as follows: 
S = (l/w2x) (dx/dt) = M(l-Vp)/3~Nnd. 
s is in Svedberg units (l0- 13 seconds), w is the angular velocity in 
radians/sec = (2~)/60rpm, x is the distance (cm) of particle from the 
rotation axis, t is the time in seconds, Mis the molecular weight (g), 
V is the partial specific volume of macromolecules (cm3/gm), p is the 
density of the solvent (g/cm3), N is Avogadro's number, n is the viscos-
ity of solvent (poise) and dis the diameter of the particle (cm). The 
S value for chylomicrons is 103-105 for VLDL is 12-400 and for LDL is 
0-12, while HDL is found in the sediment (Hatch et al., 1968). The 
interpretation of analytical ultracentrifugal results obtained for 
plasma was the major problem needed to be overcome in order to use this 
technique for lipoprotein analysis. This problem was resolved and 
plasma lipoproteins have been characterized by analytical ultracentrifu-
gation (Gofman et al., 1949). Unfortunately the analytical ultracentri-
fuge is a very costly and complicated piece of equipment and few labora-
tories in the world have one. Moreover, the stress forces exerted on 
the lipoproteins subjected to analytical ultracentrifugation cause 
reversible and irreversible changes in lipoprotein structure and charac-
teristics (Lindgren, 1980). 
The most commonly used method in research for lipoprotein analysis 
is sequential ultracentrifugation (Chapman, 1980) and the most fre-
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quently used sequential ultracentrifugal technique involved adjusting 
the plasma sample to a higher density by the addition of salt, either in 
solution or by dry weight. The sample would then be centrifuged at high 
speed for long periods of time, usually from 18-48 hours. Following 
centrifugation the fraction containing lower density lipoproteins would 
be at the top of the centrifuge tube separated from the higher density 
fraction at the bottom of the tube. The tube could then be sliced 
between the two lipoprotein fractions or the floating lower density 
fraction could be removed from the top by pipette (Havel et al., 1955). 
Ultracentrifugal techniques appear to be the best way currently availa-
ble to fractionate human HDL into the subf ractions of HDL2a HDL2b and 
HDL3 (Lindgren et al., 1979). Table 1 demonstrates the results of human 
and other species lipoproteins isolated by sequential ultracentrifuga-
tion and analyzed for protein, phospholipid, triglyceride and both 
esterified and unesterified cholesterol (Havel et al., 1955). 
Variations of ultracentrifugal techniques have been developed all 
based on the same principle of density adjustment with centrifugal force 
used in separating the various density lipoprotein fractions. Each 
technique has advantages over the other, but all suffer from some limi-
tations and differences in lipoprotein constituent values have been 
obtained using different ultracentrifugal techniques (Hojnacki et al., 
1978; Shireman et al., 1983). Ultracentrifugation can lead to lipopro-
tein degradation (Fainaru et al., 1977) and loss of cholesterol from the 
various lipoprotein fractions (Marcel et al., 1981). LDL has been dem-
onstrated to be significantly affected by ultracentrifugation, apo A-I 
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is lost from HDL and salt gradients which tend to set up prior to 
separation also interfere with lipoprotein resolution (Lindgren et al., 
1979). Another drawback to ultracentrifugation is the time involved in 
separating lipoprotein fractions, which can take up to a week to accom-
plish (Havel et al., 1955). 
2. Electrophoresis 
Apolipoproteins on the surface of lipoprotein molecules display a 
net charge which determines electrophoretic mobility and allows separa-
tion of lipoprotein classes by electrophoresis. The lipoprotein net 
charge is mostly determined by the balance of charges on terminal and 
side-chain amino acid residues of the apolipoproteins. Additional 
charge contributions could be from absorbed metal cations and fatty acid 
anions. Phospholipids contribute little to lipoprotein electrophoretic 
mobility, since over 90% of the phospholipids present in lipoproteins 
exist in the zwitterionic state at physiological and electrophoretic pH 
values (Hatch et al., 1968). 
Ultracentrifugal separation of lipoproteins has often been corre-
lated with various other methods for lipoprotein separation. The lipo-
protein bands obtained by paper electrophoresis have been correlated to 
ultracentrifugally isolated lipoproteins. The density equivalents for 
lipoproteins separated by paper electrophoresis has been determined as 
follows: alpha1 lipoprotein corresponds to HDL density 1.063-1.210 g/ml 
alpha2 lipoprotein also known as prebeta lipoprotein corresponds to VLDL 
density less than 1.006 g/ml, beta lipoprotein corresponds to LDL with 
density between 1.006 and 1.063 g/ml and the band at the origin corre-
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sponds to chylomicrons (Lees et al., 1965; Levy et al., 1966). Paper 
electrophoresis, because it is less time consuming, easier to run and 
correlates well with the ultracentrifugal methodology has been used to 
phenotype human lipoprotein disorders previously only definable by 
ultracentrifugal techniques (Fredrickson et al., 1965). Unfortunately, 
paper electrophoresis like ultracentrifugation has some problems. Reso-
lution of lipoprotein bands by paper electrophoresis was poor until it 
was improved by substituting a barbital-albumin buffer for the barbital 
buffer used previously (Lees et al., 1963), however it still required 16 
hours for an electrophoretic run. 
Cellulose .acetate used as a support medium for electrophoresis was 
found to be capable of excellent resolution of plasma lipoproteins with-
out the requirement of albumin in the buffer within 15-45 minutes (Chin 
et al., 1968; Beckering et al., 1970; Fletcher et al., 1970). The use 
of agarose gels and polyacrylamide gels for lipoprotein electrophoresis 
does not markedly improve resolution of the lipoprotein fractions over 
that of cellulose acetate nor is there any added convenience in the use 
of gels (Conlon et al., 1979; Muniz, 1977). Cellulose acetate electro-
phoresis is a suitable and convenient method for lipoprotein fractiona-
tion (Hatch et al., 1968). 
Currently, isotachophoresis and isoelectric focusing are used in 
lipoprotein research for the identification and characterization of apo-
lipoproteins (Bon et al., 1981; Eggena et al., 1972). The lipoproteins 
are usually first isolated by ultracentrifugation, delipidated then 
electrophoresed (Eggena et al., 1972). Delipidation however, does not 
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always appear to be necessary (Bon et al., 1981; Bugugnani et al., 1984; 
Godolphin et al., 1974), yet with nondelipidated lipoprotein fractions 
isolated by high resolution electrophoretic techniques, the number of 
subfractions resolved increases tremendously. However, the increased 
number of subfractions observed using high resolution techniques such 
as, isoelectric focusing could be due to different distributions of 
lipid content within the same class of lipoprotein (Rosseneu-Motreff et 
al., 1969) or protein interaction with ampholytes (Hare et al., 1978). 
Therefore, the number of subfractions of lipoproteins observed using 
high resolution techniques could be due to the techniques and not to the 
actual number of subfractions. 
Accurate quantitation of electrophoretically-separated plasma 
lipoproteins with non-specific "total" lipid stains has been difficult, 
because of each lipoprotein' s differing affinities for such stains 
(Fletcher et al., 1970). Such commonly used lipid stains as Sudan black 
B, preferentially stain unsaturated ster-01 esters and unsaturated tri-
glycerides, whereas unesterified cholesterol and phospholipids are 
stained negligibly or not at all (Schjeide et al., 1963). Moreover, the 
various cholesterol esters and triglycerides have different staining 
affinities for Sudan black B, dependent upon their particular fatty 
acids. Oil red 0, which is another commonly used "total" lipid stain, 
stains cholesterol esters more intensely than Sudan black B, but its 
staining is also dependent on the cholesterol ester's degree of fatty 
acid saturation. In addition, oil red 0 also stains triglycerides as 
well as albumin, but does not stain phospholipids or unesterified cho-
r 
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lesterol. Recently a cellulose acetaxe electrophoretic technique, which 
combines an enzymatic staining procedure for total cholesterol (Allain 
~al., 1974) has been developed for determining human plasma lipopro-
tein-cholesterol concentrations which are currently employed as risk 
factors for human atherosclerotic disease (Cobb et al., 1978). The 
enzymatic assay used cholesterol oxidase, which is specific for 3~ ster-
ols and requires a double bond in the delta 5 or delta 4 positions of 
the steroid molecule. Interference from sterols normally occurring in 
human plasma using the enzymatic staining technique is less than 0.1% 
the total plasma cholesterol concentration indicating the technique has 
a high specificity for cholesterol in plasma (Richmond, 1973). The 
method of quantitating human plasma lipoproteins using enzymes specific 
for cholesterol is more precise and accurate as opposed to "total" lipid 
staining. 
3. Polyanionic Precipitation 
Another group of methods used to separate and identify lipopro-
teins is polyanionic precipitation of which the most commonly used are 
manganese heparin or dextran sulfate precipitation (Burstein et al., 
1960; 1970; 1973). Precipitation techniques are usually rapid and can 
be adjusted to clear solutions of any particular class of lipoprotein 
. . . 
merely by titrating the anion concentrations. Lower density lipoprotein 
classes are found in the precipitate while higher density lipoproteins 
remain in the supernate. Therefore, a chylomicron free solution can be 
achieved by adding a low concentration of a polyanionic precipitating 
agent and a VLDL/chylomicron free solution can be achieved by adding a 
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higher concentration of precipitating agent. Precipitation of each 
lipoprotein fraction can be done sequentially until the solution is 
lipoprotein free. Recently, precipitation techniques have become more 
refined and have been used to separate the HDL subfractions HDL2 and 
HDL3 (Gidez et al., 1982). 
Although HDL subfraction precipitation correlates well with ultra-
centrifugal studies, there is incomplete separation of HDL3 from HDL2 , 
therefore the technique is only useful if a precise measurement of the 
two HDL subfractions is unnecessary (Daerr et al., 1983). This is indi-
cative of the major problem with precipitation methods, which is that 
although the various lipoprotein density classes can be sequentially 
precipitated, the resolution between lipoprotein classes is so close 
that a portion of the lipoprotein class which is desired in solution may 
also occur in the precipitate (Burstein et al., 1970). In a study com-
paring various precipitation techniques to sequential ultracentrifuga-
tion (Warnick et al., 1979a; 1979b), a good correlation was found 
between the methods however, differing HDL-cholesterol levels were 
obtained depending on which method was used. This would indicate that 
the various precipitation techniques are not equivalent and can lead to 
significant differences in HDL-cholesterol quantitation. Another prob-
lem with precipitation techniques is th~ inadvertent precipitatiori of 
HDL containing apolipoprotein E along with the apolipoprotein B-contain-
ing lipoproteins (Mahley et al., 1977b). 
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4. Column Techniques 
Many column techniques for obtaining pure lipoprotein fractions 
require ultracentrifugal separation from the rest of plasma proteins 
prior to applying the sample to the column. Agarose column chromatogra-
phy for example which separates lipoproteins by size requires prior 
purification by ultracentrifugation (Rudel, 1974). Heparin affinity 
chromatography is a good technique for isolating beta lipoprotein and 
those lipoprotein fractions containing apo E, especially HDL containing 
apo E, however purification of the isolated fractions requires further 
manipulation, which can affect the nature of the lipoprotein being stud-
ied (Bentzen et al., 1982). A new rapid lipoprotein separation techni-
que coupling high performance liquid chromatography (HPLC) with exclu-
sion chromatography can use plasma volumes of two micro liters, but 
sacrifices resolution, due to loss of sensitivity from using small 
plasma volumes. Therefore, only two plasma lipoprotein fractions, HDL 
and LDL, could clearly be isolated from-human plasma. (Ohno et al., 
1981). Improvement in the HPLC technique will continue to occur and 
with the use of larger plasma volumes the resolution between lipopro-
teins may be enhanced, which would make HPLC an excellent rapid techni-
que for isolating plasma lipoproteins in pure form. 
5. Immunoassay of 
Apo lipoprote ins 
Immunological techniques were developed to quantitate the apolipo-
protein concentration within plasma as an easier alternative to ultra-
centrifugal isolation. The first methods for apo A-I and apo B, the 
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major apolipoproteins of HDL and LDL respectively, involved a double 
antibody precipitation procedure which required plasma lipoprotein deli-
pidation and 60 hours of incubation (Schonfeld et al., 1974a; 1974b). A 
radioimmunodiffusion assay was later developed for Apo A-I that corre-
lated well with the double antibody procedure and with the HDL-choles-
terol concentration in plasma (Albers et al., 1976). Moreover, this 
method was easier to perform, although, delipidation was still necessary 
and the incubation time required 48-72 hours. Recently, an improved 
radioimmunoassay system for ape A-I was developed which used a detergent 
that removed the necessity for plasma lipoprotein delipidation. In 
addition, an immunoglobulin absorbent was used which removed the free 
from the bound antibody, eliminating the necessity for a second anti-
body. This system required only a 10 minute incubation and correlated 
well with double antibody techniques (Maciejko et al., 1982). Moreover, 
the new ape A-I radioimmunoassay technique also correlated well with 
HDL-cholesterol concentrations (Maciejko et al., 1983). 
Apo B quantitation using immunological techniques appears to be 
best achieved by electroimmunoassay as demonstrated by its comparison to 
radioimmunoassay and radioimmunodiffusion, since the latter two methods 
appear to underestimate the amount of ape B present. Moreover, the 
electroimmunoassay appears to be the easiest to perform (Curry et al., 
1978). A more recent assay has been developed using a competitive 
enzyme linked immunoassay for ape B substituting changes in enzyme 
activity for radioactivity. This technique has correlated well with 
angiographically described coronary artery disease (Vander Heiden et 
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~·' 1984). 
Any immunoassay is dependent on the purity of the antigen for 
which the antibody is produced. Apo A-I is a relatively easy apolipo-
protein to isolate and purify, while Apo B appears to be extremely dif-
ficult to isolate and purify (Bradley et al., 1980). Another difficulty 
with assays for apolipoproteins are that they may be found within dif-
ferent classes of lipoproteins. Apo A-I is found in chylomicrons, VLDL 
and HDL, although mostly in HDL, whereas apo B is found in VLDL and chy-
lomicrons as well as LDL (Smith et al., 1978). Epidemiological work is 
currently underway to ascertain the significance of apolipoprotein meas-
urement with regard to predicting atherosclerotic disease and the extent 
of coronary artery disease with some promising preliminary results (see 
section V.C. Lipoproteins and Atherosclerosis). However, apolipoprotein 
immunoassays greatest benefits may be in the explanation of the causes 
for atherosclerosis and the further understanding of lipoprotein metabo-
lism (Blackburn, 1983). 
C. Lipoprotein Synthesis and Metabolism 
1. Triglyceride Rich 
Lipoprotein Synthesis 
Triglyceride rich lipoproteins include both chylomicrons and· VLDL 
which are produced in the intestine and liver respectively. The liver 
in the fasting state produces about 80% of the plasma's triglyceride 
rich lipoproteins (Windmueller et al., 1968). The core lipids which 
include triglycerides and cholesterol esters are synthesized on the 
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cytoplasmic surface of the endoplasmic reticulum (ER) (Coleman et al., 
1978; Hashimoto et al., 1980; Lichenstein et al., 1980). ACAT esteri-
fies cholesterol in the rough ER and then esters are transferred to the 
smooth ER (Hashimoto, 1980). Enzymes responsible for cholesterol 
synthesis are also in the ER and the specific activity of HMG CoA reduc-
tase is highest in the smooth ER (Havel et al., 1973b), so the lipid 
core and surface lipids of the lipoprotein can all be assembled in the 
same area of the cell. 
The apolipoproteins are probably synthesized on ribosomes bound to 
the rough ER (Alexander et al., 1976). Exactly where the lipoprotein 
particles are packed is still unclear although there is some evidence it 
occurs on the smooth ER (Alexander et al., 1976). It has been proposed 
that during synthesis the apolipoprotein is inserted into the lipid 
bilayer of the ER. Apolipoprotein is being synthesized at the same time 
the core and surface lipids of the lipoprotein are being synthesized. 
The nascent lipoprotein buds off from the ER with the apolipoprotein 
attached when an excess amount of lipids are accumulated. Lipid dro-
plets may bud off without the apolipoprotein and accumulate in the cell 
when high cholesterol concentrations are present intracellularly, which 
may be reflected by high plasma cholesterol concentrations (Swany, 
1980). 
The lipoproteins after packaging are transferred into the cister-
nae and secretory vesicles of the Golgi complex. It was postulated 
that specialized tubules transfer the nascent lipoproteins to the Golgi 
apparatus from the ER (Alexander et al., 1976), although it is also pos-
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sible that the lipoproteins are transported via vesicular transport 
(Novikoff et al., 1978). Lipoproteins isolated from the Golgi apparatus 
are similar to VLDL found in the plasma except Golgi lipoproteins con-
tain more phospholipids and fewer apolipoproteins (Hamilton, 1980). The 
nascent lipoprotein particles are packaged in secretory vesicles and 
transported to the sinusoidal surface of the cell where the vesicles 
fuse with the plasma membrane and the lipoproteins are released. VLDL 
is released into Disse' s space of the liver and chylomicrons are 
released into the basolateral spaces between intestinal absorptive cells 
(Hamilton et al., 1967; Hamilton, 1972). 
2. Triglyceride Rich 
Lipoprotein CatabO'iiSm 
Extrahepatic lipoprotein lipase EC 3.1.1.34 (LPL) (Nomenclature 
Committee, 1979) is an enzyme bound to the endothelial luminal surface 
of capillaries which supply the tissues that utilize circulating trigly-
cerides (Scow et al., 1972). LPL forms free fatty acids and glycerol 
from triglycerides and the rate of the reaction is strongly dependent 
upon the particular lipoprotein present (Fielding, 1970). A protein 
cofactor present in VLDL and in chylomicrons was found to be responsible 
for increased LPL activity (Havel et al., 1973a). Further investigation 
revealed that the protein cofactor responsible for lipoprotein lipase 
activity was apo C-II (LaRosa et al., 1970). Moreover, the amount of 
apo C present in VLDL was found to be dependent on the triglyceride con-
centration of VLDL (Eisenberg et al., 1975). Chylomicrons have been 
demonstrated to receive apo C from HDL (Havel et al., 1973c). In addi-
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tion, apo C was shown to transfer from HDL to VLDL as the triglyceride 
concentration of plasma increases, while as lipolysis occurred apo C was 
transferred back to HDL (Kashyap et al., 1977). 
Two forms of lipoprotein lipase are released into the plasma of 
rats and humans upon in vivo administration of heparin (Krauss et al., 
1973; 1974). One form of lipoprotein lipase was inhibited by protamine, 
while the other form was resistant to protamine. The protamine resis-
tant lipoprotein lipase was found to be hepatic in origin, whereas the 
protamine sensitive lipoprotein lipase was found to originate from the 
capillary endothelium. The activity of the hepatic lipoprotein lipase 
appeared to be less than that of the extrahepatic lipoprotein lipase, 
since VLDL was found to be a poor substrate for hepatic lipoprotein 
lipase and an excellent substrate for extrahepatic lipoprotein lipase. 
Hepatic lipoprotein lipase has been suggested to have a greater specif-
icity for lipoprotein remnants, which are those lipoproteins that have 
already been acted upon by extrahepatic lipoprotein lipase (Krauss et 
al., 1973; 1974). Moreover, hepatic lipoprotein lipase has been found 
to have phospholipase activity (Enholm et al., 1975) and appears to be 
localized exclusively on the surface of hepatic endothelial cells (Kuusi 
et al., 1979). Hepatic lipoprotein lipase appears to act on smaller 
lipoprotein molecules preferring VLDL to chylomicrons and the lower den-
sity IDL to VLDL (Nicoll et al., 1980a). 
Removal of human plasma chylomicrons from the circulation is 
extremely rapid, since chylomicrons have a half life of about 5 minutes 
(Grundy et al., 1976; Grundy, 1978). Cholesterol incorporated into chy-
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lomicrons injected into rats was rapidly taken up by the liver with at 
least 93% of the injected cholesterol found in the liver within 1 ·hour 
after injection (Goodman, 1962). Another study also using rats found 
after 10 minutes only 20% of the chylomicron triglycerides in the liver 
although, 80% of the injected cholesterol incorporated into chylomicrons 
was found in the liver, (Redgrave, 1970). These results were duplicated 
in sheep and dogs (Bergman et al., 1971), indicating that extrahepatic 
lipoprotein lipase removed triglyceride prior to uptake by the liver of 
the chylomicron shell which contained the remaining esterified choles-
terol core. Humans with extrahepatic lipoprotein lipase deficiency have 
very high levels of triglycerides within chylomicrons, which are not 
taken up the liver. This would be consistent with the proposed specif-
icity of hepatic lipoprotein lipase (Nicoll et al., 1980) and suggests 
that a change must be made in the chylomicron molecule by extrahepatic 
lipase as triglyceride is removed and a chylomicron remnant is formed. 
The change in the chylomicron molecule may be the loss of apo C as tri-
glyceride lipolysis occurs, since apo C may inhibit chylomicron binding 
to the hepatic lipoprotein receptor (Shelburne et al., 1980; Windler et 
al., 1980a). Receptor mediated rapid uptake of lipoproteins containing 
apolipoproteins B and or Eby the liver (Brown et al., 1981) will be 
discussed further (see section II.C.4. LDL Catabolism). 
3. VLDL Catabolism and LDL 
Formation 
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Triglyceride rich VLDL formed and released from the liver, circu-
lates in the plasma and is acted upon by extrahepatic and hepatic lipo-
protein lipase which decreases the triglyceride content of VLDL, causing 
an increase in VLDL density. VLDL forms intermediate density lipopro-
tein (IDL), which has a hydrated density between 1.006-1.019 g/ml. The 
continued action of lipoprotein lipase on IDL results in the production 
of LDL with a density between 1.019-1.063 g/ml. This precursor product 
relationship of VLDL and LDL was found by the injection of labeled VLDL 
into humans and rats (Eisenberg et al., 1973a; 1973b). Apolipoprotein B 
was found to be produced in the liver and intestine of the rat 
(Schonfeld et al., 1978) and is a component of chylomicrons, VLDL and 
LDL (Schaeffer et al., 1978b). The apolipoprotein composition of LDL is 
almost completely apo B (Schaefer et al., 1978b), therefore as VLDL 
loses triglyceride by the action of lipoprotein lipase the apo B compo-
nent of VLDL remains in the plasma, but each LDL particle becomes more 
concentrated with apo B (Eisenberg et al., 1973a; 1973b). Moreover, in 
vitro incubation of VLDL with lipoprotein lipase rich plasma produced 
IDL particles (Eisenberg et al., 1975). Also, the conversion of VLDL to 
LDL was found to be a one way process, since injection of labeled LDL 
failed to show any labeled VLDL in human plasma (Langer et al., 1978). 
The interaction of VLDL with lipoprotein lipase in humans was 
found to be less efficient than lipoprotein lipase interaction with chy-
lomicrons (Grundy et al., 1976; Grundy, 1978), since the half life for 
plasma VLDL was determined to be 1-3 hours, which is much longer than 
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that for chylomicrons (Bilheimer et al., 1972; Sigurdsson, et al., 
1975). However, ape B from rat plasma VLDL was cleared more rapidly 
from rat plasma than human plasma VLDL from human plasma, but the same 
precursor product relationship exists between VLDL and LDL in both rat 
and human (Faergeman et al., 1975). The bulk of rat VLDL appears to be 
removed directly from the circulation by specific hepatic receptors 
before VLDL can be fully catabolized to LDL (see section II.C.4. LDL 
Catabolism), which would partially explain why the LDL concentration of 
rat plasma is so low (Stein et al., 1974). 
4. LDL Catabolism 
The fractional catabolic rate of LDL in humans is dependent on LDL 
clearance rather than LDL formation, since it was found that increases 
in LDL appear to be due to problems in catabolism rather than increases 
in LDL production (Sigurdsson et al., 1976). In vitro analysis has 
shown that fibroblasts when incubated with plasma lipoproteins derive 
all their cholesterol from LDL (Brown et al., 1974a). Moreover, a spe-
cific cell surface receptor that binds LDL with high affinity and spe-
cificity was found in cultured fibroblasts (Brown et al., 1974b; 
Goldstein et al., 1974a; 1976). The specificity of the lipoprotein 
receptor found in cultured fibroblasts has been determined to be for the 
apolipoproteins E and B, which are major components of LDL, VLDL and 
chylomicrons (Innerarity et al., 1978; Mahley et al., 1977c). Electron 
microscopic analysis demonstrated that LDL bound to the lipoprotein 
receptor migrated to a coated pit on the cell surface (Anderson et al., 
1976; 1977a; 1977b; Orci et al., 1978) which contained 50-80% of the LDL 
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receptors and appears to be specialized for rapid endocytosis. The 
receptor bound lipoprotein was ingested through absorptive endocytosis 
following which, the internalized LDL was incorporated into endocytotic 
vesicles that fused with lysosomes, where the protein component of LDL 
was degraded into amino acids and released into the cell culture medium 
(Goldstein et al., 1974a; 1975). The cholesteryl esters of LDL were 
hydrolyzed by a lysosomal acid lipase (Brown et al., 1975b) and the 
unesterified cholesterol was transferred to the cellular compartment 
where it was found associated with cell membranes (Brown et al., 1975c). 
Unesterified cholesterol originating from LDL also suppressed HMG Co A 
reductase (Brown et al., 1973) and activated ACAT facilitating reesteri-
fication of cholesterol within the cell (Brown et al., 1975a; Goldstein 
et al., 1974b). In addition, the LDL receptor was found to be regulated 
by feedback inhibition, so that when fibroblasts were incubated with 
LDL, the LDL receptor concentration per cell decreased (Brown et al., 
1975d). The fibroblasts in the normal state preferred cholesterol from 
LDL, since HMG Co A reductase was normally suppressed (Brown et al., 
1975c). Therefore, based primarily on in vitro studies of cultured 
fibroblasts it has been suggested that the primary function of plasma 
LDL is the transport of cholesterol to peripheral tissues to fulfill the 
tissue's cholesterol requirements (Brown et al., 1981). Moreover, using 
membrane binding studies on bovine tissue high affinity LDL receptors 
similar to those found in cultured fibroblasts were found on the mem-
branes of the adrenal gland, ovary, liver, kidney, myocardium, spleen, 
brain, erythrocytes, pancreas, thymus, skeletal muscle, testes, lung, 
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jejunum, ileum and adipose tissue (Kovanen et al., 1979a), evidence that 
this LDL receptor, also referred to as the classical LDL receptor is 
found in almost every tissue of the body. 
An alternative pathway for LDL degradation has been found to be 
the scavenger pathway, which has low affinity binding, nonspecific 
uptake and is dependent on plasma lipoprotein concentration (Goldstein 
et al., 1974a). The scavenger pathway appeared to be involved in non-
specific pinocytosis and is believed to degrade about 15% of human 
plasma LDL daily (Goldstein et al., 1977b). However, the scavenger 
pathway did not appear to remove normal LDL from the plasma, but was 
able to remove LDL which was exogenously modified to be more electroneg-
ative by acetylation or maleylation of isolated LDL using organic chemi-
cal means. In other words, the scavenger pathway was found to remove 
LDL which had lysine residues experimentally modified by acetylation or 
maleylation, thereby increasing LDL's electronegativity (Brown et al., 
1980). Acetylation of LDL probably does not occur in vivo (Goldstein et 
al., 1979) however, LDL isolated from human lymph has been found to be 
more electronegative than plasma LDL (Reich! et al., 1973; 1975). More-
over, LDL incubated with cultured endothelial cells were found to be 
more electronegative and had enhanced uptake by incubated macrophages 
(Henriksen et al., 1981). In addition, in vivo administration of the 
exogenously modified LDL particles resulted in an increased uptake into 
rat liver endothelial cells as compared to nonmodified native LDL mol-
ecules which were taken up primarily by liver parenchymal cells 
(Nagelkerke et al., 1984). The nature of any in vivo modification of 
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LDL has yet to be determined. Another macrophage receptor has been 
found distinct from the acetylated LDL receptor, which binds LDL com-
plexed with dextran sulfate. However, since dextran sulfate will bind 
to the receptor in the absence of LDL, the receptor site appears to be 
selective for dextran sulfate rather than LDL (Basu et al., 1979). 
Initially, the scavenger cell pathway was found exclusively in 
cultured macrophages whereas the classical LDL receptor pathway was 
found exclusively in parenchymal and connective tissue (Brown et al., 
1980). Monocytes incubated in vitro exhibited the characteristics of 
the classical LDL receptor pathway, but as the monocytes matured they 
expressed scavenger pathway activity indicating both receptors may exist 
on the same cell type (Fogelman et al., 1981). Since macrophages are 
derived from monocytes (Wheater et al., 1979) it is possible that as 
monocytes mature and leave the circulation they differentiate into 
macrophages and lose the ability to bind LDL by the classical receptor 
mechanism, although using immunocytochemical procedures cultured macro-
phages were observed to express both the classical and scavenger recep-
tor pathways (Traber et al., 1983). Recently, bovine endothelial cells 
were demonstrated to possess both classical LDL and scavenger receptor 
pathways (Baker et al., 1984; Stein et al., 1980). However, human 
endothelial cells may lack LDL scavenger receptors, since endothelial 
cell do not appear to have lipid deposits, when examined in humans with 
classical LDL receptor deficiencies (Buja et al., 1979). Lipid laden 
cells known as foam cells (see section V.C.2. LDL and Cholesterol) found 
in humans suffering from classical LDL receptor deficiencies were found 
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to be derived from smooth muscle cells or macrophages (Cookson, 1971) 
with at least 80% derived from macrophages (Vedeler et al., 1984). 
These foam cells were found to be distributed in tissues throughout the 
body, including the stromal cells of the thymus, spleen, skin, kidney 
and also in the aortic and mitral valves (Buja et al., 1979). The chief 
source of lipoprotein receptors in the body for both the classical 
receptor and the scavenger receptors appears to be the liver (Kovanen et 
al., 1979a), with about 75% of the body's classical LDL receptor present 
in the liver (Bilheimer et al., 1984; Spady et al., 1983). The liver 
parenchymal cells which are the hepatocytes (Leeson et al., 1981) con-
tain the classical LDL receptors, whereas the Kupfer cells contain the 
scavenger LDL receptors (Brown et al., 1980). As previously mentioned, 
rat liver endothelial cells also appear to have the scavenger cell 
receptors (Nagelkerke et al., 1984). 
The classical LDL lipoprotein receptor pathway has a limit to the 
amount of cholesterol it will take up due to feedback control on LDL 
receptors, whereas the scavenger pathway has no limit and appears to be 
the chief pathway for LDL degradation in humans with an effective lipo-
protein receptor deficiency (Goldstein et al., 1977a; 1977b). Moreover, 
massive accumulation of cholesteryl ester has been found to occur in 
mouse macrophages incubated in vitro and might account for the wide-
spread deposition of LDL-derived cholesteryl esters found in the macro-
phages of humans suffering from an effective lipoprotein receptor defi-
ciency (Goldstein et al., 1979). Humans suffering from an effective 
lipoprotein receptor deficiency have what is known as familial hypercho-
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lesterolemia, also known as hyperlipoproteinemia type Ila, which may be 
due to a lack of classical LDL lipoprotein receptors, inability of LDL 
to bind to classical lipoprotein receptors or to an inability of the 
classical lipoprotein receptor LDL complex to be internalized into the 
cell (Anderson et al., 1977b; Brown et al., 1974b; Goldstein et al., 
1976). This condition results in extremely high plasma cholesterol lev-
els and humans suffering from this disorder have a greater potential for 
developing coronary artery disease (see section V.C.2. LDL and Choles-
terol). 
5. HDL Synthesis 
HDL synthesis and secretion have been demonstrated in the small 
intestine and in the liver of humans and rats (Green et al., 1978; 1979; 
Hamilton et al., 1976; Marsh, 1974; 1976; Noel et al., 1974; Roheim et 
al., 1966). The contributions of the intestine and the liver to HDL has 
been difficult to determine, even though there is a difference in the 
apolipoprotein pattern of nascent HDL from each source. HDL from the 
intestine contains newly synthesized ape A-I and small amounts of ape E 
and ape C, while HDL from the liver has a high ape E content, but little 
ape A-I and apo C (Felker et al., 1977; Hamilton, 1976; Imaizumi et al., 
1978a; 1978b; Marsh, 1976; Wu et al., 1979). HDL secreted from perfused 
liver is disc shaped composed of proteins, phospholipids and cholesterol 
with almost no cholesteryl ester (Hamilton, 1976). The discoidal HDL 
particles may be formed from triglyceride rich lipoproteins by the 
actions of lipoprotein lipase following their secretion from the liver 
and intestine, since VLDL incubated in vitro with lipoprotein lipase 
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yields particles similar to HDL (Patsch et al., 1978). Moreover, tri-
glyceride rich lipoproteins have been proposed to be a plasma source of 
HDL due to extrahepatic lipoprotein lipase, which decreases triglycer-
ides from the core of VLDL or chylomicrons shrinking the lipoprotein 
molecule. The surface of the triglyceride rich lipoproteins, containing 
apolipoproteins and phospholipids would then bud off, due to the 
decreased size of the core which it surrounds forming nascent high den-
sity lipoproteins (Tall et al., 1978). In addition, this would explain 
the inverse relationship found between HDL concentration and VLDL con-
centration (Nikkila et al., 1978; Tall et al., 1978). Further plasma 
metabolism of HDL involves the enzyme lecithin:cholesterol acyltransfer-
ase (LCAT). 
6. LCAT 
Lecithin:cholesterol acyltransferase, EC 2.3.1.43 (Nomenclature 
Committee, 1979) abbreviated as LCAT is a plasma enzyme responsible for 
the conversion of unesterified cholesterol to esterified cholesterol 
(Glomset, 1962). Lecithin and unesterified cholesterol in ~he presence 
of LCAT produce esterified cholesterol and lysolecithin, the fatty acid 
from lecithin forming an ester linkage with the 3 ~ hydroxyl group of 
cholesterol. The source of the fatty acid of the cholesteryl ester is 
from the C-2 position of lecithin. 
LCAT has been shown to be sensitive to sulfhydryl group blockers 
like sodium p-hydroxymercuribenzoate (PHMB) or p-chloromercuribenzoate 
(PCMB) (Hellerman et al., 1943), which act as reversible inhibitors of 
cholesterol esterification (Glomset, 1962). The mercurial sulfhydryl 
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group blocker inhibit the enzyme by forming a mercaptide with the cys-
tine sulfhydryl group. The process can be reversed with a thiol donat-
ing substance such as mercaptoethanol. The reaction using PCMB as the 
thiol blocker on a protein (P) and the reverse reaction using a thiol 
donating agent (RSH) would proceed as follows: 
a. P-SH + Cl-Hg-C6H4COONa 
4 P-S-HgC6H4COONa + HCl 
b. P-S-HgC6H4COONa + RSH 
4 P-S-H + R-S-HgC6H4COONa 
(Benesch et al., 1962; Hamilton, 1960). p-Chloromercuriphenylsulfonic 
acid or p-chloromercuriphenylsulfonate (PCMPS) as shown in figure 2, 
another mercurial thiol blocking agent (Velick, 1953) used to inhibit 
LCAT activity (Glomset et al., 1970) is an analogue of PCMB with a sul-
fate group that enhances the molecule's aqueous solubility 
(Vansteveninck et al.' 1965). An LCAT inhibitor 
5,5'-dithiobis-2-nitrobenzoic acid (DTNB) (Stokke et al., 1971), which 
binds to thiol groups (Ellman, 1959), has been found to bind to two of 
four half cysteine residues found to be associated with the LCAT mol-
ecule, indicating that the SH group of at least one of two cystines may 
be at the active site and that a disulfide cross linked cysteine is 
probably present within the LCAT molecule (Chong et al., 1983). Large 
quantities of lysolecithin have also been found to inhibit LCAT activity 
(Fielding et al., 1972a), but with the addition of albumin LCAT activity 
returns to normal probably due to loss of lysolecithin from albumin 
binding (Aron et al., 1978). 
At least two protein cofactors present in the plasma appear to 
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enhance LCAT activity and they have been identified as apo A-I and a 
subfraction of the apo C family. Moreover, both protein cofactors have 
been found to be associated with lipoproteins, particularly HDL (Aron et 
al., 1978; Fielding et al., 1972b; Kostner, 1978). LCAT has been shown 
to act preferentially with HDL (Glomset, 1970), while LDL and VLDL 
seemed not to have an effect on LCAT activity, although recently LCAT 
has been demonstrated to have some activity with LDL (Barter, 1983). 
The HDL particle secreted from the perfused liver has been found to be a 
good substrate for LCAT (Hamilton, 1976) and these nascent HDL particles 
also appear to be similar to those found in the plasma of patients with 
LCAT deficiency (Forte et al., 1971). In addition, HDL3 , the denser of 
the HDL subtractions which can be isolated by ultracentrifugal techni-
ques appeared to be the preferred LCAT substrate in humans (Fielding et 
al., 1971), whereas HDL2 appeared to inhibit the LCAT reaction (Fielding 
et al., 1971; Fielding et al., 1972a; Pinon et al., 1980), although LCAT 
does not appear to be affected by the ratios of apo A~I to apo A-II in 
HDL subfractions. Moreover, studies have indicated that LCAT may form a 
complex with HDL3 and VHDL (Fielding et al., 1980; Jahani et al., 1981). 
LCAT incubated in vitro with apo A-I and cholesterol liposomes caused 
LCAT to be inhibited by the accumulation of cholesteryl esters (Chajek 
et al., 1978), which could explain why LCAT prefers cholesteryl ester 
poor HDL3 and is inhibited by cholesteryl ester rich HDL2 . The Vmax of 
LCAT activity was found to be 2.4-4 times greater for HDL3 than HDL2 , 
after incubating plasma with different mixtures of HDL2 and HDL3 and the 
Km for HDL3 was 43-60 nmol/ml and 167-391 nmol/ml for HDL2 . A pre-
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dictive model formulated on the basis of the kinetic studies showed that 
at physiological concentrations HDL2 could act as a competitive inhib-
itor of the cholesterol esterification reaction displacing the effective 
substrate HDL3 by the less effective substrate HDL2 (Barter et al., 
1984). 
In vivo esterification of cholesterol by LCAT in man has been 
estimated to be about 0.12 micromoles per ml plasma per hour (Glomset, 
1962; Nestel et al., 1967). An in vitro comparison of rat LCAT activity 
to human showed the initial rate of cholesterol esterification in the 
rat was approximately four times that of the human (Frolich et al., 
1975). However, it is not clear whether this difference is related to 
substrate concentration, enzyme or enzyme cofactors, since the compari-
son was not performed on the same substrate. Another difference between 
human and rat cholesterol metabolism was found to be that in the human 
the enzyme most responsible for plasma esterification of cholesterol is 
LCAT whereas in the rat both plasma LCAT and the liver intracellular 
enzyme ACAT are responsible for the cholesteryl esters found in plasma 
lipoproteins (Glomset, 1970). This will be discussed more thoroughly 
later (see section III.B.1. Cholesteryl Ester Transfer and Exchange). 
7. HDL Metabolism 
The half life of HDL in the plasma is on the order of five to six 
days (Brown et al., 1981). Most cells utilize the cholesterol from LDL 
via the LDL receptor pathway for cholesterol needs, however in rat adre-
nal and gonadal tissue, HDL may be the source of exogenous cholesterol 
and may regulate sterol synthesis in those tissues (Andersen et al., 
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1979). Rat adrenal cells incubated with HDL and LDL took up cholesterol 
two to three times more from HDL than LDL. Moreover, HDL-cholesterol 
uptake was enhanced when ACTH was given to the rats before adrenalec-
tomy, but LDL-cholesterol uptake was unaffected (Gwynne et al., 1976). 
It has been suggested that the uptake of HDL-cholesterol is a receptor 
mediated saturable process different from the LDL receptor pathway, 
since only the cholesterol carried by the HDL particle and not the HDL 
particle itself has been shown to be taken up by the cell (Gwynne et 
al., 1980). In addition, rat adrenal steroids have been demonstrated to 
be derived from both HDL and LDL, but in the human only from LDL has 
adrenal cholesterol uptake been demonstrated (Brown et al., 1979). Cul-
tured cells from rat ovaries obtained cholesterol exclusively from HDL 
for the production of progesterone whereas, estrogen synthesis was unaf-
fected by lipoproteins present (Weinstein et al., 1980). High affinity 
binding of HDL has been demonstrated in the rat testes, for which VLDL 
competed but LDL did not. Moreover, the binding of HDL to the gonadal 
tissue showed a two fold increase, when human chorionic gonadotropin was 
added without an increase in affinity (Chen et al., 1980). Evidence has 
been given for the existence of a lipase in the adrenals of rats and 
humans similar in nature to hepatic lipoprotein lipase (Jansen et al., 
1981). It has been proposed that hepatiC lipase favors the hydrolysis 
and removal of phospholipids from HDL. This increases the relative 
amount of unesterified cholesterol on the surface area of the HDL parti-
cle, which would facilitate the influx of unesterified cholesterol into 
those cells which had hepatic lipoprotein lipase like activity. Since 
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lipoprotein lipase activity similar to hepatic lipase has been found on 
the adrenals of humans and rats as well as the ovaries of rats, this 
could explain the specific uptake of HDL-cholesterol in those tissues 
(Jansen et al., 1980). 
Specific lipoprotein receptors as mentioned previously (see sec-
tion II.C.4. LDL Catabolism) have an affinity for HDL containing apo E, 
although there may be a qualitative and or quantitative difference 
between the rat and human LDL receptor (Drevon et al., 1981). The lipo-
protein receptor for LDL, which has been found on rat fibroblasts and 
smooth muscle cells has an affinity for in decreasing order: chylomi-
cron remnants, VLDL, LDL and HDL (apo E containing lipoproteins). More-
over, these affinities are increased if the lipoproteins are cholesterol 
enriched (Innerarity et al., 1980). Due to the long half life of HDL 
without apo E it is unlikely that a specific lipoprotein receptor exists 
for HDL as it does for LDL. LDL, VLDL and HDL were found to affect 
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cultured swine aortic smooth muscle cell· HMG Co A reductase activity in 
a concentration related response, yet HDL could not lower the enzyme's 
activity more than 25% (Assman et al., 1975). In addition, no high 
affinity binding of HDL has been detected, although low affinity uptake 
has been noted in fibroblasts probably due to nonspecific pinocytosis 
(Miller et al., 1977). Also, the binding of HDL was tinaffected by.incu-
bation with fibroblasts from patients with familial hypercholesterolemia 
(Miller et al., 1978), further proof that HDL does not compete with LDL 
for binding on the classical lipoprotein receptor. 
HDL has been postulated to remove cholesterol from the surface of 
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cells assisted by the actions of LCAT. LCAT could continuously create 
space on the surface of the HDL molecule for unesterified cholesterol to 
accumulate as the esterif ied cholesterol was internalized into the core 
of the molecule and in this way HDL would attract more unesterified cha-
lesterol from cell surfaces (Glomset et al., 1973). It has been 
reported that the uptake of cellular unesterified cholesterol by HDL is 
determined by the rate of desorption of cholesterol out of the cell mem-
brane into the aqueous phase surrounding the cell as well as the dis-
tance of diffusion to HDL (Phillips et al., 1980). The rate of choles-
terol efflux from cells may also be modulated by apolipoprotein A-I 
(Fielding et al., 198lb). fforeover, macrophage hydrolysis of cholesteryl 
esters and excretion into the medium was found to be dependent on cha-
lesterol acceptors present in the incubation medium, particularly HDL 
(Ho et al., 1980). Therefore HDL probably acts as a cholesterol scaven-
ger lipoprotein, accumulating cholesterol from the surface of cells and 
apparently does not compete with LDL for receptor binding either through 
the classical lipoprotein receptor pathway or the scavenger lipoprotein 
receptor pathway. 
D. Rat Lipoprotein 
1. Composition Compared to 
~ 
No other species outside of humans has been studied more exten-
sively as to their lipoprotein content and metabolism as the rat. Many 
remarkable similarities can be found between rat and human lipoproteins, 
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especially in the structure of the apolipoproteins and also some 
disparities can be found such as the lipoprotein and apolipoprotein dis-
tribution (Chapman, 1980). Comparison of HDL apolipoproteins between 
rat and human using SDS polyacrylamide gel electrophoresis appeared to 
indicate that the major HDL apolipoprotein, A-I, in both species was 
identical in terms of electrophoretic mobility. Apo A-II however, was 
found to be a minor component of rat serum HDL and a major component of 
human serum HDL (Swaney et al., 1974). Apo A-IV and arginine-rich apo-
lipoproteins were first found in rat HDL and not human HDL, however apo 
A-IV has since been found in human VLDL (Beisegel et al., 1979). Apo 
A-II appears to be in monomeric form in the rat as well as in other spe-
cies including the rabbit and monkey, whereas it is in dimeric form in 
the human. The minor apo C proteins found in HDL and VLDL are homolo-
gous to those of the human (Herbert et al., 1974). Arginine rich lipo-
protein also known as apo E (Smith et al., 1978) has been found in the 
human as a minor component of HDL and a major component of VLDL and chy-
lomicrons (Havel et al., 1973c). In contrast, rat apo E appears to be a 
major constituent of the HDL subfraction HDL1 and VLDL (Quarfordt et 
al., 1978; Weisgraber et al., 1977). 
Data on rat lipoprotein composition is very inconsistent and var-
ies with strain, diet, and methods used for isolation (Chapman, 1980). 
Table 2 indicates the composition of rat lipoprotein as compared to 
human lipoprotein using similar isolation techniques. Ultracentrifugal 
separation of rat plasma demonstrated that LDL had a density range 
between 1.040-1.050 g/ml, and an HDL/LDL overlap which occurred between 
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densities 1.050-1.063 g/ml (Lasser et al., 1973), in contrast to human 
HDL which has a more distinct separation between HDL and LDL (Chapman, 
1980). No lipoprotein was found in the density fraction between 
1.006-1.030 g/ml of normal rats however, rats fed a high cholesterol 
diet had lipoproteins which appeared in the 1.006-1.030 g/ml fraction, 
whereas lipoproteins decreased in the density 1.070-1.210 g/ml fraction 
(Lasser et al., 1973). Ultracentrifugal separation of rat plasma VLDL 
(density less than 1.006 g/ml), LDL (density 1.006-1.040 g/ml) and HDL 
(density 1.063-1.210 g/ml) followed by agarose gel electrophoresis indi-
cated that the lipoproteins had homogenous bands with HDL migrating in 
the prealbumin region. It was also found upon ultracentrifugation of rat 
plasma that in the density range between 1.040-1.063 g/ml LDL and HDL 
cross contaminate (Koga et al., 1969). Besides the differences in the 
major lipoprotein fractions between rat and human, a difference is 
apparent between rat and human HDL subfractions. Initially, rat HDL was 
subfractionated into density components corresponding to human HDL2 and 
HDL3 by preparative ultracentrifugation. Both HDL2 and HDL3 were char-
acterized by negative staining and electron microscopy. Rat HDL2 iso-
lated between the densities 1.063-1.125 g/ml appeared to be homogeneous 
spherical particles, whereas rat plasma HDL3 appeared to be heterogene-
ous in size and shape (Pasquali-Ronchetti et al., 1975). In contrast, 
using rate zonal ultracentrifugation for isolating rat plasma HDL sub-
fractions only HDL1 and HDL2 subfractions could be identified and no 
subfraction corresponding to human HDL3 appeared (Oschry et al., 1982). 
Currently, the evidence indicates that the rat has only two HDL subfrac-
tions as compared to three for the human. 
2. Rat Plasma Lipoprotein 
Elect;;phoretic Patterns 
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Paper electrophoresis of rat plasma using a Sudan black B stain 
revealed alpha, beta and prealbumin lipoprotein bands among the 5 major 
plasma protein bands. An alpha2 band which appeared in rat serum after 
a high cholesterol diet was found to be unstable, due to changes which 
occurred in the band upon storage of the hypercholesterolemic samples 
(Watson, 1961). Agarose gel electrophoresis of rat whole plasma com-
bined with a Sudan black B stain also appeared to suggest a prealbumin 
lipoprotein band, however in this system lipid-stained bands migrated 
consistently farther than their corresponding amide black protein-
stained bands (Johansson et al., 1976). Human plasma alpha1 lipoprotein 
also separated by agarose gel electrophoresis appeared to have the same 
electrophoretic mobility as albumin, with the lack of electrophoretic 
resolution between albumin and alpha1 lipoprotein possibly being due to 
nonspecific albumin staining (Johansson et al., 1976; Schjeide et al., 
1963). In addition, agarose starch gel electrophoresis of rat plasma 
using a combined oil red 0 and fat red 7B "total" lipid stain also 
appeared to suggest bands which had prealbumin, alpha1 , prebeta and beta 
electrophoretic mobility (Chalvardjian, 1971). The prealbumin and 
alpha1 bands appeared to correspond to HDL, since after ultracentrifugal 
fractionation of the plasma, these two bands had a density range greater 
than 1.063 g/ml, while the prebeta band corresponded to VLDL, and the 
beta band corresponded to LDL. However, no attempt was made to deter-
mine the actual cholesterol content of the prealbumin-migrating 
lipoprotein band visualized by a "total" lipid stain. 
3. Metabolism and Response to 
Hypercholesterolemia 
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Lipoprotein composition may change with dietary status. However, 
the cholesterol to protein ratio for HDL did not change in rats fed high 
cholesterol diets, indicating that the amount of cholesterol found in 
the rat plasma HDL fraction reflects the number of HDL particles pres-
ent. In contrast, the rat plasma LDL cholesterol to protein ratio 
increased in rats fed a high cholesterol diet suggesting more choles-
terol was being carried by less protein, therefore plasma LDL-choles-
terol concentration appears not to be as good an indicator of the total 
number of plasma LDL particles in the cholesterol fed rat as the plasma 
HDL-cholesterol concentration is. Yet without changing the amount of 
cholesterol in the diet, the cholesterol to protein ratios for all rat 
plasma lipoproteins remained constant, therefore plasma lipoprotein-cho-
lesterol concentrations may directly relate to plasma lipoprotein con-
centrations (Frnka et al., 1974). Dietary induced hypercholesterolemia 
produced lipoprotein profile changes in the rat including the appearance 
of two different lipoprotein fractions, a VLDL with beta electrophoretic 
mobility and an HDL of lower density referred to as HDL (Mahley et al., 
c 
1977a). HDLc has been found to have an alpha2 mobility using paper and 
agarose gel electrophoresis and was found within the density range 
·between 1.006-1.02 g/ml, yet HDL lacked apo B. Moreover, HDL lipopro-
c 
teins of alpha1 mobility and arginine rich apolipoprotein decreased in 
the density 1.08-1.210 g/ml fraction while HDL increased, when rats 
c 
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were fed high cholesterol diets. LDL and VLDL became the principle cho-
lesterol carrying rat plasma lipoproteins after dietary induced hyper-
cholesterolemia (Mahley et al., 1977a). 
A lipoprotein designated HDL1 was found by ultracentrifugally 
fractionating normal rat plasma in the density between 1.02-1.063 g/ml. 
In addition, HDL1 was separable from LDL by Geon Pevikon electrophore-
sis. HDL1 was found to be the normal rat's equivalent to HDLc present 
in the hypercholesterolemic rat (Weisgraber et al., 1977). HDL1 has a 
high arginine rich apolipoprotein content which when injected into nor-
mal rats finds its way to HDL, but in hypercholesterolemic rats is more 
predominant in beta VLDL, LDL and HDL . HDL production following high 
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dietary cholesterol feeding has been demonstrated in other species 
besides the rat, including the dog and human (Mahley, 1978). 
III. INTRAVASCULAR TRANSFER OF LIPOPROTEIN LIPIDS 
A. Lipoprotein-Unesterified Cholesterol Transfer 
1. Equilibration 
Unesterified cholesterol was found to equilibrate between plasma 
lipoproteins during an in vitro 37 °C incubation within 2-5 hours, which 
was observed using incubations of rat plasma perfused through the liver. 
However, unesterified cholesterol would not equilibrate between plasma 
lipoproteins when rat plasma was incubated at 4 °C. Moreover, unesteri-
fied cholesterol was found to exchange between all rat plasma lipopro-
teins as did triglycerides and phospholipids, but rat plasma esterified 
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cholesterol was not observed to exchange between plasma lipoprotein. 
(Roheim et al., 1963). Human cord blood incubated at 37 °C with HDL and 
LDL as the only lipoproteins present, demonstrated a net mass transfer 
of unesterified cholesterol from LDL to HDL (Sniderman et al., 1978). 
2. LCAT's Relationship to 
Unesterified Cholesterol 
Transfer 
Net transfer of unesterif ied cholesterol between plasma lipopro-
teins does not appear to occur when LCAT is inhibited (Fielding et al., 
198la; Perret et al., 1983), yet a time lag of 2-5 hours is required for 
unesterif ied cholesterol concentrations to equilibrate between the lipo-
proteins. The transfer of unesterified cholesterol to HDL is probably 
due to LCAT activity creating an unsaturated HDL particle with respect 
to unesterified cholesterol, allowing more unesterified cholesterol to 
accumulate on the HDL particle (Perret et al., 1983). Therefore, the 
time lag for equilibration of unesterif ied cholesterol between plasma 
lipoproteins incubated in vitro when LCAT was inhibited must reflect the 
time it would take for the relatively unsaturated HDL particles to reach 
saturation with respect to unesterified cholesterol. The transfer of 
unesterified cholesterol is believed to be a passive process whether 
between plasma lipoproteins or between cells and lipoproteins (Glomset 
et al., 1966; 1973; Phillips et al., 1980), however apo A-I the major 
apolipoprotein component of HDL appears to promote sterol efflux from 
the cell surf ace of fibroblasts during an in vitro incubation (Fielding 
~al., 1981b). The combination of HDL being the preferred substrate 
for LCAT activity and apo A-I promoting sterol efflux could account for 
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the passive transfer of unesterified cholesterol to the HDL molecule in 
vitro as well as in vivo, when LCAT is active . 
.c-------
B. Lipoprotein-Cholesteryl Ester Transfer 
1. Cholesteryl Ester Transfer 
and Exchange 
Rat plasma cholesteryl ester turnover was found to be dependent on 
the fatty acid moiety and the lipoprotein class, unlike human plasma 
where cholesteryl ester turnover is similar for all cholesteryl esters. 
This is due to the marked heterogeneity between cholesteryl esters of 
all rat lipoproteins as compared to the homogeneity of human plasma 
lipoprotein-cholesteryl esters (Gidez et al., 1967). An in vivo study 
on humans performed using labeled mevelonate suggested a process exists 
by which cholesteryl esters equilibrate between plasma lipoproteins. 
However, some heterogeneity was found to exist between the cholesteryl 
ester composition of each human plasma lipoprotein class, indicating 
that the same mechanism operates to equilibrate the cholesteryl ester 
content of human plasma lipoprotein fractions, but at a different rate 
(Goodman, 1964). Unesterified cholesterol and phospholipid decreased 
with a concomitant increase in cholesteryl esters after a 36 hour in 
vitro incubation of human plasma. In addition, triglycerides increased 
in HDL while cholesteryl ester decreased during the incubation suggest-
ing that a transfer and exchange of cholesteryl ester for triglycerides 
occurred between other lipoproteins and HDL (Rehnborg et al., 1964). 
Moreover, the cholesteryl ester content of human plasma VLDL increased, 
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while the cholesteryl ester content of LDL and HDL decreased after a 16 
hour incubation at 37 °C when LCAT was inhibited. At the same time, VLDL 
triglycerides were shown to decrease, while LDL and HDL triglycerides 
increased (Nichols et al., 1965). 
An exchange of cholesteryl esters between HDL and LDL was demon-
strated to occur when human cord blood was fractionated and incubated 
with HDL and LDL alone, but no evidence of cholesteryl ester transfer 
was observed. Cholesteryl ester exchange was determined by the movement 
of labeled cholesteryl ester from one lipoprotein to another without a 
concomitant change in cholesteryl ester concentration, while cholesteryl 
ester transfer was determined by changes in lipoprotein-cholesteryl 
ester concentration. However, VLDL was not included in the incubation 
medium of this study limiting the ability to determine whether lipopro-
tein-cholesteryl ester transfer could occur between HDL and VLDL 
(Sniderman et al., 1978). In contrast, net transfer of cholesteryl 
esters from HDL to VLDL was found when tritiated cholesterol dissolved 
in HDL was administered to rabbits in vivo, while lipoprotein-choles-
teryl ester exchange was not observed to occur (Barter et al., 1979b). 
The sources for human plasma VLDL cholesteryl esters were established to 
be both the liver and the plasma in humans (Barter, 1974a; 1974b), then 
it was determined that the plasma source.of VLDL cholesteryl esters was 
HDL (Barter, 1976). 
It was established by using ultracentrifugal techniques coupled 
with radioisotopic labeling of cholesteryl esters that rat plasma lacked 
significant cholesteryl ester transfer activity as compared to other 
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species (Barter et al., 1978). Many species appear to have the ability 
to transfer esterified cholesterol between plasma lipoproteins with the 
exceptions being the rat, dog and pig (Ha et al., 1982). The reported 
lack of cholesteryl ester transfer activity in rat plasma could explain 
the heterogeneity found between the cholesteryl ester composition of the 
rat's plasma lipoproteins as compared to the homogeneous cholesteryl 
ester composition of human plasma lipoproteins due to the exchange and 
transfer of cholesteryl esters between lipoproteins. Since VLDL is syn-
thesized in the liver the cholesteryl ester composition of rat plasma 
VLDL is determined by the liver and plasma HDL-cholesteryl ester compo-
sition is determined by plasma LCAT activity. 
2. Lipid Transfer Factor 
Due to the lack of lipoprotein-cholesteryl ester transfer in some 
species and not in others and to the energy requirements needed to 
remove cholesteryl ester from the core of the lipoprotein molecule, a 
plasma transfer factor was postulated to exist, which could perform the 
plasma lipoprotein-cholesteryl ester transfer process (Goodman, 1964; 
Nichols et al., 1965). The rabbit fed a high cholesterol diet was found 
to have a plasma fraction of density greater than 1.25 g/ml which could 
stimulate plasma lipoprotein-cholesteryl ester transfer or exchange and 
LCAT activity was proportional to lipoprotein-cholesteryl ester trans-
fer, although cholesteryl ester transfer still occurred when LCAT was 
inhibited (Zilversmit et al., 1975). Moreover, a cholesteryl ester 
exchange protein was isolated in the density greater than 1.210 g/ml 
plasma fraction of rabbit plasma which could be demonstrated to.exchange 
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labeled cholesteryl ester between rabbit LDL and bovine HDL. In con-
trast to the density greater than 1.25 g/ml plasma fraction, the plasma 
fraction denser than 1.210 g/ml seemed only responsible for exchange of 
cholesteryl ester between LDL and HDL, while LCAT had no relationship 
to exchange activity (Pattnaik et al., 1978). 
The possibility arose that a previously described apolipoprotein, 
apo D, might be the cholesteryl ester transfer protein, since the trans-
fer protein isolated by one group of investigators seemed to have the 
same isolation and electrophoretic characteristics as apo D (Chajek et 
al., 1978). However, a more purified lipid transfer protein did not 
have the characteristics of any previously described apolipoprotein, 
including apo D (Morton et al., 1982). A transfer complex isolated from 
human plasma had HDL substrate specificity, but it could not be estab-
lished whether this complex which contained LCAT and HDL was an artifact 
of ultracentrifugation (Fielding et al., 1980). However, it has been 
shown that HDL3 and VHDL incubated with·LCAT supply cholesteryl esters 
for transfer to VLDL. Furthermore, it was suggested that an HDL3/LCAT 
complex exists producing by LCAT activity a smaller lipoprotein which 
may be transferred to acceptor lipoproteins which could account for 
lipoprotein-cholesteryl ester transfer (Rose et al., 1982). 
Plasma LCAT activity, although not.necessary for lipoprotein·-cho-
lesteryl ester exchange was proportional to cholesteryl ester transfer 
activity in the hypercholesterolemic rabbit. Therefore, the more cho-
lesteryl ester present in plasma the more exchange or transfer of cho-
lesteryl ester between lipoproteins occurred (Zilversmit et al~, 1975). 
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Plasma lipoprotein-cholesteryl ester transfer from HDL to VLDL and 
chylomicrons was demonstrated when LCAT was inhibited, while no choles-
teryl ester transfer could be observed from HDL to LDL (Marcel et al., 
1981). However when LCAT activity was present, a net mass transfer of 
cholesteryl ester from HDL to LDL and VLDL occurred, which was only lim-
ited by the concentration of the cholesteryl ester acceptors, LDL and 
VLDL, present in the incubation medium (Chajek et al., 1978). Since LDL 
was recently shown to support a limited amount of LCAT activity (Barter, 
1983), this may account for the observed transfer of cholesteryl ester 
from HDL to LDL, because esterification of unesterified cholesterol and 
its incorporation into LDL may appear to be transfer if LCAT is not 
inhibited. Transfer of plasma lipoprotein-cholesteryl esters from HDL 
to VLDL appeared to be more rapid than cholesterol esterif ication by 
LCAT in rabbit plasma. However, lipoprotein-cholesteryl ester transfer 
or exchange in human plasma occurs at about the same rate as cholesterol 
esterification (Nestel et al., 1979). Moreover, HDL3 the subfraction 
for which LCAT is most specific in human plasma (Fielding et al., 
1972a), appears to have the most lipoprotein-cholesteryl ester transfer 
activity (Greener et al., 1984). In addition, the cholesteryl ester 
content of VLDL and chylomicrons could be due to the activity of LCAT 
and lipoprotein-cholesteryl ester transfer activity in those species 
which have a lipoprotein-cholesteryl ester transfer factor (Marcel et 
al., 1980). Therefore, the evidence indicates that the ultimate source 
of cholesteryl esters for transfer in the human is LCAT (Schwartz, et 
al., 1982). 
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Cholesteryl ester exchange has been observed between lipoproteins 
and phospholipid vesicles, but only between HDL and the vesicles, since 
LDL and VLDL could not promote exchange, when incubated alone with the 
phospholipid vesicles (Pattnaik et al., 1979). Cholesteryl ester trans-
fer from HDL to vesicles was found to require the density greater than 
1. 210 g/ml fraction of either human or rabbit serum and cholesteryl 
ester transfer was also found to occur with either HDL1 , HDL2 or HDL3 
(Young et al., 1981). LDL and VLDL incubated together appeared to 
exchange cholesteryl ester between each other, but no transfer of cho-
lesteryl esters was observed (Chajek et al., 1978). In contrast, 
another study demonstrated that lipoprotein-cholesteryl ester transfer 
may occur between LDL and VLDL (Barter et al., 1980). The probability 
of a transfer protein picking up esterified cholesterol in human plasma 
for HDL versus VLDL versus LDL is 28.9:4.65:1 (Barter et al., 1982b), 
which would explain the preference for obtaining cholesteryl ester for 
transfer from HDL (Chajek et al., 1980).· Moreover, this would suggest 
that the lipoprotein-cholesteryl ester transfer protein may be nonspe-
cific (Barter et al., 1982a). 
C. Lipoprotein-Triglyceride Transfer 
Exchange of cholesteryl ester for triglyceride between lipopro-
teins was first demonstrated in human plasma samples incubated without 
LCAT inhibition (Rehnborg et al., 1964). Further investigation indi-
cated that lipoprotein-triglyceride and cholesteryl ester transfer may 
be independent since lipoprotein triglyceride transfer can be inhibited 
by thiol group blockade, whereas lipoprotein-cholesteryl ester transfer 
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is not (Hopkins et al., 1980; 1982). However, using purified lipid 
transfer protein isolated from human plasma, both lipoprotein-choles-
teryl ester and triglyceride transfer could be demonstrated (Morton et 
al., 1982). Moreover, others believe that lipoprotein-triglyceride and 
cholesteryl ester transfer may be linked to phospholipid transfer or 
exchange (Ihm et al., 1980; 1982). Whether a single factor or lipid 
transfer complex -exists for the transfer of both lipoprotein-cholesterol 
and triglyceride remains to be established. Although early studies have 
shown that a lipoprotein-triglyceride exchange occurs between rat lipo-
proteins (Roheim et al., 1963), no evidence of significant triglyceride 
transfer could be observed in rat plasma as compared to human and rabbit 
plasma (Barter et al., 1979a; 1979d). 
D. Lipoprotein-Phospholipid Transfer 
Phospholipid exchange was demonstrated during in vitro incubations 
of rat plasma (Roheim et al., 1963). Exchange of phospholipid for unes-
terified cholesterol was also observed between rat chylomicrons and 
human HDL by what was postulated to be a passive process, initiated by 
collisions between the two particles (Lippiello et al., 1983). In con-
trast, exchange of phosphatidyl choline was found to be enhanced by a 
partially purified phospholipid transfer factor as was shown by an in 
~ incubation of unilamellar liposomes with human plasma HDL (Darnen 
et al., 1982). HDL has been shown to have a high capacity for phospha-
tidylcholine uptake and that membrane transfer can occur from phosphati-
dylcholine vesicles to HDL (Jonas, 1979), however with the addition of a 
density greater than 1.21 g/ml fraction of plasma the phosphatidyl cho-
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line transfer to HDL was markedly enhanced possibly due to alteration in 
the membrane, facilitating transfer (Tall et al., 1983b). Proteins 
facilitating the transfer of phosphatidyl choline and cholesteryl ester 
from HDL to LDL were partially purified from human plasma and the pro-
tein or proteins responsible for both transfer processes coeluted at 
every purification step. In addition, the rat was found to have a pro-
tein, which facilitated lipoprotein-phospholipid transfer, but not lipo-
protein-cholesteryl ester transfer indicating that the two processes may 
be handled by at least two different proteins (Ihm et al., 1980). This 
was confirmed, when two protein fractions were isolated from human 
plasma each having the separate ability of either lipoprotein-choles-
teryl ester or phospholipid transfer (Tall et al., 1983a). It has been 
suggested that the lipoprotein-phospholipid transfer factor exists in a 
complex with LCAT and lipoprotein-cholesteryl ester exchange protein in 
human as well as in rat plasma (Ihm et al., 1982), even though rat 
plasma has very little lipoprotein-cholesteryl ester transfer activity 
(Barter et al., 1978). This would be consistent with evidence that the 
rat may have a plasma substance which inhibits the lipoprotein-choles-
teryl ester transfer factor (Morton et al., 1981). 
E. Rat Lipoprotein-Cholesteryl Ester Transfer 
The transfer of cholesteryl ester between HDL and lower density 
lipoproteins has previously been reported to occur in rat plasma at 
extremely low rates when compared to other species such as rabbits and 
humans (Barter et al., 1978; 1979b; 1979c; Oschry et al., 1982). A 
plasma inhibitor to the lipoprotein-cholesteryl ester transfer factor 
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bas been demonstrated in the rat which may account for the low rates of 
lipoprotein-cholesteryl ester transfer observed between rat plasma HDL 
and VLDL (Morton et al., 1981). Recently, two HDL subfractions that 
were isolated from rat plasma by HDL gradient ultracentrifugation were 
found to display cholesteryl ester transfer activity employing an in 
~ assay. Rat plasma cholesteryl ester appeared to be transferred 
from a less dense HDL subfraction to a denser HDL subfraction, both iso-
lated by density gradient ultracentrifugation (Jansen et al., 1983). In 
contrast, two rat plasma HDL subfractions isolated by zonal ultracentri-
fugation, did not show any cholesteryl ester transfer activity in vitro. 
However, in vivo, transfer of cholesteryl ester between these two HDL 
subfractions was observed, with the transfer occurring from the denser 
HDL subfraction to the less dense HDL subfraction when the denser HDL 
subfraction containing radioactively-labeled cholesterol was adminis-
tered to rats (Eisenberg et al., 1984). The conflicting observations of 
these two reports regarding cholesteryl ester transfer between various 
rat plasma HDL subfractions may be due to differences in lipoprotein 
compositions resulting from separation of lipoprotein fractions employ-
ing ultracentrifugal techniques (Lindgren et al., 1979). 
IV. ESTROGENIC REGULATION OF LIPOPROTEIN RECEPTORS 
A. Hypolipidemic Effect of Estradiol on Rats 
1. Hypocholesterolemia and 
bipoprotein Clearance 
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In vivo administration of 17 a-ethinyl estradiol to rats has ·pro-
duced marked hypocholesterolemia. Estrogen treatment lowered plasma 
cholesterol levels by 90%, while plasma apolipoproteins were lowered as 
well (Davis et al., 1978). Estrogen treatment was found to cause a com-
plete disappearance of LDL in rat plasma. Moreover, the liver was the 
organ responsible for the uptake and degradation of LDL in estrogen 
treated animals as was demonstrated by injecting labeled LDL into rats 
treated with estrogen (Hay et al., 1971). This was confirmed when the 
rate of LDL clearance was found to decrease in functionally eviscerated 
rats as compared to controls, when prior to evisceration both groups had 
augmented LDL clearance due to ethinyl estradiol treatment (Chao et al., 
1979). 
2. Specific Lipoprotein 
Receptor Induction 
LDL uptake by rat liver in vivo appeared to resemble the uptake 
seen in vitro by specific LDL receptors found in fibroblasts, since the 
liver membranes removed from ethinyl estradiol treated rats showed a 
marked binding preference for LDL over HDL, required calcium for bind-
ing, failed to bind LDL which had been modified and the binding capabil-
ity was destroyed by pronase, all characteristics of the classical LDL 
binding receptor observed in fibroblasts (Kovanen et al., 1979b). Fur-
ther characterization of the binding properties of the liver membranes 
of ethinyl estradiol treated rats revealed a specificity for apo B and 
apo E containing lipoproteins (Windler et al., 1980b). Conversely 
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female rats, which were ovariectomized showed a marked increase in 
plasma cholesterol, triglycerides and apolipoproteins B, E and C. The 
main reason for the increase was found to be due to an increase in LDL 
and HDL in the ovariectomized rat (Van Lenten et al., 1983). The 
increases in those lipoproteins were probably due to the decrease in 
uptake of apo E containing HDL and apo B containing LDL by lipoprotein 
receptors which were reduced, because of the loss of estrogen stimulated 
production. 
B. Sex Hormones and Human Lipoprotein Catabolism 
1. Oral Contraceptives and 
Estrogen Replacement 
It has long been known that premenopausal women have a lower risk 
of developing coronary heart disease than men and that risk increases to 
the same as men after menopause (Barr et al., 1955). Since estrogen 
appears to produce a marked hypocholesterolemia in rats, it is interest-
ing to postulate a protective role for estrogen in the human female by 
increasing lipoprotein-cholesterol clearance and reducing the risk of 
coronary heart disease. Studies on women given estrogen replacement 
therapy following menopause and on women given oral contraceptives have 
yielded information on the influence of sex hormones on lipoprotein 
metabolism. Premenopausal women have higher plasma HDL levels than men 
(Levy et al., 1966) and plasma HDL has been inversely correlated with 
the risk of developing coronary artery disease (Gordon et al., 1977; see 
section V. C. 3. HDL-cholesterol). Women on estrogen therapy have 
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increased HDL levels (Cauley et al., 1983)., but women on combined 
estrogen-progesterone therapy do not (Cheung et al., 1977). A reduced 
plasma HDL level was found in women taking contraceptives (Arntzenius et 
al., 1978), which may be due to progesterone content, since it was found 
that HDL increases with the amount of estrogen and decreases with the 
amount or potency of progesterone administered (Bradley et al., 1978; 
Farish et al., 1983). Elevated plasma apo A-I values occur in humans 
with high plasma estrogen levels, whether the estrogen is from exogenous 
or endogenous sources (Albers et al., 1976). Myocardial infarction risk 
however, increases with the use of oral contraceptives and that 
increased risk has been found to continue after contraceptive use ceases 
in long term users (Slone et al., 1981). Women taking oral contracep-
tives were found to have a death rate 40% greater than those who had 
never taken them and the excess deaths were found to be due to circula-
tory system disease, mostly from excessive clotting (Royal College of 
General Practitioners, 1981). Moreover,. lowering the estrogen content 
of contraceptive pills was found to lower the incidence of thromboem-
belie disease (Bottiger et al., 1980a). 
2. Estrogen and Male 
Susceptibility to Myocardial 
Infarction 
While estrogens may have a protective effect toward coronary 
artery disease in women possibly by increasing their HDL-cholesterol 
levels, it has been found that men with myocardial infarction have 
higher plasma estrogen levels than those who do not have an infarction 
(Phillips et al., 1983). In contrast, testosterone was found to have a 
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significant positive correlation with plasma HDL in adult men (Heller et 
al., 1981b), yet no significant correlation could be found between tes-
tosterone or estrogen and male patients who had previous myocardial 
infarctions (Heller et al., 1981a). Unfortunately, this study was not 
controlled for drug usage nor time following the infarction, since some 
patients included in the study had their infarction eleven years prior 
to the time their steroid hormones were evaluated. Another year long 
study on adolescent boys determined an increase in plasma testosterone 
occurred with a decrease in plasma estrogen, which corresponded to an 
increase in plasma triglycerides and LDL-cholesterol, while HDL-choles-
terol decreased (Laskarzewski et al., 1983). The lipid changes however, 
may be an age related phenomenon unassociated with the change in hormone 
levels. 
The cause of estrogen's protective nature regarding myocardial 
infarction in women and the increased risk in men is unknown at present. 
A recent research news report in Science magazine (Kolata, 1983) 
received four different opinions of this problem from four researchers. 
One postulated that estrogen increased the development of atherosclero-
sis, which seems unlikely due to the decrease in risk of coronary artery 
disease associated with the raising of HDL-cholesterol levels as seen in 
women taking estrogen contraceptives (Cauley et al.,· 1983). Another 
postulates that estrogen increases blood clotting, which would agree 
with results seen in the contraceptive studies (Bottiger et al., 1980a; 
Royal College of General Practitioners, 1981). The other two researchers 
feel that estrogens either increase the work load of the heart or cause 
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coronary vasospasms leading to myocardial infarction. 
V. ATHEROSCLEROSIS 
A. Arteriosclerosis 
1. Definition 
Arteriosclerosis is a disease of blood vessels characterized by a 
thickening and hardening of the blood vessel walls with a loss of elas-
ticity, which occurs most frequently in arteries. Atherosclerosis is 
the most common form of arteriosclerosis, characterized by the localized 
accumulations of lipid containing material within or beneath the intimal 
surfaces of blood vessels. 
2. Development 
Atherosclerosis is believed to progress from fatty streaks, which 
occur in childhood resulting from the deposition of lipids mostly in the 
form of unesterif ied cholesterol or cholesterol oleate in the smooth-
muscle cells and macrophages of the arterial intima. An increased num-
ber of smooth-muscle cells and an increased amount of connective tissue 
surround and cover the deposit of cholesterol-rich lipid in the lining 
of the lumen of the artery. The connective tissue and smooth muscle 
cells surrounding the cholesterol-rich- lipid core is known as a fibrous 
plaque, however not all fatty streaks develop into fibrous plaques and 
there is considerable controversy as to whether the fatty streak is 
actually the initial condition from which the fibrous plaque develops. 
As atherosclerosis progresses, the fibrous plaque enlarges and undergoes 
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complex changes, becoming vascularized from both the lumen and the 
media. The fibrous plaque's lipid core also increases in size and 
becomes calcified. The intimal surface may disintegrate and ulcerate or 
the blood vessels may rupture and hemorrhage into the plaque. The ulti-
mate result of the atherosclerotic process is that the lumen of the 
blood vessel becomes blocked, decreasing blood flow to the tissue the 
vessel supplies (Report of the Working Group on Arteriosclerosis, 1981). 
B. Theories of Atherosclerotic Development 
1. Lipid Infiltration 
Hypothesis 
The lipid infiltration hypothesis suggests that lipids filter 
through the endothelial lining of the artery and accumulate in the 
intima of the artery. High plasma lipid levels would therefore cause an 
increase in the passive diffusion of lipid between the junctions of the 
endothelial cells with a subsequent increase in the lipid concentration 
of the arterial intima. Plasma proteins, including lipoproteins have 
been demonstrated to penetrate the intact endothelium, therefore lipo-
protein lipid could be deposited within the intima and initiate the ath-
erosclerotic process (Bratzler et al., 1977; Reich! et al., 1973). 
Moreover, the theory is supported by the 'experimental evidence that ath-
erosclerotic lesions can be induced by feeding high fat, high choles-
terol diets to experimental animals (Camejo et al., 1973; Kramsch et 
al., 1981; Mahley et al., 1974; Mahley, 1978; Shore et al., 1974), since 
high cholesterol diets increase the plasma cholesterol levels of certain 
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animal species promoting the deposit of lipid within the intima of 
arteries. This hypothesis however, does not explain why atherosclerotic 
lesions do not appear at random, but appear more frequently at areas of 
stress in the arterial tree, particularly within the coronary arteries 
(Ross, 1979). 
2. Response to Injury 
Hypothesis 
The response to injury hypothesis suggests that some form of 
injury occurs to the endothelial cells lining the lumen of the artery. 
The protective endothelial barrier could be altered in some way as to 
increase permeability toward lipoproteins and lipids, which in part 
agrees with the lipid infiltration hypothesis, but assumes an underlying 
cause for the increase in lipid permeability. Alternatively, the postu-
lated damage could be so severe as to remove the endothelial cells and 
cause platelet aggregation at the site of injury. Platelet release of 
substances including platelet derived growth factor (PDGF), would cause 
the focal migration of smooth muscle cells to the site of injury and 
their subsequent proliferation. Plasma lipid carried by lipoproteins, 
particularly LDL would have easier access to the area affected and lipid 
accumulation would ensue. Chronic injury to the area would promote the 
progression of the lesion and if the factor leading to injury was tempo-
rary the process could be reversed and the lesion regress (Ross, 1979). 
No direct evidence has demonstrated that initiation of the atheroscler-
otic lesion is due to loss of the endothelial lining, however experimen-
tally induced atherosclerotic lesions have been produced by damaging the 
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endothelial lining mechanically, by irradiation, or by changes in 
temperature, pH and osmolarity. Other factors implicated as causes for 
damaging the endothelial tissue in humans are endotoxins, hyperlipide-
mia, antigen-antibody complexes, carbon monoxide, viral infection and 
hemodynamic stress (Grundy, 1983). Hypertension has also been impli-
cated as a factor increasing the risk of developing atherosclerosis in 
humans. Experimental models of hypertension have demonstrated intracel-
lular enzymatic changes affecting cholesterol metabolism, therefore the 
initial injury caused by undue vessel stress due to hypertension could 
lead to enzyme modification of lipid metabolism, increasing deposition 
of cholesteryl esters within the cell and initiating the atherosclerotic 
process (Hayashi et al., 1982). 
3. Monoclonal Hypothesis 
The monoclonal hypothesis assumes that atherosclerosis is a pro-
liferative disease. The hypothesis suggests that the proliferative 
smooth muscle cells in the atherosclerotic lesions are derived from a 
single progenitor cell, therefore the lesions are similar to a benign 
neoplasm (Ross, 1982). The hypothesis is based on the observation that 
a single isoenzyme of glucose-6-phosphate dehydrogenase EC 1.1.1. 49 
(Nomenclature Committee, 1979) was present in lesioned arteries, whereas 
. . 
normal arteries had a mixture of the two isoenzymes (Benditt et al., 
1973). This does not necessarily mean that the lesion arises from one 
cell, but could mean that one cell type is more proliferative than the 
other. 
r 
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C. Lipoproteins and Atherosclerosis 
1. VLDL and Triglyceride 
The atherogeneity of VLDL the major triglyceride containing lipo-
protein of human plasma is as yet unresolved (Grundy, 1983; Riemersma, 
1984). The results of epidemiological studies determining whether tri-
glyceride and VLDL levels correlated to the presence or severity of ath-
erosclerotic disease have been inconsistent. A recent study has shown a 
greater amount of triglycerides and VLDL-triglycerides in patients suf-
fering from coronary artery disease as compared to normal age matched 
controls. A fat tolerance test performed on all subjects in the study 
indicated the patients with coronary artery disease cleared triglycer-
ides from the plasma slower than the normal control subjects (Tollin et 
al., 1984). The study was undertaken to confirm a previous project, 
which had demonstrated a positive correlation between serum triglyceride 
concentration and the presence of coronary artery disease (Bottiger et 
al., 1980b). Moreover, VLDL-cholesterol concentration has been shown to 
be a good predictor of coronary artery disease in humans over 50 years 
of age (Whayne et al., 1981). 
Al though many studies have shown that patients with coronary 
artery disease tend to have high plasma triglyceride levels, when other 
factors were considered the significance of high serum triglycerides as 
a predictor of the risk of obtaining coronary artery disease disap-
peared. The Framingham study demonstrated upon univariate analysis of 
the data that serum triglyceride was significantly correlated with coro-
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nary artery disease in women, however using multivariate analysis no 
significant correlation was found (Gordon et al., 1977). Serum trigly-
cerides as determined in the Framingham study were not consistently 
found to be a significant factor in coronary heart disease risk 
(Castelli et al., 1977). Apolipoprotein B, a major component of VLDL as 
well as LDL was determined in a human population, which had suffered 
from previous myocardial infarction and compared to a human population 
with hypertriglyceridemia. Higher ape B concentrations were found in 
those patients with previous myocardial infarction and in the hypertri-
glyceridemia patients with symptoms of coronary artery disease, than in 
patients with hypertriglyceridemia and no symptoms of coronary artery 
disease. Serum triglycerides although high in both populations, were 
not as important predictors of coronary artery disease as the ape B con-
centration (Sniderman et al., 1982). 
Studies attempting to link serum triglyceride levels to the sever-
ity of coronary artery disease in humans· have also suffered from incon-
sistencies. VLDL-triglyceride has been found to be significantly corre-
lated with the severity of coronary artery disease, while serum 
triglyceride results were inconclusive (Jenkins et al., 1978). Other 
studies have indicated that serum triglycerides have no discriminating 
function at all as to severity of coronary artery disease (Noma et· al., 
1983; Riesen et al., 1980; Vander Heiden et al., 1984). 
HDL-cholesterol, which will be discussed shortly has been neg-
atively correlated with coronary artery disease (Gordon et al., 1977) 
and has been negatively correlated with VLDL-triglyceride concentration 
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(Gordon et al., 1977; Miller et al., 1975; Schaeffer et al., 1978a). 
Hypertension, a primary risk factor for development of atherosclerotic 
disease is related to body mass as is plasma triglyceride concentration. 
Moreover, epidemiological studies indicate that triglyceride levels 
appear to be related to cholesterol concentration. Therefore, plasma 
triglycerides are related to factors which are in turn related to the 
risk in humans of developing atherosclerotic disease, but plasma trigly-
ceride levels alone are not necessarily related to coronary artery dis-
ease. No persuasive evidence could be found in the Western Collabora-
tive Group study or in a twenty year review of published epidemiological 
reports that triglycerides are involved in coronary heart disease 
(Hulley et al., 1980). On the other hand, a mechanism has been proposed 
whereby VLDL could be involved in the atherosclerotic process. 
Zilversmit (1973) has suggested that lipoprotein lipase by its location 
on the cell surface and its actions on VLDL creates a lipoprotein parti-
.cle with a high cholesterol content in close proximity to the cell sur-
face, thus increasing the likelihood of cholesterol being taken up into 
the intima. It has also been suggested that the liberation of free 
fatty acids by lipoprotein lipase's action on VLDL triglycerides creates 
a disturbance in the endothelial lining increasing the permeability of 
·the artery, allowing LDL or the newly ·formed VLDL remnant ready access 
to the intimal layer of the artery (Hulsmann et al., 1975). 
The epidemiological evidence thus far accumulated appears to indi-
cate that serum triglycerides and VLDL triglycerides may not play a pri-
mary role in the induction of atherosclerotic lesions. However, epide-
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miological studies are based on lipid levels determined at a particular 
time on a particular day and are unrelated to processes involved in 
actual lipid metabolism. VLDL may play an important secondary role in 
atherogenesis as the precursor to LDL (Eisenberg et al., 1973a) or by 
VLDL's inverse relationship to HDL (Miller et al., 1975). VLDL's con-
tribution to the generation of atherosclerotic disease may not be 
clearly understood until consideration is given to the plasma lipid met-
abolic processes, which can not be determined in epidemiologic studies. 
2. LDL and Cholesterol 
Recently the atherogeneity of human plasma total cholesterol has 
been demonstrated by the Lipid Research Clinics Program (1984a; 1984b). 
The program had completed a study showing that drug therapy which 
decreased plasma total cholesterol concentrations in patients suffering 
from hypercholesterolemia was responsible for a decrease in the inci-
dence of coronary heart disease and coronary artery disease. The plasma 
total cholesterol was found to be directly proportional to the LDL-cho-
lesterol level. Since LDL is the major cholesterol carrying lipoprotein 
in the human, the reduction in plasma total cholesterol found in this 
study was found to be due to a reduction in plasma LDL-cholesterol. 
This study has confirmed what has been implied since the 1950's, that 
LDL elevation in human plasma was strongly correlated with atherosclero-
sis (Gofman et al., 1954). 
Epidemiological studies have shown in almost all cases a positive 
correlation between the risk of developing either coronary heart disease 
or coronary artery disease and the plasma concentration of LDL~choles-
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terol. The Framingham study (Gordon et al., 1977; Castelli et al., 
1977) had found significant positive correlations between LDL-chol~s­
terol and coronary heart disease, but the Framingham study when adjusted 
for age did not find a significant relationship between plasma total 
cholesterol and coronary heart disease, as was also true for the 
Stockholm study (Bottiger et al., 1980b). 
Although LDL-cholesterol has been found to be a significant pre-
dictor of coronary heart disease, determination of human plasma LDL-cho-
lesterol concentration may be an even better predictor of coronary 
artery disease severity. Plasma LDL-cholesterol and ape B concentra-
tions have been found to be the best predictors of human coronary artery 
disease severity in several studies (Noma et al., 1983; Riesen et al., 
1980; Sniderman et al., 1982; Vander Heiden et al., 1984). All of these 
studies demonstrated a positive correlation between plasma LDL-choles-
terol concentration and ape B concentration and the degree of angio-
graphically measured coronary heart disease. Moreover, the ape B con-
centration appeared to be the best discriminator of coronary disease 
severity, particularly in a study, which used subjects who had plasma 
total cholesterol levels below 265 mg/dl (Whayne et al., 1981). 
Since LDL carries 70% of human total plasma cholesterol and ather-
osclerotic disease is due to the depo~i~ of cholesteiyl esters within 
the arterial wall it has been assumed that LDL-cholesterol is the pri-
mary lipoprotein involved in the human atherogenic process. The LDL 
receptor pathway however, as described by Goldstein and Brown (1977a) is 
a nonatherogenic pathway, because LDL receptors are down regulated by 
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cholesterol accumulation preventing cells from taking up more 
cholesterol than they need (see section II.C.4. LDL Catabolism). Yet, 
atherosclerosis has been found to occur when human plasma LDL-choles-
terol concentration increases due to either inherited lipoprotein recep-
tor defects or environmental factors. The increased LDL-cholesterol may 
be taken up in cells by phagocytosis via the scavenger cell pathway, 
which is not regulated by cholesterol uptake, thus cholesterol can accu-
mulate in the scavenger cells to a tremendous extent forming the foam 
cells seen in atherosclerotic lesions (Brown et al., 1980; Goldstein et 
al., 1977b; Packard et al., 1983). 
Clearly epidemiological and experimental evidence supports the 
atherogenic potential of LDL-cholesterol, although the epidemiological 
evidence for plasma total cholesterol as a risk factor for atherogenesis 
is not as convincing. One area of LDL and atherosclerotic research 
which needs to be addressed on the molecular level is the phagocytosis 
of unmodified LDL (see section II.C.4. LDL Catabolism), since the sca-
venger pathway does not appear to recognize normal LDL, but only a modi-
fied more electronegative LDL (Brown et al., 1980). Therefore, in vivo 
LDL modification prior to phagocytosis has yet to be completely under-
stood. Moreover, the relationship of other risk factors to atherogene-
sis and LDL metabolism must also be explored to determine what LDL's 
function is in atherosclerotic lesion production. 
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3. HDL-cholesterol 
Many biological systems have balances, like feedback inhibition, 
to prevent excesses from occurring. LDL, which appears to be an athero-
genic lipoprotein would hopefully be balanced by a nonatherogenic, pro-
tective lipoprotein. Studies have indicated that HDL may be that lipo-
protein. A relationship between alpha 1 lipoprotein-cholesterol (HDL) 
and reduced risk of obtaining atherosclerosis was demonstrated in the 
1950's (Barr, 1951). It was also noted that a high plasma total choles-
terol concentration was related to a high plasma beta lipoprotein-cho-
lesterol (LDL) concentration but low alpha1 lipoprotein-cholesterol con-
centration was a more consistent predictor of atherosclerotic disease. 
However, it was not until 1975 that interest was rekindled in alpha1 
lipoprotein, when a study using subjects with plasma cholesterol levels 
less than 250 mg/dl found that the HDL-cholesterol levels were signifi-
cantly lower in those patients with coronary artery disease than those 
without coronary artery disease (Miller et al., 1975). Epidemiological 
studies have consistently shown that HDL-cholesterol is negatively cor-
related to the risk of obtaining coronary heart disease (Castelli et 
al., 1977; Gordon et al., 1977). Moreover, the major apolipoprotein of 
HDL, ape A-I may be an even better discriminator of coronary artery dis-
ease than HDL-cholesterol (Maciejko, et al., 1983). 
Despite HDL-cholesterol's discriminant power in predicting the 
incidence of atherosclerotic disease, HDL-cholesterol does not appear to 
be a good predictor of the severity of atherosclerotic disease (Noma et 
al., 1983). Apo A-I, ape B, ape A-II, TC and LDL-C were found to be 
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good discriminators of severity of coronary artery disease, but 
HDL-cholesterol was not (Riesen et al., 1980). Interestingly, apo A-I 
and HDL-cholesterol have been found to be very closely correlated 
(Maciejko et al., 1983), therefore the discriminating power of apo A-I 
as compared to HDL-cholesterol should be similar, which was not indi-
cated in the study by Riesen and coworkers. Moreover, another study has 
demonstrated that HDL-cholesterol concentration is a good discriminator 
of atherosclerotic disease severity (Jenkins et Al., 1978), therefore 
the discriminatory power of HDL-cholesterol as a predictor of atheros-
clerotic disease severity is still controversial. 
Virtually every epidemiological study demonstrates a negative cor-
relation between human plasma HDL-cholesterol concentration and coronary 
artery disease or coronary heart disease. People involved in aerobic 
exercise have a lower incidence of coronary heart disease than the rest 
of the population and more HDL-cholesterol than sedentary people or 
those who exercise anaerobically (Clarkson et al., 1981; Hartung et al., 
1980). People in areas free of coronary heart disease have higher HDL-
cholesterol concentrations than people in areas of high incidence for 
coronary heart disease (Walker et al., 1978). Consumption of alcohol 
has been shown to be associated with a decreased risk of obtaining coro-
nary heart disease (Dyer et al., 1980; Klatsky et al., 1974). Moreover, 
alcohol consumption has been associated with an increase in plasma HDL-
cholesterol concentration (Haskell et al., 1984; Thornton et al., 1983). 
Although these studies do not necessarily imply a direct link between 
HDL-cholesterol and atherosclerotic risk, they are suggestive that HDL 
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plays an important role in the prevention of atherosclerotic disease. 
The protection HDL-cholesterol appears to provide from atheroscle-
rosis has been postulated to be due to HDL acting as a cholesterol sea-
venger (see section II.C.7. HDL Catabolism). In vitro studies have 
shown HDL is able to attract the unesterif ied cholesterol from tissue 
membranes (Fielding et al., 1981b). LCAT for which HDL has been demon-
strated to be the preferred substrate (Fielding et al., 1971), esteri-
fies cholesterol on the surface of the HDL molecule and the esterif ied 
cholesterol is stored in the hydrophobic core of the HDL molecule allow-
ing room for the accumulation of more unesterif ied cholesterol on the 
surface (Glomset et al., 1973). Cholesterol has been postulated to be 
cleared from the cells by this mechanism, although no direct in vivo 
evidence has proven this. Removal of cholesterol from human plasma may 
be dependent on HDL uptake by the liver or more probably by cholesteryl 
ester transfer to lower density lipoproteins (see section III.B.1. Cho-
lesteryl Ester Transfer and Exchange) which ultimately results in the 
increase of cholesteryl esters within LDL, which are then removed 
through the LDL receptor pathway (Brown et al., 1981). 
Presently, the factors which are known and can be determined to 
account for the risk in humans of developing coronary artery disease may 
be able to predict the disease only 50% o"f the time (Crouse, 1984)." The 
focus of the search for better predictors of coronary artery disease is 
on the constitutive fractions of lipoproteins and coagulation factors 
leading to thrombi, which can block the arteries. Other possible fac-
tors including dietary and psychological studies are also being 
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explored. Lipoprotein concentrations have limited value as a diagnostic 
tool in those patients showing symptoms of coronary artery disease, but 
the great value may come as a predictive index for the potential of 
developing such disease and the continued elaboration of the functional 
roles of lipoproteins will lead to the ultimate understanding of the 
atherosclerotic disease process and its cure (Blackburn, 1983). 
D. Species Susceptibility to Atherosclerosis 
1. Rat Atherosclerosis 
Proliferative lesions have been found to occur in rat arteries 
when subjected to stress or damage, but these lesions do not mimic ath-
erosclerotic lesions since they are lipid poor, unless the rat's plasma 
cholesterol is artificially elevated either by a high cholesterol diet 
or injection of cholesterol rich lipoproteins (Bishop, 1980). Simi-
larly, spontaneous arteriosclerotic lesions which appear in the rat do 
not stain for lipid and are more prevalent in the female. The occurance 
of these proliferative lesions was positively correlated to the fre-
quency of breeding indicating there may be a hormonal influence to the 
proliferative disease (Wexler, 1964). 
2. Diet 
The rat is very resistant to dietary induction of atherosclerotic 
lesions (Bishop, 1980). Atherosclerotic lesions in rats similar to 
those seen in humans however, have been produced by feeding rats high 
cholesterol diets including bile acids and inducing hypothyroidism with 
76 
propylthiouracil or irradiation (Fillies et al., 1956; Malinow et al., 
1954; Wissler et al., 1954). The rat's resistance to dietary induced 
atherosclerotic lesions is similar to that of the dog, which must also 
be made hypothyroid with a high cholesterol diet to induce atheroscler-
otic lesions (Mahley et al., 1977d). Another animal fairly resistant to 
dietary induction of atherosclerotic lesions is the mouse (Beher et al., 
1963), whereas species that are susceptible to dietary induced atheros-
clerotic lesions include, rabbits, monkeys, swine and possibly humans 
(Camejo et al., 1973; Kr ams ch et al., 1981; Mahley, 1978; Ross, 1979; 
Shore et al., 1974). 
3. Hypothyroidism 
Hypothyroidism in the human has been found to cause a hyperlipide-
mia characterized by high plasma cholesterol levels, whereas thyrotoxi-
cosis produces the opposite effect on plasma cholesterol and LDL levels 
(Mishkel et al., 1977; Walton et al., 1965). Thyroid hormones affect on 
cholesterol concentration of the plasma may be related to LDL receptors 
as it has been observed from in vitro studies on human skin fibroblasts 
- ---
that thyroxine stimulates the growth of LDL receptors (Chait et al., 
1979). The increase in extrahepatic lipoprotein receptors would 
increase LDL catabolism in vivo and thus lower the plasma cholesterol 
concentration. 
Experimentally induced hypothyroidism in rats has been found to 
affect the apo E and apo B composition of rat plasma lipoproteins. 
Moreover, both apo E and apo B concentrations increase by 100% after 
propyl thiouracil induced hypothyroidism, with a concomitant increase in 
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plasma cholesterol of 50-100% and a 20-40% decrease in plasma triglycer-
ides. The decrease in rat plasma triglycerides was believed to be due 
to an increase in lipoprotein lipase activity, whereas the increase in 
rat plasma cholesterol was due to a decrease in LDL and VLDL remnant 
removal (Dory et al., 1981). Hypothyroid rats on a high cholesterol 
diet produced qualitative and quantitative differences in the plasma 
lipoprotein profile as compared to euthyroid rats on the same high cho-
lesterol diet. Plasma apo E concentrations decreased in the cholesterol 
fed euthyroid rats as compared to an increase in the hypothyroid choles-
terol fed rats. In addition, HDL and beta migrating VLDL appeared in 
c 
the hypothyroid cholesterol fed rat plasma, whereas neither lipoprotein 
was found in the plasma of euthyroid cholesterol fed rats. Apo B and 
plasma cholesterol were increased in both rat groups, but more so in the 
hypothyroid rats (DeLamatre et al., 1981). These data suggest that the 
hypercholesterolemia induced by hypothyroidism is qualitatively differ-
ent from dietary induced hypercholesterolemia. 
4. Miscellaneous 
Atherosclerotic Factors 
HDL , the lipoprotein which appears after cholesterol feeding (see 
c 
section II.D.3. Metabolism and Response to Hypercholesterolemia) may be 
involved with the atherosclerotic process, since HDL appears in ·all 
c 
species studied when hypercholesterolemia has been induced (Mahley, 
1978). On the other hand, the atherosclerotic process was shown to be 
inhibited in monkeys fed lanthanum with a high cholesterol atherogenic 
diet, therefore it was postulated that calcium, for which lanthanum is 
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an antagonist, is an integral part of the atherosclerotic process 
(Kramsch et al., 1981). Platelet derived growth factor (PDGF) has _also 
been suggested as the initiator of the proliferative disorder associated 
with atherosclerotic lesions (Ross, 1979). Epinephrine administered 
with thyroxine and triiodothyronine was found to produce arterioscler-
otic lesions in the rabbit, which was unrelated to any hypertensive 
effect (Oester, 1959). Currently, it would appear that no one event or 
factor may be responsible for the initiation and progression of the ath-
erosclerotic lesion. The list of primary risk factors for atheroscler-
otic disease in humans includes, hyperlipidemia, hypertension, smoking 
and diabetes mellitus, with numerous possible secondary risk factors 
also implicated toward developing coronary artery disease (Grundy, 
1983). Animal models of atherosclerotic disease have provided a great 
deal of information toward understanding the initiation and progression 
of atherosclerotic lesions. In addition, animal models have provide 
insights into lipoprotein metabolism and its relation to atherosclerotic 
disease. Animal models designed to investigate lipoprotein metabolism 
and atherosclerotic progression in response to the known and proposed 
risk factors can ultimately lead to the prevention of atherosclerotic 
disease. 
CHAPTER II 
RESEARCH OBJECTIVES 
High density lipoprotein-cholesterol (HDL-C) has been implicated 
as a protective factor against atherosclerotic disease (Gordon et al., 
1977; Miller et al., 1975). Since the rat is known to have a very large 
proportionate amount of HDL-C (Chapman, 1980; Frnka et al., 1974; 
Narayan, 1971) and is also relatively resistant to the experimental 
induction of atherosclerotic disease (Chapman, 1980; Fillies et al., 
1956; Mahley et al., 1977a; Wissler et al., 1954), this animal would 
appear to be an excellent model to study the relationship of high den-
sity lipoproteins to atherosclerosis. Unfortunately, many studies which 
have utilized several different methods for determining plasma lipopro-
tein-cholesterol concentrations of the rat have yielded inconsistent 
results as indicated in a review by Chapman (1980). The coupling of an 
enzymatic determination of cholesterol (Allain et al., 1974) with cellu-
lose acetate electrophoresis (Cobb et al., 1978) has made possible a 
rapid and specific separation and analysis of human plasma lipoprotein-
cholesterol fractions, the ratios of which are currently being employed 
as risk factors for the development of human atherosclerosis. However, 
such a method has not been previously investigated with regard to the 
rat. The dissertation studies were therefore designed to compare the 
cellulose acetate electrophoretic plasma lipoprotein-cholesterol profile 
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of the rat and other experimental animals to that of the human. The 
presently reported studies were also designed to compare HDL-C levels in 
the rat determined by cellulose acetate electrophoresis to HDL-C levels 
obtained by polyanion precipitation techniques (Burstein et al., 1960; 
Kestner, 1976; Manual of Laboratory Operations, 1974). Therefore, the 
first part of this dissertation describes the technique by which we have 
characterized the cellulose acetate electrophoretic lipoprotein-choles-
terol profile of the rat and its comparison to other experimental ani-
mals. These studies have led to the discovery of a lipoprotein unique 
to rat plasma and has been named by this laboratory for its electropho-
retic mobility as prealbumin lipoprotein (PAL). 
The second part of this dissertation deals with cholesterol move-
ment between rat plasma lipoproteins and the subsequent discovery of a 
lipoprotein catabolic product possibly responsible for rat plasma cho-
lesterol clearance. In addition, this dissertation also describes a new 
technique for determining the unesterified cholesterol (UC) concentra-
tion of plasma lipoprotein fractions separated by cellulose acetate 
electrophoresis. The presently described method for analyzing plasma 
lipoprotein-UC combined with the usual method for analyzing plasma lipo-
protein-total cholesterol (TC) allows for the calculation of plasma 
lipoprotein-esterified cholesterol (EC) from the difference between 
plasma lipoprotein-TC and plasma lipoprotein-UC values. This new tech-
nique allowed us to characterize the in vitro movement of cholesterol 
between plasma lipoproteins more thoroughly. The transfer of choles-
teryl ester between high density lipoprotein (HDL) and lower density 
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lipoproteins has previously been reported to occur in rat plasma at 
extremely low rates when compared to other species such as rabbits and 
' 
humans (Barter et al., 1979c; Barter et al., 1978; Oschry et al., 1982). 
Recently however, two HDL subfractions that were isolated from rat 
plasma by HDL gradient ultracentrifugation were found to display choles-
teryl ester transfer activity employing an in vitro assay. Rat plasma 
cholesteryl ester appeared to be transferred from a less dense HDL sub-
fraction to a denser HDL subfraction, both isolated by density gradient 
ultracentrifugation (Jansen et al., 1983). In contrast, two rat plasma 
HDL subfractions isolated by zonal ultracentrifugation did not show any 
cholesteryl ester transfer activity in vitro. However in vivo, transfer 
of cholesteryl ester between these two HDL subfractions was observed 
with the transfer occurring from the denser HDL subfraction to the less 
dense HDL subfraction when the denser HDL subfraction containing radio-
actively-labeled cholesterol was administered to rats (Eisenberg et al., 
1984). The conflicting observations of these two reports regarding cho-
lesteryl ester transfer between various rat plasma HDL subfractions may 
be due to differences in lipoprotein compositions resulting from separa-
tion of lipoprotein fractions employing ultracentrifugal techniques 
(Lindgren et al., 1979). It has been suggested that electrophoretic 
techniques for isolation of plasma lipopr.otein fractions may be superior 
to ultracentrifugal methods because of the distortions leading to lipo-
protein degradation resulting from ultracentrifugation (Lindgren, 1980). 
As determined from the first part of these dissertation studies, 
two of four rat plasma lipoproteins separated using the technique of 
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cellulose acetate electrophoresis combined with an enzymatic stain for 
total cholesterol (Cobb et al., 1978), were characterized as HDL sub-
fractions and named according to their cellulose acetate electrophoretic 
mobilities as prealbumin lipoprotein (PAL) and alpha1 lipoprotein. 
Side-by-side cellulose acetate electrophoretic comparisons between rat 
whole plasma and the rat plasma HDL fraction isolated in the density 
range between 1.063-1.210 g/ml by sequential ultracentrifugation (Havel 
et al., 1955), as well as the rat plasma HDL supernates obtained by man-
ganese heparin precipitation (Manual of Laboratory Operations, 1974), 
and dextran sulfate precipitation (Kestner, 1976) confirmed that rat 
plasma prealbumin lipoprotein-cholesterol (PAL-C) and alpha1 lipoprotein 
(a1L-C) separated by cellulose acetate electrophoresis were HDL-C sub-
fractions. The other two rat plasma lipoproteins isolated by cellulose 
acetate electrophoresis were alpha2 lipoprotein-cholesterol (a2L-C) cor-
responding to VLDL-C and beta lipoprotein-cholesterol CeL-C) correspond-
ing to LDL-C. Studies presented in the second part of this disserta-
tion were designed to investigate whether the two rat plasma high 
density lipoprotein subfractions, PAL and a 1L, were involved in the 
clearance of cholesterol from rat plasma, thereby playing a possible 
role in the rat's relative resistance to dietary-induced atherosclerotic 
disease (Chapman, 1980; Fillies et al., 1956; Mahley et al., 1977a; 
Wissler et al., 1954). 
CHAPTER III 
METHODS 
I. SERUM COLLECTION 
Samples of blood were obtained from the abdominal aorta of adult 
male Sprague-Dawley rats ranging from 60-90 days of age (Holtzman Co., 
Madison, WI) under light ether (Mallinckrodt, St. Louis, MO) anesthesia 
(Grice, 1964). Samples of rabbit blood were obtained from the ear vein 
of adult male New Zealand white rabbits (Langshaw Farms, Augusta, MI). 
Samples of mouse blood were obtained from neck vessels following decapi-
tation of adult male Cox Swiss mice (Lab Supply Co., Indianapolis, IN). 
Samples of monkey blood were obtained from the femoral vein of phency-
clidine-anes thet ized adult male Rhesus monkeys (Primate Imports, New 
York, NY) courtesy of Dr. Randall from the department of Physiology. 
Samples of dog blood were obtained from the femoral artery of ethrane 
and nitrous oxide-anesthetized adult male dogs (Notsinger Kennels, St. 
Joseph, IL) courtesy of Dr. Thomas from the department of Physiology. 
Samples of human blood were obtained from the cubital vein of normal 
healthy adult male volunteers drawn while in a sitting position. All 
blood was collected in a sterile B-D vaccutainer tube with no additives 
(Becton, Dickenson and Co., Rutheford, NJ). The blood was placed in an 
ice bath, allowed to clot for 1 hour and then centrifuged at 1,000 x g 
for 15 min at 4 °C in an International refrigerated centrifuge. The 
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upper layer of serum was withdrawn and either placed in an ice bath for 
immediate analysis or frozen at -20 °C for analysis done at a later 
time. 
II. SERUM AND PLASMA TOTAL CHOLESTEROL DETERMINATION 
Serum or plasma total cholesterol levels were measured using an 
enzymatic method (Allain et al., 1974). Twenty microliters of serum or 
plasma were added to 1 ml of cholesterol reagent (Beckman Instruments 
Inc.) containing 1.6 mmol/l 4-aminoantipyrine, 21.2 mmol/l phenol, 
50,000 IU/l peroxidase, 500 IU/l cholesterol oxidase and 440 IU/l cho-
lesterol esterase in pH 7.5 phosphate buffer with chelate ions. Samples 
were mixed and incubated for 10 min at 37 °C. Absorbance was determined 
at 500 nm using a Beckman DU-8 spectrophotometer. Cholesterol concen-
trations were determined by comparison to a standard curve or by using a 
Beer Lambert constant. The assay was linear from 5 mg/dl to 500 mg/dl 
of cholesterol. 
III. LIPOPROTEIN-CHOLESTEROL AND PROTEIN DETERMINATION 
A. Lipoprotein-cholesterol Electrophoresis 
Electrophoresis was carried out according to the method of Cobb 
and Sanders (1978) on Titan III cellulose acetate plates (Helena Labora-
tories, Beaumont, TX) that were soaked overnight for optimal resolution 
in pH 8.8, 0.077 ionic strength tris-barbital buffer (Helena Laborator-
ies). Two microliters of serum or plasma were applied to the plate. 
The plate was electrophoresed at 180 volts for 25 min. Ten min prior to 
the end of the electrophoresis period, half of a second cellulose ace-
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tate plate which had soaked for at least 15 min in 0. 5 M, pH 6. 7 
phosphate buffer (Helena Laboratories) and blotted was then covered with 
enzymatic total cholesterol-staining reagent (Helena Laboratories) which 
was reconstituted with 1.5 ml of distilled water prior to electrophore-
sis. The electrophoresed sample plate was then cut in two, one half of 
which was layered carefully on top of the reagent plate and excess 
reagent and air bubbles removed, making a sandwich of the two half 
plates. The sandwiched plates were placed between two preheated devel-
opment weights and incubated on top of a Helena Laboratories microevapo-
rator hood for 25 min at 37 °C, following which the two plates were sep-
arated and the sample plate dried and examined under transmitted light 
for orange-colored lipoprotein-cholesterol bands. The orange-colored 
lipoprotein-cholesterol bands were densitometrically scanned at 500 nm 
in a Beckman DU-8 spectrophotometer with an attached densitometer. 
Lipoprotein-cholesterol concentrations were calculated by multiplying 
the relative percent of each lipoprotein·fraction, as obtained by densi-
tometric scanning, by the total serum or plasma cholesterol concentra-
tion. 
B. Protein Staining 
Half of the original sample plate containing duplicate samples of 
serum was stained for protein with Ponceau S (Briere et al., 1964). At 
the end of electrophoresis half of the sample plate was placed in 100 ml 
of Ponceau S protein stain (Helena Laboratories) for six minutes. The 
Ponceau S stained plate was then placed in 100 ml of 5% acetic acid 
three times for two minutes each with agitation. After the acetic acid 
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washes the Ponceau S stained plate was placed in 100 ml of absolute 
methanol (J. T. Baker Co., Phillipsburg, NJ) twice for two minutes each 
with agitation to dry the plate. Finally the Ponceau S stained plate 
was cleared in a solution consisting of 71 ml absolute methanol, 25 ml 
glacial acetic acid (DuPont de Nemoirs Co., Wilmington, DE) and 4 ml of 
Clear Aid (Helena Laboratories) for seven and a half minutes. The Pon-
ceau S stained plate was then held vertically for one minute to remove 
excess clearing agent and then dried. The red-colored protein bands 
were densitometrically scanned at 525 nm in a Beckman DU-8 spectropho-
tometer with an attached densitometer. 
C. "Total" Lipid Staining 
"Total" lipid staining was also initially performed on electro-
phoresed serum samples as a comparison to the total cholesterol stained 
samples. The electrophoresed serum samples on the cellulose acetate 
plate were placed in a well containing 35 ml of oil red 0 stain (Helena 
Laboratories) to which 10 ml of one normal sodium hydroxide was added 
drop by drop with agitation five minutes prior to the end of electro-
phoresis. The electrophoresed cellulose acetate plate was soaked in the 
oil red 0 stain at room temperature for one hour, following which the 
stained plate was rinsed in water for a few seconds. The oil red 0 
stained cellulose acetate plate was then wiped with cotton, placed in 
100 ml of absolute methanol for 10 seconds, followed by 15 seconds in 
100 ml of distilled water. After the water wash the plate was placed 
for 5-10 minutes in clearing solution consisting of 25 ml methanol and 
100 ml of glycerol (Mallinckrodt). The oil red 0 stained pl~te was 
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removed from the clearing solution, blotted twice and five minutes later 
sprayed with Lipe Spray (Helena Laboratories) to fix the stain. The 
red-colored lipid bands were scanned densitometrically at 525 nm in a 
Beckman DU-8 spectrophotometer with an attached densitometer. 
IV. ULTRACENTRIFUGAL ISOLATION OF RAT SERUM LIPOPROTEINS 
~ ~- -~~ 
Ultracentrifugal isolation of the rat serum HDL fraction was per-
formed according to the method of Havel, Eder and Bragdon (1955). The 
serum of two rats each was pooled from 12 rats total, making six serum 
samples from which HDL was isolated. One tenth ml of 5% EDTA (Baker) 
was added to every 10 ml of rat serum used. A stock salt solution of 
density 1.346 g/ml was made using 15.3 g sodium chloride (Baker) and 
35.4 g potassium bromide (Mallinckrodt) and making it up to 100 ml with 
distilled water. The density of the serum was adjusted to 1.063 g/ml by 
the following formula: 
(A x Y) + (B x Z) = (A + B)X 
where A is the volume of serum or serum infranate used, B is the volume 
of stock salt solution, Y is the nonprotein solvent density of serum or 
serum infranate, Z is the density of the stock salt solution and X is 
the desired nonprotein solvent density of the sample. The density 
adjusted serum was place in a 10.4 ml capacity, polycarbonate, ultracen-
trifuge bottle (Beckman Instruments Inc.) and centrifuged using a type 
40 rotor in a Beckman Model L ultracentrifuge at 40,000 rpm for another 
24 hours at 15 °C. The top two ml of supernate representing the density 
less than 1.063 g/ml fraction was removed and the remaining infranate 
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was washed in a density 1.063 g/ml salt solution and recentrifuged for 
another 24 hours. Following the removal of the density less than 1.063 
g/ml fraction from the serum, the infranate was adjusted to a density of 
1.210 g/ml by adding a concentrated salt solution of NaCl and KBr (den-
sity 1.346 g/ml) according to the formula as mentioned above. The sam-
ple was mixed and centrifuged using a type 40 rotor in a Beckman Model L 
ultracentrifuge at 40,000 rpm for another 24 hours at 15 °C. The top 1.0 
ml of the supernate representing the HDL fraction (density 1.063-1.210 
g/ml) was removed, washed with a density 1.210 g/ml salt solution and 
centrifuged at 40,000 rpm for 24 hours. Again the top 1 ml of the 
supernate was removed and the final washed 1.063-1.210 g/ml density HDL 
fraction was dialyzed using tubing (Spectrum Medical Ind. Inc., Los 
Angeles, CA) which was prewashed in distilled water for one hour. Dia-
lysis was performed overnight at 4 °C against 15 liters of 0.15 M NaCl 
solution containing 0.05% EDTA and then electrophoresed on a cellulose 
acetate plate as described above. One experiment was performed in which 
the density 1.063 infranate was dialyzed as described above without 
adjusting the density to 1.210, therefore the infranate represented the 
density greater than 1.063 g/ml plasma fraction. 
V. POLYANIO~IC PRECIPITATION OF RAT SERUM LIPOPROTEINS 
-- --- -----
A. Manganese Heparin Precipitation 
Manganese heparin precipitation of rat serum lower density lipo-
proteins was performed using a modification of the Lipid Research Clin-
ics Program Method (Manual of Laboratory Operations, 1974). A 0.1 ml 
aliquot of HDL reagent containing 1,012 mmol/l manganese chloride and 
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2,000 U/ml heparin (Worthington Diagnostics, Freehold, NJ) was added to 
1.0 ml of serum. The sample was vortexed 5 sec, placed in an ice bath 
for 30 min and then centrifuged at 1,000 x g for 30 min at 4 °C. The 
supernate containing the HDL-cholesterol was removed, analyzed for total 
cholesterol, dialyzed overnight at 4 °C against 0.15 M NaCl containing 
o. 05% EDTA and then electrophoresed on a cellulose acetate plate as 
described above. 
B. Dextran Sulfate Precipitation 
Dextran sulfate precipitation of rat serum lower density lipopro-
teins was performed according to the method of Kestner (1976). A 0.05 
ml aliquot of dextran sulfate reagent containing 20 g/l dextran sulfate 
(Dow Diagnostics Co., Indianapolis, IN) was added to 1.0 ml of serum. 
Following mixing, 0.1 ml of magnesium sulfate reagent containing 1.1 
mol/l magnesium sulfate (Dow Diagnostics Co.) was added and the mixture 
allowed to stand at room temperature for 5 min, after which it was cen-
trifuged at 1,000 x g for 10 min at 4 °C. The supernate containing the 
HDL cholesterol was removed, analyzed for total cholesterol and then 
electrophoresed on a cellulose acetate plate as described above. 
VI. RAT PLASMA COLLECTION 
Male Sprague Dawley rats betwee~ tlie ages of 60~90 days obt~ined 
from Holtzman Co. (Madison, WI) were fed a diet of rat chow from Ralston 
Purina Co. (St. Louis, MO) ad libitum and had free access to water. The 
rats were on a light-dark cycle of 12 hours light from 0600-1800 and 12 
hours dark from 1800-0600 for 2 weeks prior to the collection of blood. 
90 
samples of blood were obtained from the abdominal aorta of rats under 
light ether anesthesia (Grice, 1964) employing vaccutainer tubes con-
taining EDTA (Becton Dickenson, Rutheford, NJ). The tubes containing 
the blood were inverted several times and immediately placed in an ice 
bath, following which the blood was then centrifuged at 1500 x g for 30 
minutes at 4 °C. The upper layer of plasma was collected and either 
placed in an ice bath for immediate analysis or frozen at -20 °C for 
analysis done at a later time. 
VII. PLASMA INCUBATION 
Each plasma sample was initially divided into three 1 ml portions: 
the first 1 ml portion of plasma was subdivided into 3 individual ali-
quots, each being placed in a 400 microliter stoppered micro test tube 
and immediately frozen at -20 °C for non-incubated t 0 samples so that 
there would only be a single thaw per sample prior to each analysis. 
The second 1 ml portion of plasma was placed in a small test tube con-
taining 0.8 mg of p-chloromercuriphenylsulfonic acid (PCMPS), a lec-
ithin: cholesterol acyltransferase (LCAT) inhibitor (Glomset et al., 
1973) (Sigma Chemical Go., St. Louis, MO), while the third 1 ml portion 
of plasma was placed into an empty test tube. A 250 microliter aliquot 
of the second and third 1 ml portions of plasma was drawn into a sili-
conized Natelson blood collecting pipet, tightly sealed at both ends and 
then incubated at 37 °G for 4 hours. After the incubation period the 
pipettes were placed in an ice bath for 5 minutes and the incubated 
plasma then subdivided into 3 individual aliquots, each being placed in 
a 400 microliter stoppered micro test tube and immediately frozen at -20 
0 c for incubated t 4 hour samples. 
VIII. PLASMA UNESTERIFIED CHOLESTEROL DETERMINATION 
A. Enzymatic Determination of Unesterified Cholesterol 
1. Quinoneimine Dye 
Generation 
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A method derived from the method developed by Allain and company 
(1974) was tested by this laboratory and compared with a commercial kit 
for the enzymatic determination of unesterified cholesterol and a gas 
chromatographic method for unesterified cholesterol determination. 
Unesterified cholesterol reagent was prepared fresh as needed and con-
sisted of 5. 0 mM sodium chelate (Sigma), 2. 0 mM 4-aminoantipyrine 
(Sigma), 30, 000 U/ liter horseradish peroxidase type I (Sigma), 150 
U/liter cholesterol oxidase (Sigma), 20 mM phenol (Mallinkrodt) and 0.17 
mM polyethyleneglycol-8000 (Sigma), prepared in a 0.1 M, pH 6.7 phos-
phate buffer. Fifty microliters of plasma, standard or water (reagent 
blank) were added to test tubes containing one ml of the unesterified 
cholesterol reagent. The tubes were mixed and incubated at 37 °C for 20 
minutes after which they were placed in a room temperature water bath 
for 5 minutes. Quinoneimine was generated in direct proportion to the 
amount of unesterified cholesterol present. Absorbance was determined 
at 500 nm using a Beckman DU-8 spectrophotometer. 
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2. Lutidine Dye Generation 
Plasma unesterified cholesterol levels were measured by an enzy-
matic method (Beutler et al., 1976). Two hundred microliters of rat 
plasma were added to 2.5 ml of cholesterol color reagent (Boehringer 
Mannheim Co., Indianapolis, IN), mixed, then divided into two equal ali-
quots. One aliquot received 10 micro liters of cholesterol oxidase 
(Boehringer Mannheim) and the other aliquot was used as a sample blank. 
The aliquots were covered, mixed and incubated at 37 °C for one hour. 
Lutidine dye was generated in direct proportion to the amount of unes-
terified cholesterol present. Absorbance was determined at 405 nm using 
a Beckman DU-8 spectrophotometer. 
B. Gas Chromatographic Determination of Cholesterol 
Both plasma unesterified and total cholesterol were determined by 
gas chromatography (Macgee et al., 1973). Twenty mg of 5 a-cholestane 
(Sigma), used as an internal standard, were dissolved in 1 ml diethy-
lether and 20 ml of tetramethylammonium hydroxide (MCB, Cincinnati, OH) 
and then diluted to 100 ml with isopropanol (Mallinckrodt). This solu-
tion known as TMH-i was used for total cholesterol determination. For 
unesterified cholesterol determination, 10 mg of 5 a-cholestane were 
dissolved in 1 ml diethylether and diluted to 100 ml with isopropanol. 
Two hundred microliters of TMH-i solution were added to 13x100 
screw cap pyrex tubes. Two hundred microliters of the internal standard 
solution for the determination of unesterified cholesterol were added to 
separate tubes. Fifty microliters of plasma were added to each tube and 
mixed for 10 sec. The tube containing plasma and TMH-i solution was 
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placed in a heating block set at 70-80 °C for 15 min. The tube was then 
removed and 300 microliters of ethylacetate (Baker) added to the tube 
for the determination of unesterified cholesterol and the TMH-i tube. 
All tubes were mixed for 15-30 sec then centrifuged for 4 min at 500 x g 
at room temperature. One to two microliters of the clear upper phase 
were injected into a Varian 3740 gas chromatograph with a flame ioniza-
tion detector containing a 4 ft. silanized glass column packed with 3% 
OV17 and HP chrom W 100/120 support (Varian, Co. Sunnyvale, CA). The 
injector temperature was 300 °C, the column temperature was 250 °C and 
the detector temperature was 350 °C. Unesterified and total cholesterol 
were both determined by calculating the peak height ratio of cholesterol 
to the internal standard. The resultant ratio was divided by the ratio 
obtained in a similar manner from a cholesterol standard solution which 
had been treated in the same manner as the plasma samples undergoing 
analysis. The cholesterol/internal standard peak height ratio deter-
mined from the plasma sample divided by -the cholesterol/internal stan-
dard peak height ratio of the standard solution multiplied by the con-
centration of the standard solution equals the concentration of 
cholesterol in the plasma sample. 
D. Esterified Cholesterol and LCAT Activity Determination 
The plasma esterified cholesterol level was calculated as the dif-
ference between the plasma total and plasma unesterified cholesterol 
concentrations. Rat plasma LCAT activity was determined by the percent 
decrease in unesterified cholesterol concentration from the initial 
unesterified cholesterol concentration after a 4 hour 37 °C in vitro 
incubation (Stokke et al., 1971; Patsch et al., 1976). 
IX. LIPOPROTEIN-UNESTERIFIED AND ESTERIFIED CHOLESTEROL 
A. Lipoprotein-unesterified Cholesterol Staining 
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Electrophoresis was carried out as previously described. Ten min-
utes prior to the end of the electrophoresis period, a cellulose acetate 
plate which had been soaked for at least 15 minutes in 0.5 M, pH 6.7 
phosphate buffer, was removed from the buffer and blotted. The blotted 
plate was then covered with 1.5 ml of an enzymatic cholesterol-staining 
reagent similar to the total cholesterol-staining reagent, but lacking 
cholesterol esterase, therefore this reagent stained only the unesteri-
fied cholesterol of plasma lipoproteins separated by cellulose acetate 
electrophoresis. The enzymatic unesterified cholesterol reagent which 
was freshly prepared in our laboratory contained 1.0 U/ml cholesterol 
oxidase (Sigma), 100 U/ml horseradish peroxidase Type I (Sigma), 20.0 mM 
sodium cholate (Sigma), 4.0 mM 4-aminoantipyrine (Sigma) and 50.0 mM 
phenol (Mallinkrodt Inc. Paris, KY) in 0.5 M sodium phosphate buffer, pH 
6.7. The electrophoresed plate was carefully layered on top of the 
reagent plate and excess reagent and air bubbles were removed making 
sandwiches of the plates. The sandwiched plates were then placed 
between two preheated development plates and incubated on top of a 
Helena Laboratories microevaporator hood for 25 minutes at 37 °C. After 
the incubation, the sample plate was separated from the reagent plate, 
dried and examined under transmitted light for orange-colored lipopro-
tein-unesterif ied cholesterol bands. The orange-colored lipoprotein-un-
esterified cholesterol bands were scanned at 500 nm employing a Beckman 
r 
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DU-8 spectrophotometer with an attached densitometer. 
B. Lipoprotein-Esterified Cholesterol 
Plasma lipoprotein-total cholesterol electrophoresis and plasma 
lipoprotein-unesterified cholesterol electrophoresis combined with 
plasma total and unesterified cholesterol determinations result in mg/dl 
values for the total cholesterol (TC) content of each rat plasma lipo-
protein fraction which included both unesterified cholesterol (UC) and 
esterified cholesterol (EC), as well as the unesterified (UC) content of 
each plasma lipoprotein fraction. In addition, the esterified choles-
terol (EC) content of each plasma lipoprotein fraction was obtained from 
the difference between total cholesterol (UC + EC) and unesterified cho-
lesterol (UC) values. 
X. ESTROGEN INDUCED HYPOCHOLESTEROLEMIA 
The effect of an increased plasma cholesterol clearance on rat 
plasma lipoprotein-cholesterol fractions· separated by cellulose acetate 
electrophoresis was studied following the induction of lipoprotein 
receptor production by 17 a-ethinyl estradiol (Windler et al., 1980b). 
Adult male rats were administered either 17 a-ethinyl estradiol (Sigma) 
dissolved in propylene glycol (Sigma) or propylene glycol alone in daily 
subcutaneous doses for four days. All rats were then sacrificed on day 
5. Two rats received 0.05 mg/kg of 17 a-ethinyl estradiol daily, four 
rats received 0.5 mg/kg of 17 a-ethinyl estradiol daily, four rats 
received 1. 0 mg/kg of 17 a-ethinyl estradiol daily, and four rats 
received 2.5 mg/kg of 17 a-ethinyl estradiol daily. Five rats received 
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amounts of propylene glycol equivalent to that which was administered to 
the 17 a-ethinyl estradiol-treated rats. Rats were weighed daily _and 
their food and water intake measured. Collection and incubation of 
plasma samples from adult male rats treated with 17 a-ethinyl estradiol 
was performed as previously mentioned. 
XI. STATISTICS 
A. Mean, Standard Deviation and Standard Error 
The most commonly used parameter to describe the central character 
of data is the mean (x) (Remington et al., 1970) which is the average 
value of all numbers (x) within an experimental population (n). To cal-
culate the mean the resultant values of the data collected for the 
entire experimental population (n) are summed then divided by n: 
n 
x = 1: x./n. 
. I i 1= 
The standard deviation (s) is used to describe the dispersion of 
data around the mean in the same units as the mean. This statistic is 
derived from the measure of variability known as the variance. The var-
iance is the average squared deviation of the measurements from their 
mean, while the standard deviation is the square root of the variance: 
n - 2 ~ 
s = (1: (x.-x) /(n-1)) 
i=l 1 
The standard error to the mean (S.E.M.) is calculated by dividing 
the standard deviation (s) by the square root of the experimental popu-
lation (n): 
S.E.M. ~ = s/(n) . 
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Whereas the standard deviation is a useful statistic for describing the 
variability of the measurement, the standard error is used to establish 
a confidence interval for the true mean of a population and is useful 
for comparison of means to each other (Marks, 1982). 
B. Linear Regression 
Linear regression is used to determine the relationship of one 
variable to another. A correlation coefficient of 1, means the vari-
ables show a strong positive correlation, whereas a correlation coeffi-
cient of -1, means the variables show a strong negative correlation and 
a correlation of O, means there is no correlation between the two vari-
ables. Linear regression analysis chooses as the best estimate a line 
for the data points by the least squares procedure (Remington et al., 
1970). The algebraic equation for a line is: 
y = mx + b 
where m is the slope of the line and b is the intercept at the y axis. 
The slope of the line is estimated by summing the products of all vari-
ables x and y and subtracting from that the product of the sums of all x 
and the sums of all y divided by n. This result is divided by the 
square of sums of all x which is then divided by n and subtracted from 
the sum of all x squared: 
n n n n 2 n 2 
m = ((I x.y.)-(I (x.)I (y.))/n)/(I x.)-(I x.) /n. 
i=l 1 1 i=l 1 i=l 1 i=l 1 i=l 1 
The y intercept is estimated by the following formula: 
n n 
b = (I yi-mI xi)/n. 
i=l i=l 
Finally the correlation coefficient is described by 
r = m(s /s ) 
x y 
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where s is the standard deviation of x and s is the standard deviation 
x y 
of y. The significance of r can be estimated by calculating its t sta-
tistic as follows: 
2 2 ~ t = (r (n-2)/(1-r )) 
The t value is compared to the values in a table of critical values for 
t with n-2 degrees of freedom for a two-tailed test. The coefficient of 
determination is r 2 , which describes the amount of variation in the 
response variable measurement that can be explained by the fitted 
regression line. Therefore, a correlati-0n coefficient of 0.5 yields a 
coefficient of determination of 0.25 meaning that the model explains 25% 
of the variability in the response variable measurements (Marks, 1982) 
C. Paired Student's t-test 
The paired t-test is used when two samples of data are obtained 
from the same subject (Remington et al., 1970). Plasma incubated four 
hours was compared to the fresh sample using the paired t-test. The t 
statistic was determined as follows: 
t = d/s-d 
99 
where dis the mean difference between the paired observations and scris 
the standard error of the mean difference a. 
D. Analysis of Variance 
Analysis of variance CANOVA) was designed to compare more than two 
factor levels in a single test. This is necessary since multiple sta-
tistical testing decreases the overall significance level of the test 
(Marks, 1982). The increase in the overall significance level (OSL) can 
be determined from the following formula: 
k OSL = 1-(1-p) 
where k is the number of independent tests and p is the level of signif-
icance. It can readily be seen that a statistical test used with a sig-
nificance level (p) equalling 0.05 and only one comparison the OSL will 
remain at 0.05, but if three comparisons are made then the OSL increases 
to 0.14 and with four comparison to 0.26. Therefore, multiple testing 
increases the likelihood of rejecting the null hypothesis when it is 
true. The formula for one way ANOVA is as follows: 
n 2 2 n n 2 n 2 
F=((r T./n.-T /n)/(k-1))/((r r x .. -ccr T./n.)/(n-k)) 
i=l 1 1 i=li=l 1J i=l 1 1 
where k is the number of populations sampled, j is the index of the 
observation within samples, i is the index of sampled populations, n. is 
1 
the number of observations in sample i, n is the total number of obser-
t · · h ·th b ' · h 'th 1 T ' h f va ions, x .. 1s t e J o servat1on 1n t e 1 samp e, 1s t e sumo 
1J 
all observations, T. is the sum of the observations in sample i. The 
1 
degrees of freedom (df) in the numerator is k - 1 and in the denominator 
100 
is n - k (Remington et al., 1970). The F statistic is calculated and 
compared to values in a table for the level of significance. If the 
level of significance is less than 0.05 then there is a significant dif-
ference between the means which were being compared, but the test will 
not determine which means were different. 
E. Duncan's New Multiple Comparison Test 
The ANOVA determined whether a difference existed between compared 
means and the Duncan's New Multiple Range Test was designed to determine 
which means were different with a constant overall significant level. 
Using the Duncan's test the difference between means must exceed a crit- / 
ical value to be considered significantly different. The critical value 
is determined using the mean squared error obtained from the analysis of 
variance, the number of samples (n) and the value q, which is obtained 
from a table. The value q is dependent on the mean squared error 
degrees of freedom (v), the level of significance (a) and the number of 
steps (r) each mean is from the mean to which it is being compared. The 
formula for the critical difference (CD) is as follows: 
~ CD = q (MSE/n) . 
a;r;v 
The MSE is the denominator of the ANOVA equation with degrees of freedom 
of n-k (Kirk, 1982). 
CHAPTER IV 
RESULTS 
I. COMPARISON OF RAT PLASMA LIPOPROTEIN AND PROTEIN PROFILES 
---
Figure 3 presents a comparison of the cellulose acetate electro-
phoretic migration of adult male rat serum proteins stained for total 
cholesterol and for protein. Four orange-colored cholesterol-staining 
lipoprotein bands were detected in the serum of adult male rats and have 
been named according to their plasma protein-staining electrophoretic 
mobilities. Beta lipoprotein-cholesterol, abbreviated as a1-c, had a1-
globulin mobility corresponding to low density lipoprotein (LDL) and 
accounted for an average of 13.6% of the total plasma lipoprotein-cho-
lesterol. Alpha2 lipoprotein-cholesterol, abbreviated as a 2L-C, had 
a2-globulin mobility corresponding to very low density lipoprotein 
(VLDL) and accounted for 5.1% of the total plasma lipoprotein-choles-
terol. Alpha1 lipoprotein-cholesterol, abbreviated as a 1 L-C had 
a 1-globulin mobility corresponding to high density lipoprotein (HDL) and 
accounted for 55.9% of the total plasma lipoprotein-cholesterol. A 
fourth band was found to migrate faster than rat albumin with prealbumin 
mobility accounting for the remaining 25.4% of the total plasma lipopro-
tein-cholesterol, and has been presently named as prealbumin lipopro-
tein-cholesterol and abbreviated as PAL-C. 
Figure 4 compares a "total" lipid stain (oil red 0) to the spe-
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cific enzymatic cholesterol stain both performed after cellulose acetate 
electrophoresis. The cholesterol stain offers sharper resolution 
between the lipoprotein bands without staining albumin as appeared to 
occur with the "total" lipid stain. Moreover, quantitation of lipopro-
tein-cholesterol could be performed using the enzymatic cholesterol 
stain, whereas the "total" lipid stain was semiquantitative at best. 
However, the "total" lipid stain did offer the advantage of staining 
lipoproteins containing high concentrations of triglycerides such as 
chylomicrons, which usually have a very low cholesterol content and 
could not be seen by a specific cholesterol stain. 
Overnight-fasting of adult male rats did not affect the relative 
percentages of the presently obtained lipoprotein-cholesterol profile. 
However, the resolution of PAL-C was markedly influenced by the amount 
of time the cellulose acetate plate was presoaked in tris-barbital 
buffer as shown in figure 5. It was found that overnight soaking of the 
cellulose acetate plate was necessary for the optimal resolution of 
PAL-C from a 1L-C. Although it is not clear as to why the resolution was 
improved by increased soaking time, it is possible that the cellulose 
acetate plate's absorptivity changes upon prolonged soaking which could 
improve the resolution between PAL-C and a 1L-C bands found in rat 
plasma. 
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II. SPECIES COMPARISON 
Figure 6 presents the comparative distribution of plasma lipopro-
tein-cholesterol fractions separated by cellulose acetate electrophore-
sis in normal adult male rat, mouse, rabbit, dog, monkey and human serum 
samples. PAL-C found in rat serum was not present in serum samples of 
the adult mouse, rabbit, dog, monkey or human, indicating that PAL may 
be a new plasma lipoprotein with a cellulose acetate electrophoretic 
mobility faster than albumin. The present data also suggest that PAL 
may be a plasma lipoprotein that may be unique to the rat. All the spe-
cies studied except the human were found to have higher amounts of a 1L-C 
compared to their amounts of eL-C present. 
Serum lipoprotein-cholesterol values in terms of mg/dl of the var-
ious normal adult nonfasting animals studied by cellulose acetate elec-
trophoresis are given in table 3. The concentration of PAL-C and a L-C 1 
in adult male rat serum was found to be 15 ± 4 (± S.D.) and 33 ± 7 
mg/dl, respectively. The sum of PAL-C and a 1L-C of the adult male rat 
was found to be 81.4% of the total serum cholesterol concentration which 
appears to agree with previous reports in the literature for the total 
amount of rat serum high density lipoprotein-cholesterol as determined 
by ultracentrifugal separation of lipoproteins (Frnka et al., 1974; 
Havel et al., 1955; Hanninen et al., - 1978; Narayan et al., 1968; 
Narayan, 1971). One of the currently-used coronary artery disease risk 
ratios obtained by dividing the LDL-cholesterol (LDL-C) concentration by 
the HDL-cholesterol (HDL-C) concentration (Gordon et al., 1977) was 
found to be lowest for those species least responsive to diet-induced 
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atherogenesis (rat, mouse and dog) and highest in those species (rabbit, 
monkey and human) most prone to diet-induced atherogenesis (Beher et 
al., 1963; Camejo et al., 1973; Kramsch et al., 1981; Mahley et al., 
1974; Mahley, 1978; Ross, 1979; Shore et al., 1974). In addition, the 
adult male human was also found to differ markedly from the experimental 
animals studied with regard to another currently-employed coronary 
artery disease risk ratio (Gordon et al., 1977), having a serum total 
cholesterol to HDL-cholesterol ratio almost three times as great as the 
other species. 
III. PAL: A HIGH DENSITY LIPOPROTEIN 
Figure 7 characterizes PAL-C and a 1L-C separated by cellulose ace-
tate electrophoresis as rat plasma high density lipoprotein-cholesterol 
employing ultracentrifugation (Havel et al., 1955). Only two cholester-
al-staining bands were found to occur in the high density frac-
tion(l.063-1.210 g/ml) of normal adult rat serum separated by ultracen-
trifugation. These two bands had cellulose acetate electrophoretic 
mobilities corresponding to PAL-C and a 1L-C, indicating that both belong 
to the HDL-cholesterol fraction of rat plasma. Moreover, figure 8 dem-
onstrates essentially the same comparison of the denser plasma fraction 
(greater than 1.063 g/ml) to whole serum indicating that PAL and a 1L are 
both high density lipoproteins. However, the dialyzed plasma fraction 
with a density greater than 1.063 g/ml demonstrates better resolution 
between the PAL and a 1L bands than the rat plasma fraction separated 
between the densities 1.063-1.210 g/ml. This could be due to the stabi-
lizing influence of albumin, which improved the electrophoretic resolu-
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tion of plasma proteins when paper was used as a support medium (Lees et 
al., 1963). Confirmation that PAL and a 1L were high density lipoproteins 
of the adult rat was achieved by using two different polyanionic precip-
itation methods (Kestner, 1976; Manual of Laboratory Operations, 1974). 
The manganese heparin supernate containing the high density lipoprotein 
fraction of rat plasma was dialyzed prior to cellulose acetate electro-
phoresis in order to remove the manganese, since manganese interferes 
with the enzymatic cholesterol reagent (Steele et al., 1976; Thompson et 
al., 1981). Dialysis of the dextran sulfate supernatant fraction con-
taining the high density lipoprotein fraction of rat plasma prior to 
cellulose acetate electrophoresis was found to be unnecessary. Two cho-
lesterol-staining bands were also found to occur in both the 1,000 x g 
manganese heparin high density lipoprotein supernate and the 1,000 x g 
dextran sulfate high density lipoprotein supernate, with electrophoretic 
mobilities corresponding to PAL-C and a 1L-C, as shown in figures 9 and 
10. These results offer additional evidence that both PAL-C and a 1L-C 
belong to the HDL-C fraction of rat plasma. It is also interesting to 
note that albumin is present in the HDL supernates of both precipitation 
methods and the resolution of PAL from a 1L is equivalent to that of the 
density greater than 1.063 g/ml plasma fraction indicating that albumin 
may be a factor in the increased resolution of PAL from a 1L using cellu-
lose acetate electrophoresis. 
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IV. METHOD COMPARISON 
Figures 11 and 12 show that a positive correlation using linear 
regression analysis exists between rat serum HDL-C levels determined by 
cellulose acetate electrophoresis and rat serum HDL-C levels determined 
by either the manganese heparin precipitation method or by the dextran 
sulfate precipitation method. The total HDL-C concentration for the 
cellulose acetate electrophoretic method was obtained by adding the 
PAL-C and a 1L-C concentrations. Figure 13 demonstrates that the best 
correlation exists between the two precipitation techniques as would be 
expected. Although the three methods demonstrated a statistically sig-
nificant positive correlation, figure 14 shows that statistically sig-
nificant differences in absolute HDL-C levels in identical samples of 
adult male rat serum were obtained by each method. Statistical compari-
sons were made using an analysis of variance and Duncan's new multiple 
range test. Mean values for adult male rat HDL-C concentration 
obtained by cellulose acetate electrophoresis were 44 ± 2 mg/dl (± 
S.E.M.), with the mean PAL-C being 12 ± 1 mg/dl and the mean a 1L-C 
being 32 ± 2 mg/dl. In contrast, mean values for the HDL-C concentration 
obtained by manganese heparin precipitation and dextran sulfate precip-
itation were 34 ± 2 and 27 ± 2 mg/dl respectively. Not only did both 
polyanionic precipitation methods yield statistically significant dif-
ferent values from those obtained by the electrophoretic method, but 
both polyanionic precipitation methods yielded statistically significant 
different values from each other. 
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V. RAT PLASMA LIPOPROTEIN-CHOLESTEROL MOVEMENT 
Figure 15 shows a progressive decrease in a 1L-TC concentration 
along with a progressive increase in PAL-TC concentration during a 4 
hour incubation of adult rat plasma at 37 °C. At the end of the 4 hour 
incubation period, PAL-TC had increased from 25.0% to 63.2% of the 
plasma lipoprotein-cholesterol while alL-TC had decreased from 51.9% to 
21.4% of plasma lipoprotein-cholesterol. No statistically significant 
change in plasma total cholesterol was observed during the 4 hour in 
vitro incubation period. These data indicated a marked movement of 
total cholesterol from a 1L to PAL during the in vitro incubation period. 
Figure 16 depicts the changes in the lipoprotein profile as demonstrated 
densitometrically both at 1 hour and 4 hours after incubation at 37 °C. 
Although not clearly seen in figure 16, table 4 demonstrates that incu-
bation of rat plasma appears to affect the electrophoretic mobility of 
eL and to some extent the mobility of a2L as eL moves toward the a2L 
region. e1 increases its mobility by 25 .·8% whereas a2L electrophoretic 
mobility increased by 11.9%. PAL and a 1L mobility were unaffected by the 
incubation. Interestingly, the addition of 2.0 ml'I PCMPS a known LCAT 
inhibitor (Glomset et al., 1970) increased the mobility of eL slightly, 
but not significantly, while after a 4 hour 37 °c in vitro incubation e1 
mobility does not differ significantly from the initial mobility as com-
pared to the fresh sample containing 2.0 mM PCMPS. However, eL electro-
phoretic mobility increased significantly in the sample containing PCMPS 
when compared to the fresh sample with no additives. It is possible 
that LCAT may be responsible for the increase in electrophoretic mobil-
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itY of 6L, but PCMPS, which is a relatively nonspecific sulfhydryl group 
inhibitor (Vansteveninck et al., 1965) could have affected other plasma 
enzymes or the LDL molecule specifically, preventing the increased 
mobility that was seen after a four hour in vitro incubation of rat 
plasma. The observed increase in 6L electrophoretic mobility and lipo-
protein-cholesterol movement between lipoproteins was an indication that 
a dynamic process continued to exist in plasma incubated in vitro at 
physiological temperatures and was an indication of possible problems 
that could occur if a plasma sample was not analyzed immediately after 
being taken or steps are not taken to inhibit either lipoprotein-choles-
terol movement or increased lipoprotein electronegativity. Moreover, it 
was an indication that a process could be occurring in vivo affecting 
rat plasma lipoprotein-cholesterol composition and lipoprotein integ-
rity, which we attempted to study by in vitro incubations. 
Figure 17 indicates that statistically significant changes 
occurred in plasma lipoprotein-UC concentrations in 3 out of 4 rat 
plasma lipoprotein fractions during a 4 hour 37 °C in vitro incubation 
of plasma. The decrease in a 1L-TC concentration appears to be due to a 
change in a 1L-UC which decreased by 202 ± 5 nmol/ml plasma/4 hr since 
a 1L-EC remained unchanged. The increase in PAL-TC concentration which 
amounted to 295 ± 18 nmol/ml plasma/4 hr appears to be due to both an 
increase in PAL-UC of 75 ± 16 nmol/ml plasma/4 hr and an increase in 
PAL-EC of 220 ± 21 nmol/ml plasma/4 hr. In addition, 6L-UC was found to 
decrease by 41 ± 10 nmol/ml plasma over the 4 hour incubation period, 
while 6L-EC remained unchanged. The observed loss of UC from 6L and a 1L 
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together with the concomitant increase in PAL-EC suggested that either 
the UC of aL was first transferred to a 1L, where the UC was esterified 
by LCAT to EC which was then transferred to PAL or on the other hand, 
the UC of aL and a 1L was transferred directly to PAL, where the UC was 
then esterified. These two possibilities were therefore investigated by 
inhibiting the esterification of rat plasma by the addition of 2.0 mM 
PCMPS, a known LCAT inhibitor (Glomset et al., 1970). 
VI. LIPOPROTEIN-CHOLESTEROL MOVEMENT WITH LCAT INHIBITION 
----
Confirmation that rat plasma UC esterification is inhibited by the 
addition of PCMPS was obtained by the following observations. In the 
absence of PCMPS, rat plasma UC was found to decrease by 38. 4 ± 4. 4% 
following a 4 hour 37 °C in vitro incubation of plasma. In the presence 
of 2. 0 mM PCMPS however, rat plasma UC was found to decrease by only 
3.3 ± 0.8% under identical conditions. Figure 18 shows that in the 
presence of 2.0 mM PCMPS, instead of a loss of UC from a 1L occurring in 
incubated rat plasma, there was a 44 ± 13 nmol/ml plasma/4 hr increase 
in a 1L-UC, along with a loss of 41 ± 5 nmol/ml plasma/4 hr in the aL 
fraction, demonstrating that rat plasma SL-UC concentrations decreased 
by the same amount during a 4 hour incubation period of plasma both in 
the presence or absence of 2.0 mM PCMPS. These results indicated that 
UC was transferred from SL to a 1L since the amount of a 1L-UC increase 
was equal to the SL-UC decrease over the 4 hour incubation period in 
LCAT-inhibited plasma. In addition, these data also suggested that fol-
lowing the transfer of UC from SL to a 1L in rat plasma incubated without 
2.0 mM PCMPS, the transferred UC was then esterified, and the resulting 
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EC either transferred to PAL or alternatively, a 1L itself might have 
been partially catabolized to PAL, causing the presently observed 
increased concentration of PAL-EC. 
A cholesteryl ester transfer factor may be present in rat plasma 
since PAL-EC decreased by 59 ± 34 nmol/ml plasma/4 hr while a 1L-EC 
increased by 93 ± 39 nmol/ml plasma/4 hr in adult rat LCAT inhibited 
plasma following a 4 hour 37 °C in vitro incubation. This suggested 
that cholesteryl ester transfer may occur between the two rat plasma HDL 
subfractions from PAL to a 1L, but does not appear to be physiologically 
significant since it was only observed in LCAT inhibited plasma. How-
ever, it may be significant that the increase of 14% in rat plasma 
a 1L-EC in the presence of 2.0 mM PCMPS observed in the present studies 
was similar to the increases in VLDL cholesteryl ester found in rat 
plasma incubated under similar conditions as previously reported using 
ultracentrifugation to separate lipoproteins in order to assay for lipo-
protein-cholesteryl ester transfer activity (Barter et al., 1978). 
These data indicate that rat plasma may possess a lipoprotein-choles-
teryl ester transfer factor inhibitor as has previously been reported to 
be present in the rat and other species lacking significant lipoprotein-
cholesteryl ester transfer activity (Morton et al., 1981). 
The a2L fraction was the only lipoprotein fraction of rat plasma 
whose cholesterol concentration did not appear to be affected by the 4 
hour 37 °C in vitro incubation. The a2L-TC concentration did not sig-
nificantly change nor did the a2L-EC or a2L-UC concentration in adult 
male rat plasma incubated either in the absence or presence of 2. 0 mM 
pCMPS, indicating that LCAT had no effect on a 2L-cholesterol 
concentration. 
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Figures 19 and 20 present changes in esterified to unesterified 
cholesterol ratios of lipoprotein fractions separated by cellulose ace-
tate electrophoresis following a 4 hour 37 °C in vitro incubation of 
adult male rat plasma in the presence and absence of 2.0 mM PCMPS. The 
EC/UC ratio of alL increased by 500% in plasma incubated in the absence 
of PCMPS because of a decrease in UC without any change in EC as shown 
in figure 17. The EC/UC ratio of eL showed a statistically significant 
increase after incubation of rat plasma both in the presence and absence 
of 2.0 mM PCMPS because of a decrease in eL-UC without any change in the 
eL-EC concentration. a2L appeared to have a relatively constant EC/UC 
ratio throughout the in vitro incubation. The observed increase in the 
EC/UC ratio of a 1L incubated rat plasma is most likely due to LCAT 
esterification of a 1L-UC. However, inasmuch as the a 1L-EC concentration 
was found to be unchanged during the incubation period, this suggests 
that the EC generated by LCAT activity must in some way have been incor-
porated into PAL, which was the only lipoprotein fraction in which a 
significant increase in EC concentration occurred when rat plasma was 
incubated without PCMPS. 
It is possible that the incorporation of EC from a 1L into PAL may 
be due to a specific transfer of EC from a 1L to PAL, but this would not 
explain the subsequent increase in UC necessary to keep the EC/UC ratio 
of PAL constant during the incubation period. In addition, the EC 
transfer from a 1L to PAL, was not demonstrated in LCAT-inhibited plasma, 
112 
although LCAT inhibition by PCMPS does not appear to affect the transfer 
of cholesteryl esters between plasma lipoproteins of other species (Ha 
et al., 1982). Another explanation of our data may be that PAL is the 
preferred substrate for rat plasma LCAT and that UC from both a 1L and BL 
is passively transferred to PAL, where it is then esterified by LCAT. 
That BL may be passively transferred is suggested since there is no evi-
dence for an energy requiring process or transfer protein in order that 
unesterified cholesterol may be moved from one lipoprotein to another. 
However, when PCMPS was added to rat plasma causing an inhibition of 
LCAT, a transfer of UC did occur from BL to a 1L. It has been previously 
reported that equilibration of UC between plasma lipoproteins is slow 
relative to LCAT activity. If LCAT is inhibited, then the preferred 
LCAT substrate may be relatively unsaturated with respect to UC, and in 
order to regain equilibrium, UC would have to be transferred to the pre-
ferred LCAT substrate to achieve relative saturation and equilibrium 
with the other plasma lipoproteins (Perret et al., 1983). It would 
therefore be expected that if PAL were the preferred rat LCAT substrate, 
then UC should have been transferred from BL to PAL to establish equi-
librium once LCAT is inhibited. The data however, suggests that a 1L and 
not PAL is the preferred substrate for rat LCAT activity, since a 1L 
receives BL-UC as presently demonstrated in LCAT-inhibited rat plasma. 
Still another explanation of our data is that in the rat, PAL is a cata-
bolic product of a 1L, the a 1L in some way splitting to form a PAL parti-
cle containing a specific amount of UC and EC. Further investigation of 
this possibility was therefore performed using the technique of obtain-
113 
ing rats with hypocholesterolemia that is induced by the in vivo 
administration of 17 a-ethinyl estradiol (Davis et al., 1978). 
VII. RAT PLASMA LIPOPROTEIN-CHOLESTEROL CLEARANCE 
Adult male rats administered subcutaneous doses of 17 a-ethinyl 
estradiol dissolved in propylene glycol did not differ significantly 
from rats receiving only propylene glycol with regard to body weight or 
food intake. Figure 21 shows that the plasma total cholesterol concen-
trations of rats receiving 17 a-ethinyl estradiol were markedly lower 
than vehicle control rats. The plasma total cholesterol of adult male 
rats administered 0.05 mg/kg of 17 a-ethinyl estradiol daily was signif-
icantly lower after 5 days than the control group by an average of 
50.9%. Rats receiving daily doses of 0.5 mg/kg of 17 a-ethinyl estra-
dial had 73.6% lower plasma cholesterol levels after 5 days than control 
rats. Rats receiving daily doses of 1.0 mg/kg of 17 a-ethinyl estradiol 
had 90.6% lower plasma cholesterol than control rats and those rats 
receiving daily doses of 2.5 mg/kg of 17 a-ethinyl estradiol had 81.1% 
lower plasma cholesterol values at 5 days compared to control rats. 
Figure 22 presents the effects of in vivo administration of 17 
a-ethinyl estradiol on lipoprotein-total cholesterol concentrations 
before and after a 4 hour 37 °c in vitro incubation of adult male rat 
----
plasma. The lower plasma cholesterol values observed after 17 a-ethinyl 
estradiol administration are primarily reflected in the values of PAL-TC 
and eL-TC. The lowest dose of 17 a-ethinyl estradiol (0.05 mg/kg daily 
for 4 days) resulted in PAL-TC levels that were 96.7% lower than control 
rats and eL-TC levels that were 92. 9% lower than control rats._ Both 
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PAL-TC and 6L-TC apparently disappeared from the plasma of rats receiv-
ing 0.5 mg/kg and higher doses of 17 a-ethinyl estradiol, whereas a 1L-TC 
and a2L-TC remained present at all doses of 17 a-ethinyl estradiol even 
though both a 1L-TC and a2L-TC showed decreased levels. The cholesterol 
present in the plasma of adult male rats administered 0.5 mg/kg and 
higher of 17 a-ethinyl estradiol therefore appeared to be carried exclu-
sively by a 1L and a2L. Only PAL-TC reappeared following a 4 hour in 
vitro incubation of those plasma samples in which PAL-TC was previously 
not detected as a result of an in vivo 17 a-ethinyl estradiol adminis-
tration. In addition, a concomitant decrease in a 1L-TC was found to 
occur in incubated plasma of rats administered 0.5 mg/kg and higher 17 
a-ethinyl estradiol. Unlike PAL-TC, 6L-TC could not be detected in 
incubated plasma of rats administered 0.5 mg/kg and higher 17 a-ethinyl 
estradiol either before or after a 4 hour 37 °C in vitro incubation. 
The fact that PAL-TC reappeared in the plasma of 17 a-ethinyl estradiol-
treated rats after a 4 hour in vitro incubation at 37 °C and that a 1L-TC 
decreased during the same incubation with LCAT remaining active suggests 
that PAL of the rat may be a product of plasma a 1L catabolism and that 
a1L is the preferred substrate for rat LCAT activity, as summarized in 
figure 23. In addition, a 1L-cholesterol appears to be linked to LCAT 
activity since PAL-cholesterol concentrations did not change as drasti-
cally when rat plasma was incubated at 37 °C in the presence of PCMPS, 
an LCAT inhibitor, which is summarized in figure 24. However, statisti-
cally significant changes in the cholesterol concentration of a 1L, PAL 
and 6L still occur. These changes appear to reflect the processes of 
unesterified and possibly esterified cholesterol transfer. 
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PAL-TC 
decreased due to a decrease in PAL-EC while a 1L-TC increased as a result 
of both an increase in UC and EC. In addition 6L-TC decreased as a 
result of a UC decrease. The increase in a 1L-UC was the same as the 
6L-UC decrease indicating that the UC most probably came to a 1L from 6L. 
The EC drop in PAL with a concomitant increase in a 1L-EC indicated that 
transfer of EC may have occurred from PAL to a 1L under these conditions. 
Moreover, the present data suggest that PAL, like 6L, may be cleared by 
hepatic lipoprotein receptors of the rat since both PAL-TC and 6L-TC 
appear to be rapidly removed from rat plasma following the induction of 
lipoprotein receptor production by 17 a-ethinyl estradiol. 
l 
CHAPTER V 
DISCUSSION 
I. CELLULOSE ACETATE LIPOPROTEIN-CHOLESTEROL ELECTROPHORESIS 
Resolution of plasma lipoproteins by paper electrophoresis has 
been greatly improved by employing a barbital-albumin buffer (Lees et 
al., 1963). However, paper electrophoresis of plasma lipoproteins gen-
erally requires 16 hours for completion. Cellulose acetate used as a 
support medium for electrophoresis is capable of excellent resolution 
of plasma lipoproteins without the requirement of albumin in the buffer, 
within 15-45 minutes (Beckering et al., 1970; Chin et al., 1968; 
Fletcher et al., 1970). Accurate quantitation of electrophoretically-
separated plasma lipoproteins with nonspecific "total" lipid stains has 
been difficult, because of each lipoprotein's differing affinities for 
such stains (Fletcher et al., 1970). Such commonly used lipid stains as 
Sudan black B, preferentially stain unsaturated sterol esters and unsa-
turated triglycerides, whereas unesterified cholesterol and phospholi-
pids are stained negligibly or not at all (Schjeide et al., 1963). 
Moreover, the various cholesteryl esters and triglycerides have differ-
ent staining affinities for Sudan black B, dependent upon their particu-
lar fatty acids. Oil red 0, which is another commonly used "total" 
lipid stain, stains cholesteryl esters more intensely than Sudan black 
B, but its staining is also dependent on the cholesterol ester's degree 
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of fatty acid saturation. In addition, oil red 0 also stains 
triglycerides as well as albumin, but does not stain phospholipids or 
unesterified cholesterol. Recently a cellulose acetate electrophoretic 
technique, which combines an enzymatic staining procedure for total cho-
lesterol (Allain et al., 1974) has been developed for determining human 
plasma lipoprotein-cholesterol concentrations which are currently 
employed as risk factors for human atherosclerotic disease (Cobb et al., 
1978). . The method of quantitating human plasma lipoproteins using 
enzymes specific for cholesterol is more precise and accurate as opposed 
to "total" lipid staining. 
Ultracentrifugation and poly anionic precipitation techniques, 
although commonly used for human plasma lipoprotein fractionation, may 
hot be ideal methods for the analysis of rat plasma lipoprotein-choles-
terol concentrations. Ultracentrifugation may lead to lipoprotein deg-
radation and loss of lipoprotein-cholesterol in the rat (Fainaru et al., 
1977; Marcel et al., 1981) as well as the loss of apolipoproteins from 
HDL in the human (Hojnacki et al., 1978; Lindgren et al., 1979). 
Another drawback to ultracentrifugation is the time involved in separat-
ing lipoprotein fractions, which can take up to a week to accomplish 
(Havel et al., 1955). A major problem with precipitation methods is 
that although the various lipoprotein density classes can be sequen-
tially precipitated, the resolution between lipoprotein classes is so 
close that a portion of the lipoprotein class which is desired in solu-
tion may also occur in the precipitate (Burstein et al., 1970). In a 
study comparing various precipitation techniques to sequential ultracen-
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trifugation (Warnick et al., 1979a; 1979b), a good correlation was found 
between the methods however, differing HDL-cholesterol levels were 
obtained depending on which method was used. This would indicate that 
the various precipitation techniques are not equivalent and can lead to 
significant differences in HDL-C quantitation. Another problem with 
precipitation techniques is the inadvertent precipitation of HDL con-
taining apolipoprotein E along with the apolipoprotein B-containing 
lipoproteins (Mahley et al., 1977b). 
Cellulose acetate electrophoresis coupled with an enzymatic cho-
lesterol stain offers several advantages over other methods for measur-
ing the distribution of rat plasma lipoprotein-cholesterol. The cellu-
lose acetate electrophoretic method utilizes only 2 µl of serum 
which permits multiple sampling from the same animal. In contrast, both 
the polyanion precipitation and ultracentrifugal methods require several 
ml of serum. The cellulose acetate electrophoretic method has been 
presently found to fractionate rat plasma into four lipoprotein-contain-
ing cholesterol bands, compared to only three lipoprotein bands which 
have been observed in rat serum employing paper electrophoresis (Mahley 
et al., 1977a; Watson, 1961). Polyanion precipitation methods yield 
only two fractions, namely HDL-C in the supernate and lower density 
lipoprotein-cholesterol consisting of both VLDL-C and LDL-C as a precip-
itate. In addition, the present data indicates that polyanion precipi-
tation methods employing rat serum resulted in a loss of 29-40% of the 
HDL-total cholesterol. 
This dissertation describes a new method for the determination of 
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unesterified cholesterol in plasma lipoprotein fractions. The reagent 
we used was derived from the enzymatic technique for the measurement of 
plasma total cholesterol (Allain et al., 1974) and the method was 
derived from that for lipoprotein-total cholesterol analysis by cellu-
lose acetate electrophoresis (Cobb et al., 1978). The unesterified cho-
lesterol reagent was used to determine the UC concentrations of rat 
plasma and compared favorably to two established techniques for the 
determination of plasma UC (Beutler et al., 1976; Macgee et al., 1973) 
with identical results observed for all methods employed. We have used 
this method to describe the plasma cholesterol metabolism of the rat in 
an in vitro assay. This method has great potential for the study of 
cholesterol metabolism not only in the rat but other experimental sys-
tems as well including the human. The advantages of electrophoretic 
separation and specific cholesterol staining techniques include, small 
sample requirments, high resolution, short assay time, greater accuracy 
and precision and fewer artifacts as compared to other methods for 
plasma lipoprotein fractionation, such as ultracentrifugation or polyan-
ionic precipitation (Fainaru et al., 1977; Hojnacki et al., 1978; Kuni-
take et al., 1982; Lindgren et al., 1979; Mahley et al., 1977b; Marcel 
et al., 1981; Warnick et al., 1979a; 1979b). 
II. COMPARISON OF SPECIES PLASMA LIPOPROTEIN-CHOLESTEROL 
Plasma lipoprotein-cholesterol ratios for various animal species 
have been obtained employing cellulose acetate electrophoretic separa-
tion of lipoproteins coupled with an enzymatic cholesterol stain. The 
LDL-C/HDL-C ratios were presently found to be markedly higher in the 
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rabbit, monkey and human, species known to be more prone to experimen-
tally-induced atherosclerotic lesions (Camejo et al., 1973; Kramsch et 
al., 1981; Mahley, 1978; Ross, 1979; Shore et al., 1974), than the 
~ ~ ~ 
LDL-C/HDL-C ratios of the rat, mouse and dog, which are species less 
prone to induced atherosclerotic lesions (Beher et al., 1963; Fillies et 
al., 1956; Mahley et al., 1974; 1977b; Mahley, 1978; Wissler et al., 
1954). The total cholesterol to HDL-C ratio was also found to be higher 
in those species most prone to induced atherosclerotic lesions, although 
the species differences between the total cholesterol/HDL-C ratios 
appear to be less marked than the species differences between the 
LDL-C/HDL-C ratios. Human epidemological evidence has shown that the 
LDL-C/HDL-C ratio is positively correlated to the risk of developing 
atherosclerotic disease (Gordon et al., 1977), therefore it is possible 
that a high LDL-C/HDL-C ratio may be an important indicator of species 
susceptibility to the experimental-induction of atherosclerotic disease. 
III. PAL: ~UNIQUE RAT PLASMA L~POPROTEIN 
The present data employing cellulose acetate electrophoresis com-
bined with an enzymatic cholesterol stain clearly demonstrates for the 
first time that adult male rat plasma contains a rapidly-moving choles-
terol-containing high density lipoprotein with an electrophoretic mobil-
ity equivalent to prealbumin. Previous electrophoretic studies of rat 
plasma apparently have not demonstrated prealbumin lipoprotein due to 
either differences in the electrophoretic medium or due to the semiquan-
titative nature of the "total" lipid stains employed (Fletcher et al., 
1970; Schjeide et al., 1963). Agarose gel electrophoresis of rat plasma 
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HDL following ultracentrifugal separation demonstrated a single lipid-
staining band whose migration appeared to include the prealbumin region 
(Koga et al., 1969). Agarose gel electrophoresis of rat whole plasma 
combined with a Sudan black B stain also appeared to suggest a prealbu-
min lipoprotein band, however in this system lipid-stained bands 
migrated consistently farther than their corresponding amido black pro-
tein-stained bands (Johansson et al., 1976). Human plasma alpha1 lipo-
protein also separated by agarose gel electrophoresis appeared to have 
the same electrophoretic mobility as albumin, with the lack of electro-
phoretic resolution between albumin and a 1L possibly being due to non-
specific albumin staining (Johansson et al., 1976; Schjeide et al., 
1963). In addition, agarose-starch gel electrophoresis of rat plasma 
using a combined oil red 0 and fat red 7B "total" lipid stain also 
appeared to suggest bands which had prealbumin, alpha1 , prebeta and beta 
electrophoretic mobility (Chalvardj ian, 1971). The prealbumin and 
alpha1 bands appeared to correspond to HDL, since after ultracentrifugal 
fractionation of the plasma, these two bands had a density range greater 
than 1.063 g/ml, while the prebeta band corresponded to VLDL, and the 
beta band corresponded to LDL. However, no attempt was made to deter-
mine the actual cholesterol content of the prealbumin-migrating lipopro-
tein band visualized by a "total" lipid stain. Moreover, a side-by-side 
electrophoretic comparison of total lipid-stained and protein-stained 
plasma was not performed using the agarose-starch gel electrophoretic 
technique and moreover, the prealbumin lipid-staining band was visual-
ized from albumin by the difference in albumin's staining color. The 
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agarose-starch gel method combined with a "total" lipid stain is quite 
semiquantitative with densitometric analysis being extremely difficult 
due to albumin interference. On the other hand, the present studies 
employing cellulose acetate electrophoresis combined with an enzymatic 
cholesterol stain allow for the easy distinction between prealbumin 
lipoprotein and albumin, as well as an accurate comparative quantitation 
of the cholesterol concentration of prealbumin lipoprotein and other rat 
plasma lipoproteins. 
Based on the smaller cholesterol content of PAL, as indicated in 
table 3, this high density lipoprotein fraction of rat plasma obtained 
by cellulose acetate electrophoresis may be similar to the HDL1 subfrac-
tion isolated from rat plasma by rate zonal ultracentrifugation (Eisen-
berg et al., 1984) or by density gradient centrifugation (Jansen et al., 
1983), which would therefore make a 1L obtained by cellulose acetate 
electrophoresis similar to HDL2 isolated by centrifugation. One problem 
with this interpretation is the rapid electrophoretic mobility of PAL on 
cellulose acetate, since apolipoprotein E-containing lipoproteins have 
been found to migrate in the a2-globulin region using paper electro-
phoresis, and HDL1 of the rat has been reported to have a high apolipo-
protein E-content (Mahley et al., 1977a; Weisgraber et al., 1977). How-
ever, rat plasma PAL isolated by celltilo~e acetate el~ctrophoresi~ may 
contain other apolipoproteins besides apolipoprotein E, which might 
enhance its electrophoretic mobility. 
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IV. FAST BETA LIPOPROTEIN 
The lipid rich a fraction of human plasma was shown to be sensi-
tive to storage and temperature since a globulin electrophoretic mobil-
ity increased when stored for long periods (Armstrong et al., 1947). A 
similar study demonstrated that within 36 hours human plasma a globulin 
acquires a2 globulin electrophoretic mobility. However, the i~crease in 
mobility can be prevented for at least 10 days by storage at 0-4 °C or 
by heating the serum at 50 °C for 3 hours (Hoch et al., 1954), which 
would indicate that a plasma enzyme was probably involved in this elec-
trophoretic transformation. More evidence of enzymatic involvement was 
indicated when the increase in a1 electrophoretic mobility was inhibited 
by sodium bromoacetate or heating at 58 °C as demonstrated using paper 
electrophoresis with a "total" lipid stain after a 72 hour 37 °C incuba-
tion of either horse or human serum (Tayeau et al., 1956). We have 
redemonstrated this increase in beta lipoprotein electrophoretic mobil-
ity for the first time in rat plasma and have shown that PCMPS a known 
sulfhydryl group inhibitor (Velick, 1953) also inhibits the increased 
electrophoretic mobility of a1 after a 37 °C in vitro incubation. 
The increased mobility of a lipoprotein at first may have seemed 
trivial, an artifact of incubation, but in light of recent findings as 
to the increased uptake of electronegative LDL by the scavenger pathway 
(Brown et al., 1980), this change in mobility may have some influence on 
the pathogenesis of atherosclerosis. Human plasma a lipoprotein was 
shown to have increased electrophoretic mobility after it passed into 
the lymph (Reichl et al., 1973; 1975). Moreover, LDL incubated with 
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cultured endothelial cells was found to be more electronegative and had 
enhanced uptake by incubated macrophages (Henriksen et al., 1981) .. In 
addition, in vivo administration of the modified LDL particles resulted 
in an increased uptake into liver endothelial cells as opposed to the 
unmodified LDL which was taken up by liver parenchymal cells (Nagelkerke 
et al., 1984). Therefore, it has been demonstrated that increased elec-
tronegativity of LDL can occur in vivo as well as in vitro and that a 
pathway for the clearance of this more electronegative LDL exists. 
Moreover, the macrophage scavenger pathway, responsible for the clear-
ance of LDL with increased electronegativity has been implicated as a 
factor leading to atherosclerotic lesions (Goldstein et al., 1979). 
The mechanism for the increased mobility of LDL is not known 
though several possibilities may be explored. Heparin, an endogenously 
produced substance has been shown to increase the electrophoretic mobil-
ity of lipoproteins possibly by its activation of lipoprotein lipase 
(Houtsmuller, 1966) or by complexing with the LDL molecule as dextran 
sulfate complexes with LDL, thus increasing LDL's negative charge and 
its affinity for the macrophage receptor (Basu et al., 1979). The pos-
sibility exists that an enzyme may be involved which is heat labile and 
sensitive to sulfhydryl group inhibition. The enzyme could act in some 
way to degrade the LDL apolipoproteins~ which could reveal more electro-
negative groups. Another possibility could be that the enzyme degrades 
the lipid content of LDL or transfers it to another lipoprotein, causing 
a conformational change which could reveal electronegative groups on the 
LDL molecule. One other possibility is the transfer of apolipoproteins 
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from other lipoproteins to the LDL molecule which could increase its 
electronegativity. These possibilities all remain to be explored in the 
future. 
V. RAT PLASMA LIPOPROTEIN-CHOLESTEROL MOVEMENT 
Esterified cholesterol transfer between HDL and VLDL particles 
isolated by ultracentrifugal techniques has been found to occur during 
the in vitro incubation of plasma of rabbits, humans and other animal 
species (Barter et al., 1978; 1979; Ha et al., 1982; Nichols et al., 
1965; Zilversmit et al., 1975). However, esterified cholesterol trans-
fer between plasma HDL and VLDL in rats has either not been observed 
(Oschry et al., 1982) or has been reported to occur at such a low rate 
as to be physiologically insignificant (Barter et al., 1978). The pres-
ent studies suggest that movement of cholesteryl ester does occur from 
a 1L to PAL, two high density lipoprotein fractions of rat plasma sepa-
rated by cellulose acetate electrophoresis. In contrast, the present 
data also suggest that when rat plasma LCAT was inhibited, lipoprotein-
cholesteryl ester transfer activity may still be present, but EC move-
ment was found to occur from PAL to a 1L rather than from a high density 
lipoprotein to the very low density lipoproteins as found in other spe-
cies (Ha et al., 1982). The observed cholesteryl ester movement from 
a 1L to PAL appears to be the physiologically significant process since 
movement of EC in the opposite direction could only be demonstrated when 
LCAT was inhibited. The presence in rat plasma of an inhibitor to cho-
lesteryl ester transfer as has been previously reported (Morton et al., 
1981) would indicate that the significant movement of cholesteryl ester 
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from a 1L to PAL as presently reported was most probably due to LCAT 
activity and not to lipoprotein-cholesteryl ester transfer. 
Figure 25 shows our proposed in vivo mechanism for cholesterol 
clearance by circulating plasma lipoproteins in the adult male rat based 
on current knowledge of rat lipoprotein metabolism and from the present 
data obtained from in vitro incubation studies of rat plasma coupled 
with 17 a-ethinyl estradiol-induced rat hypocholesterolemia. It would 
appear that a 1L is the preferred substrated for LCAT activity in rat 
plasma similar to HDL3 being the preferred substrate for LCAT in humans 
(Fielding et al., 1971; 1972a; Jahani et al., 1981). The catabolic con-
version of a 2L (VLDL) to 6L (LDL) by the action of lipoprotein lipase 
(Eisenberg et al., 1973a) occurs only in vivo since the enzyme is bound 
to the endothelial walls of the vasculature (Eisenberg et al., 1982) and 
generally released by highly anionic compounds like heparin (Krauss et 
al., 1973) and would therefore not be a factor in the present in vitro 
assay. 
It has been reported that the uptake of cellular UC by HDL is 
determined by the rate of desorption of cholesterol out of the cell mem-
brane into the aqueous phase surrounding the cell as well as the dis-
tance of diffusion to HDL (Phillips et al., 1980). The rate of choles-
terol efflux from ·cells may also be modulated by apolipoprotein A-I 
(Fielding et al., 1981b). The transfer of UC to HDL is probably due to 
--
LCAT activity creating an unsaturated HDL particle with respect to UC, 
allowing more UC to accumulate on the HDL particle (Perret et al., 
1983). The exchange of UC between lipoproteins occurs constantly 
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(Roheim et al., 1963), but seems to be temperature dependent, since at 4 
0 c no exchange of UC occurs between lipoproteins (Perret et al., 1983). 
Net transfer of UC between plasma lipoproteins has been reported not to 
occur when LCAT is inhibited (Perret et al., 1983; Fielding et al., 
198la; 1981b), however, a net transfer of UC between eL and a 1L was 
observed during the presently reported in vitro incubation of rat 
plasma. A possible explanation for this net transfer of UC between rat 
eL and a 1L may involve a 1L being relatively unsaturated with respect to 
UC due to LCAT activity, with net transfer of UC from eL to a 1L occur-
ring in order to achieve equilibrium. Moreover, the UC transfer from eL 
to a 1 L observed in LCAT inhibited plasma incubated for 4 hours may 
reflect the same process indicating that esterification of UC by LCAT 
occurs at a faster rate than UC can be transferred to a 1L to achieve 
relative saturation, which would explain the 2-4 hours needed for equil-
brium to be achieved between the UC concentrations of incubated rat 
plasma lipoproteins as has been reported previously (Perret et al. , 
1983; Roheim et al., 1963). 
VI. RAT PLASMA LIPOPROTEIN-CHOLESTEROL CLEARANCE 
17 a-Ethinyl estradiol has been reported to induce the production 
of hepatic lipoprotein receptors that are specific for apolipoprotein B 
(apo B) and apolipoprotein E (apo E) containing lipoproteins (Windler et 
al., 1980b), suggesting that PAL because of its rapid clearance from the 
plasma in 17 a-ethinyl estradiol-treated rats may therefore contain 
either of these two apolipoproteins. However, since PAL is a high den-
sity lipoprotein, it is more probable that PAL contains apo E rather 
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than apo B (Quarfordt et al., 1978). The fact that apo E-containing 
lipoproteins have been found to migrate to the a2-globulin region using 
paper electrophoresis (Mahley et al., 1977a; Weisgraber et al., 1977) 
together with the finding that PAL migrates much further when electro-
phoresed on cellulose acetate, suggests that PAL may contain other apo-
lipoproteins besides apo E which enhance its electrophoretic mobility. 
Apolipoprotein analysis of the cellulose acetate electrophoretically-
separated rat plasma lipoproteins are currently being undertaken in this 
laboratory to determine which apolipoproteins are associated with PAL 
and a 1L in order to establish whether PAL and a 1L are similar to the 
ultracentrifugally-separated less dense HDL1 and more dense HDL2 sub-
fractions of rat plasma. The conflicting reports of rat plasma choles-
teryl ester transfer between HDL1 and HDL2 (Eisenberg et al., 1984; Jan-
sen et al., 1983) or between HDL and VLDL (Barter et al., 1978) may be 
due to the apo E content of the lipoproteins since the apo E content has 
been found to be greatly affected by ultracentrifugal isolation of lipo-
proteins (Fainaru et al., 1977; Kunitake et al., 1982). 
The present data suggest that the clearance of rat plasma choles-
terol appears to be through an HDL pathway in which a 1L is catabolized 
to PAL in the plasma, with the catabolism of a 1L being apparently 
related to LCAT activity. PAL may then be removed from the plasma by 
hepatic lipoprotein receptors, which can be induced by 17 a-ethinyl 
estradiol (Windler et al., 1980). This is in marked contrast to the 
human in which cholesterol accumulates in LDL, as a result of choles-
teryl ester transfer from HDL to VLDL (Barter et al., 1979b) with subse-
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quent metabolism of VLDL to LDL (Eisenberg et al., 1973a). LDL is then 
cleared from human plasma by LDL receptors (Brown et al., 1981). Since 
HDL has been negatively correlated to the risk of developing atheroscle-
rosis in humans (Miller et al., 1975), it is possible that the rat's 
relative resistance to dietary-induced atherosclerotic lesions (Fillies 
et al., 1956; Mahley et al., 1977a; Wissler et al., 1954) may be due to 
a major role that the HDL subfractions, a 1L and PAL, may play in clear-
ing cholesterol from rat plasma. 
CHAPTER VI 
SUMMARY 
The plasma lipoprotein-cholesterol profile of the adult male rat 
was investigated using cellulose acetate electrophoresis combined with 
an enzymatic stain for total cholesterol and an enzymatic stain for 
unesterified cholesterol developed for these studies. A comparison of 
the electrophoretically determined serum lipoprotein-cholesterol profile 
of the adult male rat with mouse, rabbit, dog, monkey and human serum 
was performed. Four cholesterol-staining lipoprotein bands were 
detected in rat serum, while only three bands were present in the other 
species studied. The apparently unique lipoprotein-cholesterol band in 
the rat was found to electrophoretically migrate faster than rat albumin 
with prealbumin mobility and has been named prealbumin lipoprotein-cho-
lesterol (PAL-C). PAL-C of the rat, accounting for 25.4% of the total 
serum cholesterol of the adult male rat, was shown to be an HDL fraction 
employing ultracentrifugation as well as a polyanion precipitation tech-
nique. Therefore, HDL of rat plasma is composed of both a prealbumin 
and an a 1 lipoprotein fraction as can be determined by cellulose acetate 
electrophoresis. 
It was found using cellulose acetate electrophoresis and staining 
for both total and unesterified cholesterol that following a four hour 
37 °C in vitro incubation of rat plasma, the total cholesterol concen-
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trations of both PAL and a 1 L change due to a decrease in the 
unesterified cholesterol concentration of a 1 L with a concomitant 
increase in the esterif ied cholesterol concentration of PAL. In the 
presence of PCMPS, a lecithin: cholesterol acyl transferase inhibitor, 
incubated rat plasma demonstrated a decrease in PAL-total cholesterol 
with a concomitant increase in a 1L-total cholesterol. In addition, a 
net transfer of unesterified cholesterol occurred from ~L to a 1L, both 
in the presence and absence of PCMPS. Hypocholesterolemia induced by 
the in vivo administration of 17 a-ethinyl estradiol to rats resulted in 
the disappearance of both PAL and ~L-total cholesterol from plasma. 
However, PAL-total cholesterol reappeared in rat plasma during an in 
vitro 4 hour incubation at 37 °C while a 1L-total cholesterol decreased. 
The present data suggest that both PAL-cholesterol and ~L-cholesterol 
are cleared from rat plasma by hepatic lipoprotein receptors induced by 
17 a-ethinyl estradiol and that PAL of the rat may be a product of 
plasma a 1L catabolism. 
CHAPTER VII 
FIGURES 
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Figure 2a. p-Chlorornercuriphenylsulfonic Acid 
2b. p-Chlorornercuriphenylsulfonate Sodium Salt (PCMPS) 
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Figure 3. A comparison between the lipoprotein-cholesterol profile and 
the protein profile of rat serum as separated by cellulose acetate elec-
trophoresis. Following electrophoresis of duplicate 2 microliter ali-
quots of serum on different halves of the cellulose acetate plate, the 
plate was cut into two equal parts. One part was enzymatically stained 
for total cholesterol and the second part stained for protein with Pon-
ceau S. (PAL-C is prealbumin lipoprotein-cholesterol; a 1L-C is alpha1 
lipoprotein-cholesterol; a2L-C is alpha2 lipoprotein-cholesterol; 61-C 
is beta lipoprotein-cholesterol; PA is prealbumin; A is albumin; a 1 is 
alphal globulin; a2 is alpha2 globulin; el is beta! globulin; e2 is 
beta2 globulin; l is gamma globulin.) 
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Figure 4. A comparison between the lipoprotein-cholesterol profile and 
the lipoprotein profile of rat serum as separated by cellulose acetate 
electrophoresis. Following electrophoresis of duplicate 2 microliter 
aliquots of serum on different halves of the cellulose acetate plate, 
the plate was cut into two equal parts. One part was enzymatically 
stained for total cholesterol and the second part stained for "total" 
lipids with oil red 0. (PAL-C is prealbumin lipoprotein-cholesterol; 
HDL-C is high density lipoprotein-cholesterol; VLDL-C is very low den-
sity lipoprotein-cholesterol; LDL-C is low density lipoprotein-choles-
terol; PAL is prealbumin lipoprotein; a 1L is alpha1 lipoprotein; pre-6L 
is prebeta lipoprotein; 61 is beta lipoprotein.) 
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Figure 5. Improved resolution of PAL-C from a 1L-C by soaking cellulose 
acetate plate overnight. Two microliter aliquots of adult rat plasma 
were applied to two cellulose acetate plates, one of which had been 
presoaked overnight in tris-barbital buffer; the other being presoaked 
for 1 hour in tris-barbital buffer. Both plates were then electro-
phoresed in the same chamber simultaneously. (PAL-C is prealbumin lipo-
protein-cholesterol; a 1L-C is alpha1 lipoprotein-cholesterol; a 2L-C is 
alpha2 lipoprotein-cholesterol; ~L-C is beta lipoprotein-cholesterol.) 
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Figure 6. Comparison of the serum lipoprotein-cholesterol profiles of 
the normal adult male rat, mouse, rabbit, dog, monkey and human, deter-
mined by cellulose acetate electrophoresis combined with an enzymatic 
cholesterol stain. (PAL-C is prealbumin lipoprotein-cholesterol; a1L-C 
is alpha1 lipoprotein-cholesterol; a2L-C is alpha2 lipoprotein-choles-
terol; BL-C is beta lipoprotein-cholesterol; PA is prealbumin; A is 
albumin; a 1 is alpha1 globulin; a2 is alpha2 globulin; B1 is beta1 glob-
ulin; B2 is beta2 globulin; f is gamma globulin.) 
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Figure 7. Cellulose acetate electrophoresis of the high density frac-
tion (1.063-1.210 g/ml) of adult male rat serum obtained by ultracentri-
fugation. A sample of the corresponding whole serum was stored at -20 
°C during the time required to isolate the high density fraction and 
was subsequently electrophoresed on the same plate. (PAL-C is prealbu-
min lipoprotein-cholesterol; a1L-C is alpha1 lipoprotein-cholesterol; 
a2L-C is alpha2 lipoprotein-cholesterol; at-C is beta lipoprotein-cho-
lesterol.) 
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Figure 8. Cellulose acetate electrophoresis of the high density fraction 
(greater than 1.063 g/ml) of adult male rat serum obtained by ultracen-
trifugation. A sample of the corresponding whole serum was stored at 
-20 °C during the time required to isolate the high density fraction, 
and was subsequently electrophoresed on the same plate. (PAL-C is pre-
albumin lipoprotein-cholesterol; a 1L-C is alpha1 lipoprotein-choles-
terol; a2L-C is alpha2 lipoprotein-cholesterol; aL-C is beta lipopro-
tein-cholesterol.) 
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Figure 9. Cellulose acetate electrophoresis of the dialyzed supernate 
obtained after manganese heparin precipitation of adult male rat serum. 
A sample of the corresponding whole serum was stored at -20 °C during 
the time it took to dialyze the manganese heparin supernate against 0.15 
M sodium chloride solution containing 0.05% EDTA at 4 °C, and was subse-
quently electrophoresed on the same plate. (PAL-C is prealbumin lipo-
protein-cholesterol; a 1L-C is alpha1 lipoprotein-cholesterol; a2L-C is 
alpha2 lipoprotein-cholesterol; ~L-C is beta lipoprotein-cholesterol.) 
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Figure 10. Cellulose acetate electrophoresis of the supernate obtained 
after dextran sulfate precipitation of adult male rat serum. A sample 
of the corresponding whole serum was stored at -20 °C during the time 
required to isolate the high density fraction and was subsequently elec-
trophoresed on the same plate. (PAL-C is prealbumin lipoprotein-choles-
terol; a 1L-C is alpha1 lipoprotein-cholesterol; a 2L-C is alpha2 lipopro-
tein-cholesterol; ~L-C is beta lipoprotein-cholesterol.) 
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Figure 11. Correlation of rat plasma high density lipoprotein-choles-
terol levels determined by cellulose acetate electrophoresis versus man-
ganese heparin precipitation method. The line was drawn with a slope of 
1.02 obtained by linear regression analysis; y-intercept=9.30. (PAL-C 
is prealbumin lipoprotein-cholesterol; a1L-C is alpha1 lipoprotein-cho-
lesterol.) 
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Figure 12. Correlation of rat plasma high density lipoprotein-choles-
terol levels determined by cellulose acetate electrophoresis versus dex-
tran sulfate precipitation method. The line was drawn with a slope of 
1.08 obtained by linear regression analysis; y-intercept=15.65. (PAL-C 
is prealbumin lipoprotein-cholesterol; a1L-C is alpha1 lipoprotein-cho-
lesterol.) 
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Figure 13. Correlation of rat plasma high density lipoprotein-choles-
terol levels determined by dextran sulfate precipitation versus manga-
nese heparin precipitation method. The line was drawn with a slope of 
0.95 obtained by linear regression analysis; y-intercept=-5.7. 
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Figure 14. Comparison of rat plasma high density lipoprotein-cholesterol 
(HDL-C) levels determined by cellulose acetate electrophoresis, manga-
nese heparin precipitation and dextran sulfate precipitation. Statisti-
cal analysis was performed using one way analysis of variance followed 
by Duncan's new multiple range test. (PAL-C is prealbumin lipoprotein-
cholesterol; a1L-C is alpha1 lipoprotein-cholesterol.) 
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Figure 15. Kinetic changes in adult male rat plasma lipoprotein-total 
cholesterol fractions separated by cellulose acetate electrophoresis 
during a 4 hour in vitro incubation of plasma at 37 °C. (PAL-C is pre-
albumin lipoprotein-cholesterol; a 1L-C is alpha1 lipoprotein-choles-
terol; a2L-C is alpha2 Jipoprotein-cholesterol; eL-C is beta lipopro-
tein-cholesterol.) 
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Figure 16. Comparisons of rat plasma lipoprotein-cholesterol profiles 
after a 1 hour and 4 hour in vitro incubation at 37 °c. (PAL-C is pre-
albumin lipoprotein-cholesterol; a1L-C is alpha1 lipoprotein-choles-
terol; a2L-C is alpha2 lipoprotein-cholesterol; eL-C is beta lipopro-
tein-cholesterol.) 
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Figure 17. Changes in lipoprotein-cholesterol fractions separated by 
cellulose acetate electrophoresis following a 4 hour 37 °C in vitro 
---
incubation of adult male rat plasma. Statistical analysis between the 
initial lipoprotein-cholesterol concentrations and those after four 
hours of incubation was performed using a paired Student's t-test. (PAL 
is prealbumin lipoprotein; a 1L is alpha1 lipoprotein; a2L is alpha2 
lipoprotein; ~L is beta lipoprotein.) 
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Figure 18. Changes in lipoprotein·cholesterol fractions separated by 
cellulose acetate electrophoresis following a 4 hour 37 °C in vitro 
~ ~~
incubation of adult male rat plasma in the presence of an LCAT inhibitor 
(2.0 mM PCMPS). Statistical analysis between the initial lipoprotein-
cholesterol concentrations and those after four hours of incubation was 
performed using a paired Student's t-test. (PAL is prealbumin lipopro-
tein; a 1L is alpha1 lipoprotein; a2L is alpha2 lipoprotein; et is beta 
lipoprotein.) 
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Figure 19. Changes in esterified to unesterified cholesterol ratios of 
lipoprotein fractions separated by cellulose acetate electrophoresis 
following a 4 hour 37 °c in vitro incubation of adult male rat plasma. 
~ ~~-
Statistical analysis between the initial lipoprotein-esterified choles-
terol to unesterified cholesterol ratios and those after four hours of 
incubation was performed using a paired Student's t-test. (PAL is pre-
albumin lipoprotein; a 1L is alpha1 lipoprotein; a 2L is alpha2 lipopro-
tein; a1 is beta lipoprotein.) 
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Figure 20. Changes in esterified to unesterified cholesterol ratios of 
lipoprotein fractions separated by cellulose acetate electrophoresis 
following a 4 hour 37 °C in vitro incubation of adult male rat plasma in 
the presence of an LCAT inhibitor (2.0 mM PCMPS). Statistical analysis 
between the initial lipoprotein-esterified cholesterol to unesterified 
cholesterol ratios and those after four hours of incubation was per-
formed using a paired Student's t-test. (PAL is prealbumin lipoprotein; 
a 1L is alpha1 lipoprotein; a 2L is alpha2 lipoprotein; ~L is beta lipo-
protein.) 
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CHANGES IN ESTERIFIED TO UNESTERIFIED CHOLESTEROL RATIOS OF LIPOPROTEIN FRACTIONS 
SEPARATED BY CELLULOSE ACETATE ELECTROPHORESIS FOLLOWING A 4 HOUR 37 •c 
IN VITRO INCUBATION OF ADULT MALE RAT PLASMA CONTAINING 2.0 mM PCMPS 
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Figure 21. Effect of 17 a-ethinyl estradiol on total cholesterol con-
centration of adult male rat plasma. Rats were administered daily doses 
of 17 a-ethinyl estradiol subcutaneously for 4 days and sacrificed on 
day 5. All plasma total cholesterol concentrations of rats given 17 
a-ethinyl estradiol were statistically significantly lower than the con-
trol animals. The control value represents the mean plas~a total cho-
lesterol concentration of 5 rats. The 0.05 mg/kg dose of 17 a-ethinyl 
estradiol represents the mean plasma total cholesterol concentration of 
2 rats. All other points represent the mean plasma total cholesterol 
concentration of 4 rats. Statistical analysis was performed using one 
way analysis of variance followed by Duncan's new multiple range test. 
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Figure 22. Effects of in vivo administration of 17 a-ethinyl estradiol 
on lipoprotein-total cholesterol concentration before and after a 4 
hour 37· °C in vitro incubation of adult male rat plasma. Rats were 
administered daily doses of 17 a-ethinyl estradiol subcutaneously for 4 
days and sacrificed on day 5. Statistical analysis was performed using 
one way analysis of variance followed by Duncan's new multiple range 
test. (PAL is prealbumin lipoprotein; a 1L is alpha1 lipoprotein; a2L is 
alpha2 lipoprotein; 6L is beta lipoprotein.) 
EFFECTS OF ETHINYL ESTRADIOL ON LIPOPROTEIN·TOTAL CHOLESTEROL CONCENTRATION 
BEFORE AND AFTER A 4 HOUR 37 •c IN VITRO INCUBATION OF ADULT MALE RAT PLASMA 
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Figure 23. Proposed intravascular lipoprotein catabolic transformation 
of adult male rat alpha1 lipoprotein following a 4 hour 37 °C in vitro 
incubation of plasma. Statistical analysis between the initial lipopro-
tein-cholesterol concentrations and those after four hours of incubation 
was performed using a paired Student's t-test. (PAL is prealbumin lipo-
protein; a 1L is alpha1 lipoprotein; a 2L is alpha2 lipoprotein; at is 
beta lipoprotein.) 
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PROPOSED INTRAVASCULAR LIPOPROTEIN CATABOLIC TRANSFORMATION OF ADULT MALE 
RAT ALPHA1 LIPOPROTEIN FOLLOWING A 4 HOUR 37 •c IN VITRO INCUBATION OF PLASMA 
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Figure 24. Inhibition of intravascular lipoprotein catabolic transforma-
tion of adult male rat alpha1 lipoprotein following a 4 hour 37 °C in 
vitro incubation of plasma containing an LCAT inhibitor (2.0 mM PCMPS). 
Statistical analysis between the initial lipoprotein-cholesterol concen-
trations and those after four hours of incubation was performed using a 
paired Student's t·test. (PAL is prealbumin lipoprotein; a 1L is alpha1 
lipoprotein; a2L is alpha2 lipoprotein; aL is beta lipoprotein.) 
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INHIBITION OF INTRAVASCULAR LIPOPROTEIN CATABOLIC TRANSFORMATION OF ADULT MALE RAT 
ALPHA1 LIPOPROTEIN FOLLOWING A 4 HOUR 37 •c IN VITRO INCUBATION OF PLASMA CONTAINING 
2.0 mM PCMPS 
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Figure 25. Proposed in vivo mechanism for cholesterol clearance by cir-
culating plasma lipoproteins in the adult male rat. (PAL is prealbumin 
lipoprotein; a1L is alpha1 lipoprotein; a2L is alpha2 lipoprotein; BL is 
beta lipoprotein.) 
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{·0 Br"own !!_ tl·, Science fil.:6:8-635, 1981. 
Figure 25 
UC trawer 
181 
CHAPTER VII I 
TABLES 
TABLE 1 
DISTRIBUTION AND COMPOSITION OF LIPOPROTEINS IN VARIOUS MAMMALS* 
Serum Density <I.019 gm/ml Density 1.019-1.063 gm/ml Density >1.0li~ 
TC PL TC TC PL Protein TC TC PL Protein TC TC PL TC 
Species l'[ l'[ l'[ l'[ 
(mg/IOD ml) (mg/100 ml) fmg/100 mll (mq/100 ml) 
ean va ues 
young adult 179 226 0.79 23 28 17 0.82 103 74 60 1.39 4CI 123 n.40 
human> 
Rabbit 41 93 0.44 15 IR 14 0.83 9 11 12 O,R3 17 fiQ n.2s 
Rat 50 114 0.44 6 17 12 0.35 IO 13 17 0. 77 31 711 n.4n 
Pig 106 161 0.66 8 12 10 0.67 51 37 3fi 1.4 41 102 0.40 
Hamster 121 269 0.45 25 44 21 0.57 29 34 22 0.85 61 176 0.35 
Dog 150 362 0.41 2 10 9 0.20 10 lg 17 0.53 127 325 n.~Q 
Monkey 173 295 0.59 17 20 13 0.85 64 64 52 1.0 RO 206 0.39 
*From Havel ~~-· 1955. Abbreviations: TC : total cholesterol, PL: phospholipid 
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TABLE 2 
DISTRIBUTION AND COMPOSITION OF HUMAN AND RAT SERUM LIPOPROTEINS SEPARATED BY SEQUENTIAL ULTRACENTRIFUGATION* 
Species Density Cholesterol Unesterified Total Triglyceride Phospholipid Protein 
( g/ml) Ester Cholesterol Cholesterol 
(Mean percent of lipoprotein weight) 
Human Chylomicrons 6.0 3.1 g_ 1 81.3 7.0 2.5 
Rat <1.006 (VLDL) 4.2 8.9 13.l 61.l 12.0 13.8 
Human <1. 019 16.2 6.0 18.2 51.8 17.q 7.1 
(VLDL & IDL) 
Rat 1. 006-1. 019 12.5 18.l 30.6 41.1 12.0 16.3 
(IDL) 
Human l.Olg-I.063 39.4 7.5 46.9 9.3 23.1 20.7 
(LDL) 
Rat 1. 019-1. 063 15.0 1g.1 34.1 12.2 n.2 21i.5 
(LDL) 
Human 1.063-1.210 17.4 2.0 19.4 8. l ?6.1 41;.4 
(HDL) 
Rat 1.063-1.210 15.0 14.8 29.8 2.8 21i.O 41.4 
(HDL) 
*Human data from Bragdon!!_~., 1956 and Rat data from Pasqua 1 i-Ronchetti !!_ ~·, 1975. 
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TABLE 3 
SERUM LIPOPROTEIN-CHOLESTEROL VALUES OF ~MAL, NONFASTING ANIMALS 
Total PAL-C a1L-C ca 2L-C Bl.-C LDL-C* TOTAL-C* 
n Cholesterol mg/dl 111g/dl mq/dl 1119/dl llM::r Rol-t 
111g/dl 
(Mean t SD) 
(Mean t SD) (Mean t SD) (Mean t SD) (Mean t SD) 
Adult Male 15 59 t 11 15 t 4 33 t 7 3 t 1 8 t 2 0.17 1.23 
Rat Ser111 
Adult Male 6 127 t 20 0 109 t 15 7 t 3 11 t s 0.10 1.16 
Mouse Ser111 
Adult Male 
Rabbit 10 34 t 8 0 20 t 6 J t 2 11 t J o.ss 1.70 
Ser111 
Adult Male 3 139 t 15 0 116 t 11 12 t 2 11 t 3 0.09 t.20 
Dog Ser111 
Adult Male 
Monkey 3 147 t 25 0 R9 t 30 12 t s 46 t 5 O.'SZ 1.65 
Ser1111 
Adult Male 
H1111an 13 183 t 47 0 44 t 9 12 t fi 127 t 4fi 3.05 4.33 
Ser111 
(21-39 yrs) 
• To calculate the c0111Parat1ve ratios (2), LDL-C 1s ass1111ed to be equivalent to BL-C and HDL-C ts assUllM!lf to be 
equivalent to PAL-C + a1L-C. 
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TABLE 4 
CHANGES IN ELECTROPHORETIC MOBILITY OF ADULT MALE RAT PLASMA LIPOPROTEIN FRACTIONS FOLLOWING A FOUR HOUR 37 °c 
IN VITRO INCUBATION AND COMPARED TO RAT PLASMA INCUBATED WITH AN LCAT INHIBITOR (2.0 mM PCMPS)a. 
PAL 
Distance from Sample Application (millimeters) 
Electrophoretic Mobility 27.0 ± 0.4 21.2 ± 0.2 
Rat Plasma t 0 
Electorphoretic Mobility 27.1 ± 0.8 21.5 ± 0.4 
Rat Plasma t4 
% Change in Electrophoretic 
Mobility t4 Compared to 0.4% 1.4% 
Rat Plasma t 0 
Electrophoretic Mobility 
Rat Plasma t 0 with 27.0 ± 0.3 21.3 ± 0.1 2.0 mM PCMPS 
Electrophoretic Mobility 
Rat Plasma t 4 with 26.4 ± 0.3 21.0±0.3 2.0 mM PCMPS 
% Change in Electrophoretic 
Mobility t 4 compared to -2.2% -1.4% 
Rat Plasma to with 
2.0 mM PCMPS 
a Results are expressed as the mean± S.E.M. of 9 animals 
b Significantly different from Rat Plasma t 0 value p < 0.05 c Significantly different from Rat Plasma t 4 value p < 0.05 
16.0 ± 0.2 
17.9 ± o.5b 
11.9% 
16.2 ± o.2c 
16.0 ± o.2c 
-1.3% 
SL 
12.8 ± 0.1 
16.1 ± 0.4b 
25.8% 
13.2 ± o.2c 
13.9 ± 0.3b,c 
5.3% 
, 
APPENDIX A 
r 
PAL-C 
a1L-C 
~L-C 
f!L-C 
RAT SERUM STORAGE AND THE LIPOPROTEIN-CHOLESTEROL PROFILE 
TABLE 5 
STORAGE EFFECTS ON THE LIPOPROTEIN-CHOLF.STEROL CONCENTRATION OF RAT SERUM 
FRESH SERUM STORED SERUM STORED SERUM STORED SF.RUM STORED 
SERUM 4 °c, 4 HOURS -20 °c, 4 HOURS 4 °c, 24 HOURS -20 °c, 24 HOURS 
9.2 :!: 2.2 12.1 :!: 3.1 11.1 :!: 2.9 12.7 :!: 3.8 12.0 :!: 3.9 
21.s :1: 2.1 18.S :!: 2.3 19.4 :!: 2.3 19.4 :!: 2.3 21.0 :!: 2.2 
4.1 :!: 0.4 4.6 :!: o.s 4.0 :!: 0.3 4.0 :!: 0.8 3.1 :!: 0.4 
10.8 :!: 1.2 10.3 :!: 0.9 11.0 :!: 1.3 9.4 :!: 0.9 9.3 :!: o.s 
Values represent the mean cholesterol concentration in mg/dl :!: S.E.M. 
of 4 animals fasted overnight 
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Aliquots of rat serum were analyzed for lipoprotein-cholesterol content 
by cellulose acetate electrophoresis combined with an enzymatic stain 
for total cholesterol immediately after serum collection, after 4 hours 
at 4 °C, after 4 hours at -20 °C, after 24 hours at 4 °C or after 24 
hours at -20 °C. Results are shown in table 5 above. None of the lipo-
protein fractions was found to be statistically different under any of 
the five conditions as determined by analysis of variance. Therefore, 
the effects of serum storage on the observed phenomena as reported in 
this dissertation are minor and would not necessarily affect the conclu-
sions drawn from these studies. 
APPENDIX B 
PAL-C 
a 1L-C 
a 2L-C 
BL-C 
RAT PLASMA LIPOPROTEIN-CHOLESTEROL PROFILE AND THIMEROSAL 
TABLE 6 
EFFECTS OF A BACTERIOSTATIC AGENT ON THE LIPOPROTEIN-CHOLESTEROL CONCENTRATION 
OF ADULT MALE RAT PLASMA AS DETERMINED BY CELLULOSE ACETATE ELECTROPHORESIS 
BEFORE AND AFTER A FOUR HOUR 37 °c INCUBATION 
RELATIVE % LIPOPROTEIN-CHOLESTEROL RELATIVE % LIPOPROTEIN CHOLES'!"F:ROL 
PRIOR TO INCUBATION AFTER A 4 HOUR INCUBATION AT 37 °c 
CONTROL PLASMA CONTAINING CONTROL PLASMA CONTAINING 
PLASMA 0.015% THIMEROSAL PLASMA 0.015% THIMF.ROSAL 
29.0 :i- 3.~ 29.6 :i- 4.3 69.1 ± 3.6a 76.1 ± 3.7a 
47.2 :i- 1.7 45.fl :i- 3.1 19.5 ± 2.5a 11.5 :i- 2.ha 
5.6 :i- 0.5 5.4 :i- 0.9 2.1 :i- o.2a 2.0 :i- o.1a 
18.2 :i- 1.6 19.2 :i- 1.6 9.3 ± l.4a 8.4 :i- l.Sa 
Values represent the mean :i- S.E.M. of 4 animals fasted overnight. 
a Significantly different vs. non-incubated plasma using Duncan's new multiple 
range test (p < 0.05) 
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A bacteriostatic agent, thimerosal, was added to plasma samples at a 
final concentration of 0.015%. No significant differences were observed 
between non-incubated plasma with and without thimerosal or between 
plasma incubated at 37 °C for 4 hours with and without thimerosal. 
Apparent movement of cholesterol from a 1L to PAL was observed in plasma 
incubated for 4 hours at 37 °C whether thimerosal was present or not as 
indicated by table 6 above. In addition, a similar transfer of choles-
terol from a 1L to PAL was observed under sterile techniques. This indi-
cates that the movement of cholesterol from a 1L-C to PAL-C was not due 
to bacterial contamination. 
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